Sentence,class,file
"Post-voiding urine volume and nephropathy www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.1.82bladder capacity, decreased detrusor contractility, and  increased post-voiding residual (PVR) urine [1,6,7].",Non-OADS,/arxiv_data1/oa_pdf/7b/5e/kjim-30-82.PMC4293568.pdf
"1, January 2015 http://dx.doi.org/10.3904/kjim.2015.30.1.82patient age was 60 ± 1 years.",OADS,/arxiv_data1/oa_pdf/7b/5e/kjim-30-82.PMC4293568.pdf
"Post-voiding urine volume and nephropathy www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.1.82tomatic phase, appropriate preventive and therapeutic  approaches could be taken.",Non-OADS,/arxiv_data1/oa_pdf/7b/5e/kjim-30-82.PMC4293568.pdf
"1, January 2015 http://dx.doi.org/10.3904/kjim.2015.30.1.82 assess any potential associations.",Non-OADS,/arxiv_data1/oa_pdf/7b/5e/kjim-30-82.PMC4293568.pdf
Post-voiding urine volume and nephropathy www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.1.82Res Clin Pract 2007;78:42-50.,Non-OADS,/arxiv_data1/oa_pdf/7b/5e/kjim-30-82.PMC4293568.pdf
"ORIGINAL ARTICLE Copyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:88-95 http://dx.doi.org/10.3904/kjim.2015.30.1.88 INTRODUCTION There is increasing evidence that pain control is related to not only the quality of life (QOL) but also the survival  of cancer patients [1].",Non-OADS,/arxiv_data1/oa_pdf/0d/ea/kjim-30-88.PMC4293569.pdf
"Low-dose transdermal fentanyl in opioid-naïve cancer pain www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.1.88World Health Organization (WHO) three-step treat - ment, from nonopioids, to weak and then strong opi - oids, has been considered the proper approach to cancer  pain since its introduction [2].",Non-OADS,/arxiv_data1/oa_pdf/0d/ea/kjim-30-88.PMC4293569.pdf
"1, January 2015 http://dx.doi.org/10.3904/kjim.2015.30.1.88[18].",Non-OADS,/arxiv_data1/oa_pdf/0d/ea/kjim-30-88.PMC4293569.pdf
Low-dose transdermal fentanyl in opioid-naïve cancer pain www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.1.88Patient and investigator satisfaction with treatment Questionnaires for satisfaction were obtained from pa - tients and investigators at the follow-up visit.,Non-OADS,/arxiv_data1/oa_pdf/0d/ea/kjim-30-88.PMC4293569.pdf
"1, January 2015 http://dx.doi.org/10.3904/kjim.2015.30.1.88Although strong opioids are recommended as the  first-line medication in patients with moderate-to-se - vere cancer pain, there is no consensus regarding the  appropriate starting doses in opioid-naïve patients.",Non-OADS,/arxiv_data1/oa_pdf/0d/ea/kjim-30-88.PMC4293569.pdf
"Low-dose transdermal fentanyl in opioid-naïve cancer pain www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.1.88patches in opioid-naïve patients reported dropout rates  of 4% to 10% due to AE [28,29].",Non-OADS,/arxiv_data1/oa_pdf/0d/ea/kjim-30-88.PMC4293569.pdf
"1, January 2015 http://dx.doi.org/10.3904/kjim.2015.30.1.88versus opioid rotation in patients with chronic cancer  pain.",Non-OADS,/arxiv_data1/oa_pdf/0d/ea/kjim-30-88.PMC4293569.pdf
Low-dose transdermal fentanyl in opioid-naïve cancer pain www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30.1.882010;26:2765-2768.,Non-OADS,/arxiv_data1/oa_pdf/0d/ea/kjim-30-88.PMC4293569.pdf
"ORIGINAL ARTICLECopyright © 2015 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med 2015;30:96-103 http://dx.doi.org/10.3904/kjim.2015.30 .1.96 INTRODUCTION In pediatric patients, respiratory viruses (RVs) are con - sidered important pathogens in acute respiratory tract  infections, resulting in hospitalization and acute care  visits [1-3] for which diagnostic evaluations for RVs are  frequently performed [4].",Non-OADS,/arxiv_data1/oa_pdf/14/60/kjim-30-96.PMC4293570.pdf
"Respiratory virus multiplex RT-PCR test www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30 .1.96with the emergence of severe acute respiratory syn - drome, avian influenza A (H5N1), and pandemic influ - enza H1N1 in 2009 [3].",Non-OADS,/arxiv_data1/oa_pdf/14/60/kjim-30-96.PMC4293570.pdf
"1, January 2015 http://dx.doi.org/10.3904/kjim.2015.30 .1.96PCR, according to the manufacturer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/14/60/kjim-30-96.PMC4293570.pdf
Respiratory virus multiplex RT-PCR test www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30 .1.96The list of detected RVs is presented in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/14/60/kjim-30-96.PMC4293570.pdf
"1, January 2015 http://dx.doi.org/10.3904/kjim.2015.30 .1.96tients coinfected with an RV and a bacterium, RSV and  hematologic malignancy were more common features  than in patients infected with a single RV.",Non-OADS,/arxiv_data1/oa_pdf/14/60/kjim-30-96.PMC4293570.pdf
Respiratory virus multiplex RT-PCR test www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30 .1.96were often reported late.,Non-OADS,/arxiv_data1/oa_pdf/14/60/kjim-30-96.PMC4293570.pdf
"1, January 2015 http://dx.doi.org/10.3904/kjim.2015.30 .1.96a bacterial/viral coinfection, RVs other than influenza,  including RSV, HMPV, and HRV, were detected.",OADS,/arxiv_data1/oa_pdf/14/60/kjim-30-96.PMC4293570.pdf
Respiratory virus multiplex RT-PCR test www.kjim.org http://dx.doi.org/10.3904/kjim.2015.30 .1.96ison of multiplex PCR assays and conventional tech - niques for the diagnostic of respiratory virus infections  in children admitted to hospital with an acute respiratory  illness.,Non-OADS,/arxiv_data1/oa_pdf/14/60/kjim-30-96.PMC4293570.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7780 | DOI: 10.1038/srep07780 8",Non-OADS,/arxiv_data1/oa_pdf/ea/b9/srep07780.PMC4293588.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7774 | DOI: 10.1038/srep07774 8",Non-OADS,/arxiv_data1/oa_pdf/40/d7/srep07774.PMC4293589.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ec/9f/srep07781.PMC4293590.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/36/38/srep07762.PMC4293591.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7762 | DOI: 10.1038/srep07762 10",Non-OADS,/arxiv_data1/oa_pdf/36/38/srep07762.PMC4293591.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1c/b5/srep07761.PMC4293592.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/05/fe/srep07784.PMC4293593.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7784 | DOI: 10.1038/srep07784 9",Non-OADS,/arxiv_data1/oa_pdf/05/fe/srep07784.PMC4293593.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/25/d8/srep07782.PMC4293594.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7782 | DOI: 10.1038/srep07782 7",Non-OADS,/arxiv_data1/oa_pdf/25/d8/srep07782.PMC4293594.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7767 | DOI: 10.1038/srep07767 9,Non-OADS,/arxiv_data1/oa_pdf/19/f8/srep07767.PMC4293597.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/be/08/srep07715.PMC4293599.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6b/92/srep07772.PMC4293600.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7772 | DOI: 10.1038/srep07772 13",Non-OADS,/arxiv_data1/oa_pdf/6b/92/srep07772.PMC4293600.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9b/c0/srep07787.PMC4293603.pdf
The molecular formulas and MS/MS fragment information obtained by TOF were further searchedin the database of METLIN (http://metlin.scripps.edu) for putative identification.,OADS,/arxiv_data1/oa_pdf/87/93/srep07785.PMC4293604.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/87/93/srep07785.PMC4293604.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7785 | DOI: 10.1038/srep07785 9",Non-OADS,/arxiv_data1/oa_pdf/87/93/srep07785.PMC4293604.pdf
"Gallagher, S. Boeing’s Dreamliner batteries ‘‘inherently unsafe’’—and yours may be too jArs Technica 19/1/2013, ,http://arstechnica.com/business/2013/01/boeings- dreamliner-batteries-inherently-unsafe-and-yours-may-be-too/ .",Non-OADS,/arxiv_data1/oa_pdf/c5/00/srep07788.PMC4293605.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7788 | DOI: 10.1038/srep07788 12",Non-OADS,/arxiv_data1/oa_pdf/c5/00/srep07788.PMC4293605.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7771 | DOI: 10.1038/srep07771 9",Non-OADS,/arxiv_data1/oa_pdf/81/e1/srep07771.PMC4293606.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7776 | DOI: 10.1038/srep07776 7",Non-OADS,/arxiv_data1/oa_pdf/f4/32/srep07776.PMC4293607.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/65/99/srep07766.PMC4293618.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/af/95/srep07789.PMC4293619.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7714 | DOI: 10.1038/srep07714 7",Non-OADS,/arxiv_data1/oa_pdf/04/8a/srep07714.PMC4293620.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors’ work resulted in a patent co-operation treaty; International Application No PCT/AU2014/000791, ‘‘ANALYSING INTRACELLULAR CALCIUM FLUX IN CELLS INCLUDING T CELLS’’, filed on the 8th of August 2014.",Non-OADS,/arxiv_data1/oa_pdf/c5/bb/srep07760.PMC4293621.pdf
"Disorders of the Nervous System Cerebellar Directed Optogenetic Intervention Inhibits Spontaneous Hippocampal Seizures in aMouse Model of Temporal Lobe Epilepsy 1,2 Esther Krook-Magnuson, Gergely G. Szabo,  Caren Armstrong, Mikko Oijala, and Ivan Soltesz DOI: http://dx.doi.org/10.1523/ENEURO.0005-14.2014 Department of Anatomy and Neurobiology, University of California, Irvine, Irvine, California 92697 Abstract Temporal lobe epilepsy is often medically refractory and new targets for intervention are needed.",Non-OADS,/arxiv_data1/oa_pdf/55/15/ENEURO.0005-14.2014.PMC4293636.pdf
DOI:http://dx.doi.org/10.1523/ENEURO.0005-14.2014 Copyright © 2014 Krook-Magnuson et al.,Non-OADS,/arxiv_data1/oa_pdf/55/15/ENEURO.0005-14.2014.PMC4293636.pdf
http://dx.doi.org/10.1016/j.jare.2014.05.006,OADS,/arxiv_data1/oa_pdf/8c/55/main.PMC4293666.pdf
J King Saud Univ Sci 2014. http://dx.doi.org/ 10.1016/j.jksus.2014.04.001 .,OADS,/arxiv_data1/oa_pdf/8c/55/main.PMC4293666.pdf
http://dx.doi.org/10.1016/j.jare.2013.12.007,OADS,/arxiv_data1/oa_pdf/f5/36/main.PMC4293667.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2015) 6,1 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2014.11.014 2090-1232 ª2014 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/51/c7/main.PMC4293668.pdf
http://dx.doi.org/10.1016/j.jare.2014.09.001,OADS,/arxiv_data1/oa_pdf/81/56/main.PMC4293669.pdf
http://dx.doi.org/10.1016/j.jare.2014.05.001,OADS,/arxiv_data1/oa_pdf/8b/06/main.PMC4293670.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2015) 6, 3–15 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2014.10.003 2090-1232 ª2014 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/45/00/main.PMC4293671.pdf
http://dx.doi.org/10.2174/2213235x11301010028 .,Non-OADS,/arxiv_data1/oa_pdf/45/00/main.PMC4293671.pdf
BMC Bioinformatics 2007;8:234. http://dx.doi.org/10.1186/1471-2105-8-234 .,OADS,/arxiv_data1/oa_pdf/45/00/main.PMC4293671.pdf
< http://mdl.imv.liu.se >.,Non-OADS,/arxiv_data1/oa_pdf/45/00/main.PMC4293671.pdf
Bioinformatics 2011;12:400. http://dx.doi.org/10.1186/1471- 2105-12-400 .,OADS,/arxiv_data1/oa_pdf/45/00/main.PMC4293671.pdf
http://dx.doi.org/10.1016/j.jare.2014.07.002,OADS,/arxiv_data1/oa_pdf/e5/68/main.PMC4293672.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2015) 6, 63–71 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2014.11.002 2090-1232 ª2014 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/db/04/main.PMC4293674.pdf
<http://www.pharmainstitute.com/glossary/ index.cfm?id=2128&search_term=lead%20 compound&select=TRUE > [accessed 20.08.14].,OADS,/arxiv_data1/oa_pdf/db/04/main.PMC4293674.pdf
Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.Malaria J 2009;8:2. http://dx.doi.org/10.1186/1475-2875-8-2 .,Non-OADS,/arxiv_data1/oa_pdf/db/04/main.PMC4293674.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2015) 6, 17–33 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2014.11.009 2090-1232 ª2014 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/13/fe/main.PMC4293675.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2015) 6, 45–62 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2014.11.008 2090-1232 ª2014 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/11/95/main.PMC4293676.pdf
Available from: http://www.lincolnshire.nhs.uk/policies/ doc./390‑vol‑6‑no‑11‑pace‑bulletin.,Non-OADS,/arxiv_data1/oa_pdf/91/eb/IJPhS-76-483.PMC4293679.pdf
Available from: http://www.globinmed.com.,Non-OADS,/arxiv_data1/oa_pdf/21/9b/IJPhS-76-548.PMC4293688.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/ - licenses/by -nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/2d/TOMICROJ-8-144.PMC4293735.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non- Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ )  which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/73/TONURSJ-8-64.PMC4293736.pdf
Available at http://www.hcup-us.ahrq.gov/reports/statsbriefs/sb65.pdf [11] Laine L. GI risk and risk factors of NSAIDs.,OADS,/arxiv_data1/oa_pdf/25/9c/TORJ-8-110.PMC4293738.pdf
"BMC Geriatrics 8: 1 Available online at http://www.biomedcentral.com/1471-2318/8/1 [22] Nilsson-Ehle H, Jagerburg R, Landahl S, et al.",OADS,/arxiv_data1/oa_pdf/25/9c/TORJ-8-110.PMC4293738.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/9c/TORJ-8-110.PMC4293738.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/11/TORJ-8-116.PMC4293739.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/ - licenses/by -nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/5a/TOMICROJ-8-138.PMC4293740.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/82/TORJ-8-100.PMC4293741.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/licenses/   by-nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/92/TOBIOCJ-8-100.PMC4293742.pdf
"Thus far, more than 2500 human mature  miRs have been discovered (http://www.mirbase.org/).",Non-OADS,/arxiv_data1/oa_pdf/d0/94/CG-15-481.PMC4293743.pdf
Approximately 80% of those af- fected with OA have significant movement limitations and  25% are unable to perform activities of daily living  [http://www.who.int/chp/topics/rheumatic/en/].,Non-OADS,/arxiv_data1/oa_pdf/d0/94/CG-15-481.PMC4293743.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/ - licenses/by -nc/3.0/) which permits unrestricted, non -commercial  use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/6c/TOBIOCJ-8-107.PMC4293754.pdf
"“CanMEDS is an educational framework identifying and describing  seven roles that lead to optimal health and healthcare outcomes: Medical expert (central role), communicator, collaborator, manager, health advocate, scholar, and professional.” These two quotes are from http://www.royalcollege.ca/portal/ page/portal/rc/resources/aboutcanmeds.",Non-OADS,/arxiv_data1/oa_pdf/13/9a/AMS-4-125.PMC4293828.pdf
http://dx.doi.org/10.1016/j.jare.2012.06.001,OADS,/arxiv_data1/oa_pdf/ba/c7/main.PMC4293869.pdf
http://dx.doi.org/10.1016/j.jare.2012.07.005,OADS,/arxiv_data1/oa_pdf/5f/4d/main.PMC4293870.pdf
http://dx.doi.org/10.1016/j.jare.2012.06.003,OADS,/arxiv_data1/oa_pdf/18/17/main.PMC4293871.pdf
http://dx.doi.org/10.1016/j.jare.2012.07.006,OADS,/arxiv_data1/oa_pdf/59/92/main.PMC4293872.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.jare.2012.",OADS,/arxiv_data1/oa_pdf/59/92/main.PMC4293872.pdf
http://dx.doi.org/10.1016/j.jare.2012.07.001,OADS,/arxiv_data1/oa_pdf/07/90/main.PMC4293873.pdf
http://dx.doi.org/10.1016/j.jare.2012.07.002,OADS,/arxiv_data1/oa_pdf/01/18/main.PMC4293875.pdf
http://dx.doi.org/10.1016/j.jare.2012.05.007,OADS,/arxiv_data1/oa_pdf/99/89/main.PMC4293876.pdf
< http://www.physionet.org/cgi-bin/atm/ATM >.,Non-OADS,/arxiv_data1/oa_pdf/99/89/main.PMC4293876.pdf
http://dx.doi.org/10.1016/j.jare.2012.07.007,OADS,/arxiv_data1/oa_pdf/8d/0b/main.PMC4293877.pdf
http://dx.doi.org/10.1016/j.jare.2012.07.009,OADS,/arxiv_data1/oa_pdf/b4/77/main.PMC4293878.pdf
http://dx.doi.org/10.1016/j.jare.2012.07.004,OADS,/arxiv_data1/oa_pdf/7b/31/main.PMC4293879.pdf
http://dx.doi.org/10.1016/j.jare.2012.07.008,OADS,/arxiv_data1/oa_pdf/d2/a0/main.PMC4293880.pdf
http://dx.doi.org/10.1016/j.jare.2012.05.006,OADS,/arxiv_data1/oa_pdf/64/ba/main.PMC4293881.pdf
http://dx.doi.org/10.1016/j.jare.2013.06.007,OADS,/arxiv_data1/oa_pdf/e0/26/main.PMC4293882.pdf
< http://www.wds.worldbank.org/external/ default/WDSContentServer/WDSP/IB/2008/07/21/000333037_20080721033036/Rendered/PDF/444660PPAPOP0051520Box 327410B01PUBLIC1.pdf > [accessed 5.03.10].,Non-OADS,/arxiv_data1/oa_pdf/e0/26/main.PMC4293882.pdf
< http://www.nci.cu.edu.eg/lectures/Cancer_statistics 2002-2007.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/e0/26/main.PMC4293882.pdf
http://dx.doi.org/10.1016/j.jare.2012.07.003,OADS,/arxiv_data1/oa_pdf/2a/a2/main.PMC4293883.pdf
http://dx.doi.org/10.1016/j.jare.2013.07.002,OADS,/arxiv_data1/oa_pdf/8e/5e/main.PMC4293884.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.004,OADS,/arxiv_data1/oa_pdf/5c/6b/main.PMC4293885.pdf
http://dx.doi.org/10.1016/j.jare.2012.12.001,OADS,/arxiv_data1/oa_pdf/58/3a/main.PMC4293886.pdf
( http://www.path.cam.ac.uk/ ~schisto/schistosoma/schisto_pathology_granuloma ).446 T. Elbaz and G. Esmat,Non-OADS,/arxiv_data1/oa_pdf/58/3a/main.PMC4293886.pdf
In (http://www.gastrohep.com/images/image.asp?id=1152 ).Hepatic and Intestinal Schistosomiasis 447,Non-OADS,/arxiv_data1/oa_pdf/58/3a/main.PMC4293886.pdf
Travel Med Infect Dis 2012 S pii: S1477-8939(12)00084-1. doi : http://dx.doi.org/10.1016/ j.tmaid.2012.06.001 .,Non-OADS,/arxiv_data1/oa_pdf/58/3a/main.PMC4293886.pdf
http://dx.doi.org/10.1016/j.jare.2012.05.002,OADS,/arxiv_data1/oa_pdf/f1/a1/main.PMC4293887.pdf
http://dx.doi.org/10.1016/j.jare.2013.01.005,OADS,/arxiv_data1/oa_pdf/39/8a/main.PMC4293888.pdf
http://dx.doi.org/10.1016/j.jare.2013.09.004,OADS,/arxiv_data1/oa_pdf/2d/2b/main.PMC4293905.pdf
http://dx.doi.org/10.1016/j.jare.2013.06.009,OADS,/arxiv_data1/oa_pdf/40/ed/main.PMC4293906.pdf
http://dx.doi.org/10.1016/j.jare.2013.11.003,OADS,/arxiv_data1/oa_pdf/11/b0/main.PMC4293907.pdf
[2]http://water.epa.gov/drink/contaminants/index.cfm .,OADS,/arxiv_data1/oa_pdf/11/b0/main.PMC4293907.pdf
http://dx.doi.org/10.1016/j.jare.2013.09.001,OADS,/arxiv_data1/oa_pdf/e7/83/main.PMC4293908.pdf
"The func- tional motifs such as Prokaryotic membrane lipoprotein lipidattachment site, RGD (motif), and amidation of the geneproducts were predicted by using the computer software Gene- runner version 3.05 (hastings Software Inc. Hastings, NY, USA; http://www.generunner.net ).",OADS,/arxiv_data1/oa_pdf/e7/83/main.PMC4293908.pdf
http://dx.doi.org/10.1016/j.jare.2013.10.002,OADS,/arxiv_data1/oa_pdf/3c/2e/main.PMC4293909.pdf
http://dx.doi.org/10.1016/j.jare.2013.09.002,OADS,/arxiv_data1/oa_pdf/31/6b/main.PMC4293910.pdf
http://dx.doi.org/10.1016/j.jare.2013.10.003,OADS,/arxiv_data1/oa_pdf/3e/d8/main.PMC4293911.pdf
http://dx.doi.org/10.1016/j.jare.2013.10.004,OADS,/arxiv_data1/oa_pdf/a7/e7/main.PMC4293912.pdf
http://dx.doi.org/10.1016/j.jare.2013.09.003,OADS,/arxiv_data1/oa_pdf/74/bf/main.PMC4293913.pdf
http://dx.doi.org/10.1016/j.jare.2013.07.004,OADS,/arxiv_data1/oa_pdf/ec/41/main.PMC4293914.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/42/ppa-9-041.PMC4293917.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 41–45Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  41OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7151 0Factors associated with adherence to  nucleos(t)ide analogs in chronic hepatitis B  patients: results from a 1-year follow-up study Jie Peng Junhua Yin shaohang cai Tao Yu chunxiu Zhong nanfang hospital, southern Medical  University, guangzhou, guangdong  Province, People’s republic of chinaAbstract:  Little is known about the factors associated with patient compliance with nucleos(t)ide  analog (NUC) treatment for chronic hepatitis B (CHB).",Non-OADS,/arxiv_data1/oa_pdf/f9/42/ppa-9-041.PMC4293917.pdf
"Mean adherence to various NUC treatment proto - cols varied from 81% to 91%, as reported in three studies.3,4,9 Two studies showed  significant associations between good or perfect adherence and complete virologic  suppression.10,11 Older age, a history of treatment for CHB using NUCs, use of NUCs correspondence: Jie Peng nanfang hospital, southern Medical  University, no 1838, guangzhou Avenue  north, guangzhou, guangdong Province  510515, People’s republic of china  Tel +86 20 6278 7428 Fax +86 20 8771 9653 email pjie138@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Peng et al Running head recto: Adherence and chronic hepatitis B treatment DOI: http://dx.doi.org/10.2147/PPA.S71510",Non-OADS,/arxiv_data1/oa_pdf/f9/42/ppa-9-041.PMC4293917.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f9/42/ppa-9-041.PMC4293917.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/bb/opth-9-069.PMC4293918.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 69–71Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  69Case RepOR topen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S6946 6progression to macula-off tractional retinal  detachment after a contralateral intraoperative  intravitreal bevacizumab injection for proliferative  diabetic retinopathy Leonid Zlotcavitch1 Harry W Flynn Jr2 Robert L avery3 aleksandra Rachitskaya2 1University of Miami, Miller school  of Medicine, 2Bascom palmer  eye Institute, Department of  Ophthalmology, University of Miami,   Miller school of Medicine, Miami, FL,   Usa; 3California Retina Consultants,   santa Barbara, C a, UsaAbstract:  We report a patient with progression to a macula-off tractional retinal detachment in  a fellow eye after a contralateral intraoperative intravitreal bevacizumab injection.",Non-OADS,/arxiv_data1/oa_pdf/c3/bb/opth-9-069.PMC4293918.pdf
"Correspondence: Harry W Flynn Jr 900 NW 17th st, Miami, FL 33136, Usa tel +1 305 326 6303 Fax +1 305 326 6417 email HFlynn@med.miami.ed u Journal name: Clinical Ophthalmology Article Designation: Case Report Y ear: 2015 Volume: 9 Running head verso: Zlotcavitch et al Running head recto: Contralateral detachment after intravitreal bevacizumab DOI: http://dx.doi.org/10.2147/OPTH.S69466",Non-OADS,/arxiv_data1/oa_pdf/c3/bb/opth-9-069.PMC4293918.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c3/bb/opth-9-069.PMC4293918.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/bb/opth-9-069.PMC4293918.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/21/tacg-8-001.PMC4293919.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2015:8 1–8The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S7558 3Genomic-based tools for the risk assessment,  management, and prevention of type  2 diabetes Katherine A Johansen Taber Barry D Dickinson Department of Science and  Biotechnology, American Medical  Association, Chicago, iL, USA Correspondence: Katherine A Johansen  Taber   Department of Science and  Biotechnology, American Medical  Association, 330 N wabash Ave, Suite   39300, Chicago, iL  60611, USA   Tel +1 312 464 4964  email katherine.johansen@ama-assn.or gAbstract:  Type  2 diabetes (T2D) is a common and serious disorder and is a significant risk  factor for the development of cardiovascular disease, neuropathy, nephropathy, retinopathy,  periodontal disease, and foot ulcers and amputations.",Non-OADS,/arxiv_data1/oa_pdf/40/21/tacg-8-001.PMC4293919.pdf
"Available from: http://www.cdc.gov/diabetes/pubs/statsreport14/ national-diabetes-report-web.pd f. Accessed December 10, 2014.",OADS,/arxiv_data1/oa_pdf/40/21/tacg-8-001.PMC4293919.pdf
Available  from: http://nsgc.org/p/cm/ld/fid =43.,Non-OADS,/arxiv_data1/oa_pdf/40/21/tacg-8-001.PMC4293919.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/40/21/tacg-8-001.PMC4293919.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/21/tacg-8-001.PMC4293919.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2011/017783s021lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/40/21/tacg-8-001.PMC4293919.pdf
Available from: http://www.accessdata.fda.gov/ drugsatfda_docs / label/2013/020051s020lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/40/21/tacg-8-001.PMC4293919.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2011/011641s066lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/40/21/tacg-8-001.PMC4293919.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/f9/ott-8-117.PMC4293920.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 117–123OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  117Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7482 0clinical and epidemiological study of egFr  mutations and eMl4-alK fusion genes among  indian patients with adenocarcinoma of the lung Dc Doval1 K Prabhash2 s Patil3 h chaturvedi4 c goswami5 aK Vaid6 s Desai2 s Dutt7 Vh Veldore8 n Jambhekar2 a Mehta1 D hazarika8 s azam1 s gawande9 s gupta10 1rajiv gandhi cancer institute  and research centre, new Delhi,   2Tata Memorial hospital, Mumbai,   3Bangalore institute of Oncology,   hcg group, Bengaluru, 4Max super  speciality hospital, new Delhi, 5B.",Non-OADS,/arxiv_data1/oa_pdf/82/f9/ott-8-117.PMC4293920.pdf
"However, it needs an accurate histological classification as correspondence: Dinesh chandra Doval Department of Medical Oncology, rajiv  gandhi cancer institute and research  centre, sector V, rohini, new Delhi,  110085, india Tel +91 11 4702 2252 email dcdoval@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Doval et al Running head recto: EGFR mutations and EML4-ALK fusion genes in lung adenocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S74820",Non-OADS,/arxiv_data1/oa_pdf/82/f9/ott-8-117.PMC4293920.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/82/f9/ott-8-117.PMC4293920.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/f9/ott-8-117.PMC4293920.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2a/4a/ppa-9-047.PMC4293921.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 47–55Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  47OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7410 4Use of Q methodology to assess the concerns  of adult female individuals seeking orthodontic  treatment linjie Yao1 Xingqiao Xu2 Zhenyu ni3 Minling Zheng3 Feiou lin3 1Department of Pedodontics,  2Department of Oral and Maxillofacial  surgery, 3Department of Orthodontics,  school and hospital of stomatology,  Wenzhou Medical University, Wenzhou,  People’s republic of chinaBackground:  Orthodontic treatment may cause functional restrictions, discomfort, and pain,  which may lead to dental anxiety and noncooperation among patients.",Non-OADS,/arxiv_data1/oa_pdf/2a/4a/ppa-9-047.PMC4293921.pdf
"Keywords:  orthodontic treatment, Q methodology, adult female patient Introduction A person’s oral condition can affect their physical, psychological, and social health.1  Orthodontic treatment can improve an individual’s appearance, oral function, psycho - social well-being, and quality of life.2–4 Care and attention during orthodontic treatment  have been found to show a positive correlation with treatment satisfaction.5 Sergl et al  highlighted a strong interrelationship between a patient’s attitude at the beginning of  orthodontic treatment, their ability to accommodate the discomfort associated with  an orthodontic appliance, the type and intensity of discomfort encountered, and the  resulting overall compliance with the treatment.6 However, orthodontic treatment  and appliances may cause functional limitations, discomfort, and pain,7–9 which may  lead to dental anxiety.10 It has been reported that patients’ lack of information about  the risks of orthodontic treatment or fear about pain and discomfort could adversely  affect their compliance during treatment.10–12 Studies have shown that the number of correspondence: Feiou lin Department of Orthodontics, school  and hospital of stomatology, Wenzhou  Medical University, 113 Xue Yuan West  road, lu cheng District, Wenzhou,  Zhejiang 325027, People’s republic  of china Tel +86 577 8806 3012 Fax +86 577 8806 3666 email linfeiousci@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Y ao et al Running head recto: Q methodology for orthodontic treatment concerns DOI: http://dx.doi.org/10.2147/PPA.S74104",Non-OADS,/arxiv_data1/oa_pdf/2a/4a/ppa-9-047.PMC4293921.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/2a/4a/ppa-9-047.PMC4293921.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/bd/opth-9-095.PMC4293922.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 95–108Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  95Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S7640 6endophthalmitis: state of the art Kamyar vaziri Stephen G Schwartz Krishna Kishor Harry w Flynn Jr Department of Ophthalmology,   Bascom Palmer eye institute,   University of Miami Miller School  of Medicine, Miami, FL, USAAbstract:  Endophthalmitis is an uncommon diagnosis but can have devastating visual outcomes.",Non-OADS,/arxiv_data1/oa_pdf/07/bd/opth-9-095.PMC4293922.pdf
"Reported incidence rates Correspondence: Stephen G Schwartz Bascom Palmer eye institute, University  of Miami Miller School of Medicine,  311 9th Street North, #100, Naples,  FL 34102, USA Tel +1 239 659 3937 Fax +1 239 659 3982 email sschwartz2@med.miami.ed uJournal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Vaziri et al Running head recto: Endophthalmitis: state of the art DOI: http://dx.doi.org/10.2147/OPTH.S76406",Non-OADS,/arxiv_data1/oa_pdf/07/bd/opth-9-095.PMC4293922.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/07/bd/opth-9-095.PMC4293922.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/bd/opth-9-095.PMC4293922.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/21/tacg-8-009.PMC4293923.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2015:8 9–17The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  9Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S5902 4The genetics of Ménière’s disease Giuseppe Chiarella1 C Petrolo1 e Cassandro2 1Department of experimental and  Clinical Medicine, Audiology and  Phoniatrics Unit, Magna Graecia  University of Catanzaro, Catanzaro,   italy; 2Department of Medicine and  Surgery, University of Salerno,    Salerno, italy Correspondence: Giuseppe Chiarella   Department of experimental and Clinical  Medicine, Audiology and Phoniatrics Unit,  Magna Graecia University of Catanzaro,  Loc Germaneto  88100, Catanzaro, italy   Tel/Fax +39 0961 3647 202   email chiarella@unicz.i tAbstract:  Our understanding of the genetic basis of Ménière’ s disease (MD) is still limited.",Non-OADS,/arxiv_data1/oa_pdf/68/21/tacg-8-009.PMC4293923.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/68/21/tacg-8-009.PMC4293923.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/21/tacg-8-009.PMC4293923.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/dd/ott-8-125.PMC4293924.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 125–136OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  125Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S7272 2Advances in the targeted therapy of liposarcoma Zhonghai Guan1 Xiongfei Yu1 Haohao wang1 Haiyong wang1 Jing Zhang1 Guangliang Li2 Jiang Cao3 Lisong T eng1 1Department of Surgical Oncology,   First Affiliated Hospital, College  of Medicine, Zhejiang University,   2Department of Medicine Oncology,   Zhejiang Cancer Hospital, 3Clinical  Research Center, The 2nd Affiliated  Hospital, School of Medicine, Zhejiang  University, Hangzhou, Zhejiang,   People’s Republic of ChinaAbstract:  Liposarcoma (LPS) is the most common type of soft-tissue sarcoma.",Non-OADS,/arxiv_data1/oa_pdf/4d/dd/ott-8-125.PMC4293924.pdf
"Myxoid-cell LPSs, lacking round cell Correspondence: Lisong Teng Department of Surgical Oncology, First  Affiliated Hospital, College of Medicine,  Zhejiang University, 79 Qingchun  Road, Hangzhou, Zhejiang 310003,  People’s Republic of China Tel +86 571 8706 8873;   +86 136 6667 6918 Fax +86 571 8723 6628 email lsteng@zju.edu.c n Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Guan et al Running head recto: Advances in the targeted therapy of liposarcoma DOI: http://dx.doi.org/10.2147/OTT.S72722",Non-OADS,/arxiv_data1/oa_pdf/4d/dd/ott-8-125.PMC4293924.pdf
Available from: http://www.cancer.gov/cancertopics/ druginfo/fda-pazopanibhydrochloride.,Non-OADS,/arxiv_data1/oa_pdf/4d/dd/ott-8-125.PMC4293924.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4d/dd/ott-8-125.PMC4293924.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/dd/ott-8-125.PMC4293924.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/35/tcrm-11-063.PMC4293927.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 63–73Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  63Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5550 6Biologics in the management of ulcerative   colitis – comparative safety and efficacy   of TNF-α antagonists  Rebecca Fausel1 Anita Afzali1,2 1Division of Gastroenterology,   Department of Medicine, University  of washington, Seattle, wA, USA;   2inflammatory Bowel Disease  Program, U w Medicine – Harborview  Medical Center, Seattle, wA, USAAbstract:  Ulcerative colitis can cause debilitating symptoms and complications such as  colonic strictures, colonic dysplasia, colorectal cancer, and toxic megacolon or perforation.",Non-OADS,/arxiv_data1/oa_pdf/72/35/tcrm-11-063.PMC4293927.pdf
"The goals of treatment  include resolution of gastrointestinal symptoms, healing of the colonic mucosa, pre - vention of long-term disease complications, as well as improvement of extra-intestinal  symptoms.1 Correspondence: Anita Afzali Harborview Medical Center, 325 Ninth  Avenue, Box 359773, Seattle, wA, USA Tel +1 206 744 7055 Fax +1 206 744 8698 email anitaa@medicine.washington.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Fausel and Afzali Running head recto: Biologics in the management of ulcerative colitis DOI: http://dx.doi.org/10.2147/TCRM.S55506",Non-OADS,/arxiv_data1/oa_pdf/72/35/tcrm-11-063.PMC4293927.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/72/35/tcrm-11-063.PMC4293927.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/35/tcrm-11-063.PMC4293927.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/c9/opth-9-077.PMC4293928.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 77–90Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  77Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S5900 9Pediatric cataract: challenges and future   directions Anagha Medsinge1,2 Ken K Nischal1,2 1Pediatric Ophthalmology, Strabismus,   and Adult Motility, Children’s Hospital  of Pittsburgh of University of  Pittsburgh Medical Center, (UPMC)  2University  of Pittsburgh School of  Medicine, Pittsburgh, PA, USAAbstract:  Cataract is a significant cause of visual disability in the pediatric population  worldwide and can significantly impact the neurobiological development of a child.",Non-OADS,/arxiv_data1/oa_pdf/ee/c9/opth-9-077.PMC4293928.pdf
"Furthermore, early diagnosis can  be achieved by genetic counseling and testing in cases of hereditary cataracts.4 However, certain issues specific to pediatric eyes, such as increased postoperative  inflammation, axial growth after cataract extraction, implant-power calculation, sec - ondary glaucoma, posterior-capsule opacification (PCO), and amblyopia management, Correspondence: Ken K Nischal Pediatric Ophthalmology, Strabismus,  and Adult Motility, Children’s Hospital  of Pittsburgh of University of Pittsburgh  Medical Center, (UPMC) 4401 Penn Avenue  – Suite 5000, Pittsburgh, PA 15224, USA Tel +1 412 692 5918 Fax +1 412 692 3203 email nischalkk@upmc.ed uJournal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Medsinge and Nischal Running head recto: Pediatric cataract DOI: http://dx.doi.org/10.2147/OPTH.S59009",Non-OADS,/arxiv_data1/oa_pdf/ee/c9/opth-9-077.PMC4293928.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ee/c9/opth-9-077.PMC4293928.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/c9/opth-9-077.PMC4293928.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/bb/tcrm-11-075.PMC4293929.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 75–81Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  75Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/TCRM.S5769 5Management of bipolar i depression: clinical  utility of lurasidone Lillian Jan Findlay1  Peggy el-Mallakh1  Rif S el-Mallakh2  1College of Nursing, University  of Kentucky, Lexington, KY, USA;   2Department of Psychiatry and  Behavioral Sciences, University  of Louisville School of Medicine,   Louisville, KY, USAAbstract:  Lurasidone is a benzisothiazol derivative second-generation antipsychotic.",Non-OADS,/arxiv_data1/oa_pdf/bb/bb/tcrm-11-075.PMC4293929.pdf
"Antidepressants can indeed increase the likelihood of a manic switch,21 Correspondence: Rif S el-Mallakh  401 e. Chestnut Street, Suite 610,  Department of Psychiatry and Behavioral  Sciences, University of Louisville School  of Medicine, Louisville, KY 40202, USA email rselma01@louisville.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Findlay et al Running head recto: Management of bipolar I depression  DOI: http://dx.doi.org/10.2147/TCRM.S57695",Non-OADS,/arxiv_data1/oa_pdf/bb/bb/tcrm-11-075.PMC4293929.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/bb/bb/tcrm-11-075.PMC4293929.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/bb/tcrm-11-075.PMC4293929.pdf
Available from: http://www.sunovion.com/ news/latuda-press-room.html.,Non-OADS,/arxiv_data1/oa_pdf/bb/bb/tcrm-11-075.PMC4293929.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/fe/rru-7-001.PMC4293930.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pResearch and Reports in Urology 2015:7 1–7Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  1PeRsPectivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/RRU.S7412 5cost analysis of adjuvant management strategies  in early stage (stage i) testicular seminoma John A cox1,2 shefali R Gajjar3 thomas B Lanni Jr4 todd A swanson1 1Department of Radiation Oncology,  University of texas Medical Branch,  Galveston, tX, 2Department of  Radiation Oncology, indiana University  school of Medicine, indianapolis, iN,  3University of texas Medical Branch  school of Medicine, Galveston, tX,  4Department of Radiation Oncology,  William Beaumont Hospital, Royal  Oak, M i, UsA correspondence: todd A swanson   Department of Radiation Oncology,  University of texas Medical Branch,   301 University Boulevard, Galveston,  77555 tX, UsA   tel +1 409 772 2531  Fax +1 409 747 0025  email taswanso@ utmb .eduBackground:  Accep table  post-orchiectomy adjuvant therapy strategies for stage I seminoma  patients include surveillance, para-aortic radiation therapy (RT), dog-leg RT, and a single  cycle of carboplatin.",Non-OADS,/arxiv_data1/oa_pdf/4c/fe/rru-7-001.PMC4293930.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/4c/fe/rru-7-001.PMC4293930.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/fe/rru-7-001.PMC4293930.pdf
Available from: http://www.nap.,Non-OADS,/arxiv_data1/oa_pdf/4c/fe/rru-7-001.PMC4293930.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/81/nss-7-001.PMC4293931.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNature and Science of Sleep 2015:7 1–11Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  1OrigiNal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NSS.S7343 7The burden of insomnia in Japan Kazuo Mishima1 Marco da costa  DiBonaventura2 hillary gross2 1Department of Psychophysiology,   National institute of Mental health,   National center of Neurology and  Psychiatry, Kodaira, T okyo, Japan;   2Kantar health, New Y ork, NY, USa correspondence: Marco dacosta  DiBonaventura   Kantar health, 11 Madison avenue,   12th Floor, New York, NY 10010, USa   Tel +1 212 706 3988   Fax +1 212 647 7659   email marco.dibonaventura@ kantarhealth.co mObjectives:  Several studies have suggested that patients who experience insomnia report a  number of significant impairments.",Non-OADS,/arxiv_data1/oa_pdf/4e/81/nss-7-001.PMC4293931.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/4e/81/nss-7-001.PMC4293931.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/81/nss-7-001.PMC4293931.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/b6/opth-9-073.PMC4293932.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 73–76Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  73Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S7577 1posterior microphthalmos and papillomacular  fold-associated cystic changes misdiagnosed  as cystoid macular edema following cataract  extraction ahmad a albar1 sawsan r Nowilaty1 Nicola G Ghazi1,2 1Vitreoretinal Division, King  Khaled eye specialist Hospital,   riyadh, saudi arabia; 2Department  of Ophthalmology, University  of Virginia, Charlottesville, V a, UsaPurpose:  Novel spectral-domain optical coherence tomography (SD-OCT) findings in posterior  microphthalmos (PM) include cystoid changes in the papillomacular fold (PMF).",Non-OADS,/arxiv_data1/oa_pdf/c7/b6/opth-9-073.PMC4293932.pdf
"We report a case that underscores this clinical finding aiming to increase  awareness of this entity among ophthalmologists.Correspondence: Nicola G Ghazi King Khaled eye specialist Hospital,  al Urubah road, riyadh 11462,  saudi arabia tel +971 52693 3400 email nicola.ghazi@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Case report Y ear: 2015 Volume: 9 Running head verso: Albar et al Running head recto: Papillomacular fold in eyes with posterior microphthalmos DOI: http://dx.doi.org/10.2147/OPTH.S75771",Non-OADS,/arxiv_data1/oa_pdf/c7/b6/opth-9-073.PMC4293932.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c7/b6/opth-9-073.PMC4293932.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/b6/opth-9-073.PMC4293932.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/ef/vhrm-11-035.PMC4293933.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 35–48Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  35ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S6588 5Influence of immune activation and inflammatory  response on cardiovascular risk associated with  the human immunodeficiency virus Luis M Beltrán1 Alfonso Rubio-Navarro2 Juan Manuel Amaro- Villalobos2 Jesús egido2–4 Juan García-Puig1 Juan Antonio Moreno2 1Metabolic-Vascular Unit, Fundación  IdiPAZ-Hospital Universitario La Paz,   Madrid, Spain; 2Vascular, Renal, and  Diabetes Research Lab, IIS-Fundación  Jiménez Díaz, Madrid, Spain; 3Centro  de Investigación Biomédica en Red de  Diabetes y Enfermedades Metabólicas  Asociadas (CIBERDEM), Madrid,   Spain; 4Fundación Renal Iñigo Alvarez  de Toledo-Instituto Reina Sofía de  Investigaciones Nefrológicas (FRIAT - IRSIN), Madrid, Spain Correspondence: Juan Antonio Moreno   Vascular, Renal, and Diabetes Research  Lab, IIS-Fundación Jiménez Díaz, Avda,  Reyes Católicos 2, 28040 Madrid, Spain   Tel +34 915 504 800 ext 3168   email jamoreno@fjd.e sAbstract:  Patients infected with the human immunodeficiency virus (HIV) have an increased  cardiovascular risk.",Non-OADS,/arxiv_data1/oa_pdf/a6/ef/vhrm-11-035.PMC4293933.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/a6/ef/vhrm-11-035.PMC4293933.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/ef/vhrm-11-035.PMC4293933.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/db/sccaa-8-015.PMC4293935.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pStem Cells and Cloning: Advances and Applications 2015:8 15–26Stem Cells and Cloning: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  15ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SCCAA.S6659 7Failure of Y-27632 to improve the culture of adult  human adipose-derived stem cells Nuno Jorge Lamas1–3 Sofia C Serra1,2 António J Salgado1,2 Nuno Sousa1,2 1Life and Health Sciences Research  Institute (ICVS), School of Health  Sciences (ECS), University of Minho,   Braga, Portugal; 2ICVS/3B’s-PT  Government Associate Laboratory,   Braga/Guimarães, Portugal; 3Clinical  Pathology Department, Centro  Hospitalar do Alto Ave (CHAA), EPE,   Guimarães, Portugal Correspondence: Nuno Sousa   Life and Health Sciences Research  Institute (ICVS), School of Health  Sciences (ECS), University of Minho,   Campus de Gualtar, Braga, Portugal   Tel +351 253 604 806   Fax +351 253 604 809   Email njcsousa@ecsaude.uminho.p tAbstract:  Y -27632 is a well-known inhibitor of the Rho-associated coiled kinase (ROCK)  and has been shown to significantly improve the culture of a variety of multipotent stem cell  types.",Non-OADS,/arxiv_data1/oa_pdf/22/db/sccaa-8-015.PMC4293935.pdf
"Stem Cells and Cloning: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/stem-cells-and-cloning-advances-and-applications-journa lStem Cells and Cloning: Advances and Applications is an international,  peer-reviewed, open access journal.",Non-OADS,/arxiv_data1/oa_pdf/22/db/sccaa-8-015.PMC4293935.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/db/sccaa-8-015.PMC4293935.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/45/0a/ott-8-137.PMC4293936.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 137–145OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  137Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7379 4low preoperative lymphocyte to monocyte ratio  predicts poor cancer-specific survival in patients  with esophageal squamous cell carcinoma Ying huang1 Ji-Feng Feng2 1Department of Operating Theatre,   Zhejiang cancer hospital, hangzhou,   People’s republic of china;   2Department of Thoracic surgery,   Zhejiang cancer hospital, hangzhou,   People’s republic of chinaBackground:  Recent studies have shown that the lymphocyte to monocyte ratio (LMR) is a  useful predictive factor in various cancers.",Non-OADS,/arxiv_data1/oa_pdf/45/0a/ott-8-137.PMC4293936.pdf
"It is well known that systemic inflam matory response plays an important role in can - cer progression.7,8 The systemic inflam  matory response, which is usually measured by  peripheral blood-based parameters, such as C-reactive protein, neutrophil, lymphocyte  or platelet count, has been shown to be a predictive factor in various cancers, including correspondence: Ji-Feng Feng Department of Thoracic surgery,  Zhejiang cancer hospital,  no 38 guangji road, hangzhou 310022,  People’s republic of china Tel +86 571 8812 8052 email jifzhejiang@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Huang and Feng Running head recto: Low preoperative LMR predicts poor cancer-specific survival DOI: http://dx.doi.org/10.2147/OTT.S73794",Non-OADS,/arxiv_data1/oa_pdf/45/0a/ott-8-137.PMC4293936.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/45/0a/ott-8-137.PMC4293936.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/0a/ott-8-137.PMC4293936.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cc/6a/sar-6-001.PMC4293937.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pSubstance Abuse and Rehabilitation 2015:6 1–14Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S4558 5New developments in the management   of opioid dependence: focus on sublingual   buprenorphine–naloxone Michael Soyka1,2 1Department of Psychiatry and  Psychotherapy, Ludwig-Maximilians- Universität, Munich, Germany;    2Private Hospital Meiringen,   Meiringen, Switzerland Correspondence: Michael Soyka   Private Hospital Meiringen, PO Box  612,  willigen, Meiringen  3860, Switzerland   Tel +41 339 728 295  Fax +41 339 728 291  email m ichael.",Non-OADS,/arxiv_data1/oa_pdf/cc/6a/sar-6-001.PMC4293937.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/cc/6a/sar-6-001.PMC4293937.pdf
Visit http://www.dovepress.com/testimonials.php   to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/6a/sar-6-001.PMC4293937.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNanotechnology, Science and Applications 2015:8 1–17Nanotechnology, Science and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSA.S4377 3innovations in nanotechnology   for water treatment ilka Gehrke Andreas Geiser Annette Somborn-Schulz Fraunhofer institute for  environmental, Safety and energy  T echnology UMSiCHT, Oberhausen,   Germany Correspondence: ilka Gehrke   Fraunhofer institute for environmental,  Safety and energy Technology UMSiCHT,  Osterfelder Straße  3, 46047 Oberhausen,  Germany   Tel +49 208 8598 1260  Fax +49 208 8598 1295  email ilka.gehrke@umsicht.fraunhofer.d eAbstract:  Important challenges in the global water situation, mainly resulting from worldwide  population growth and climate change, require novel innovative water technologies in order to  ensure a supply of drinking water and reduce global water pollution.",Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
Available from: http://www.unesco.org/new/en/natural- sciences/environment/water/wwap/wwdr/wwdr4-201 2.,Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
Available from: http://www.nano.,Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
"Available from: http://ec.europa.eu/research/participants/data/ref/ h2020/wp/2014_2015/main/h2020-wp1415-leit-nmp_en.pd f. Accessed  July 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
"Available from:  http://ec.europa.eu/research/horizon2020/pdf/work-programmes/ climate_action_environment_resource_efficiency_and_raw_ materials_ draft_work_programme.pd f. Accessed July  24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
Available from: http://eur-lex.europa.eu/legal-content/EN/ALL/;ELX_ SESSIONID =GctYTQvNMZSqByVl1X23LRQSM0JpVbD2gTFpbL NTKKRlfJLB2tym!-1120470413?uri =CELEX:32006R190 7.,Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
"Available from:  http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri =OJ:L:2011:27 5:0038:0040:EN:PD F. Accessed July  24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
Available from: http://eur-lex.europa.eu/legal-content/EN/ TXT/?uri =CELEX:32000L006 0.,Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
"Available from: http://www.epa.gov/ncer/ nano/factsheet/nanofactsheetjune07.pd f. April  16, 2014.",OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
Available from: http://cfpub.epa.gov/ncea/ cfm/recordisplay.cfm?deid =23097 2.,OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
"Nanotechnology, Science and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nanotechnology-science-and-applications-journa lNanotechnology, Science and Applications is an international, peer-reviewed, open  access journal that focuses on the science of nanotechnology in a wide range of  industrial and academic applications.",Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
"Available from: http://www.fda.gov/downloads/Cosmetics/  InternationalActivities/ICCR/UCM348951.pd f. Accessed July  24,  2014.",Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
Available from: http://echa.europa.,Non-OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
Available from: http://cfpub.epa.gov/ncea/cfm/recordisplay.,OADS,/arxiv_data1/oa_pdf/40/5e/nsa-8-001.PMC4294021.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/3e/opth-9-091.PMC4294022.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 91–93Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  91Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S7498 1the use of endoillumination probe-assisted  Descemet membrane endothelial keratoplasty  for bullous keratopathy secondary to argon  laser iridotomy akira Kobayashi Hideaki Y okogawa Natsuko Yamazaki toshinori Masaki Kazuhisa sugiyama Department of Ophthalmology,   Kanazawa University Graduate school  of Medical science, Kanazawa, JapanPurpose:  To report the first case of Descemet membrane endothelial keratoplasty (DMEK)  for bullous keratopathy (BK) secondary to argon laser iridotomy (ALI).",Non-OADS,/arxiv_data1/oa_pdf/b6/3e/opth-9-091.PMC4294022.pdf
"A 71-year-old woman presented with decreased visual  acuity (20/200) in her right eye due to BK secondary to ALI that was performed  Correspondence: akira Kobayashi Department of Ophthalmology,  Kanazawa University Graduate school  of Medical science, 13-1 takara-machi,  Kanazawa-shi, Ishikawa-ken 920-8641,  Japan email kobaya@kenroku.kanazawa-u.ac.j p Journal name: Clinical Ophthalmology Article Designation: Case report Y ear: 2015 Volume: 9 Running head verso: Kobayashi et al Running head recto: Endoillumination probe-assisted DMEK DOI: http://dx.doi.org/10.2147/OPTH.S74981",Non-OADS,/arxiv_data1/oa_pdf/b6/3e/opth-9-091.PMC4294022.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b6/3e/opth-9-091.PMC4294022.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/3e/opth-9-091.PMC4294022.pdf
A biomarker may be used tosee how well the body responds to a treatment for adisease or condition’ (http://www.cancer.gov/dictionary).Biomarkers may be assessed early in drug development toindicate that drug has reached its target and elicited someresponse.,Non-OADS,/arxiv_data1/oa_pdf/da/19/bcp0079-0056.PMC4294077.pdf
Competing Interests All authors have completed the Uniﬁed CompetingInterest form at http://www.icmje.org/coi_disclosure.pdf Population pharmacokinetic–pharmacodynamic modelling in clinical oncology Br J Clin Pharmacol / 79: 1/6 7,Non-OADS,/arxiv_data1/oa_pdf/da/19/bcp0079-0056.PMC4294077.pdf
Available athttp://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071590.pdf (lastaccessed 7 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/da/19/bcp0079-0056.PMC4294077.pdf
"CA4P has progressed to phase II trials in patients withrelapsed ovarian cancer and to phase III trials in patientswith anaplastic thyroid cancer, primarily in combinationwith conventional chemotherapy (http://www.oxigene.com/product-development/zybrestat).",Non-OADS,/arxiv_data1/oa_pdf/e4/03/bph0171-4902.PMC4294113.pdf
Supporting information Additional Supporting Information may be found in the online version of this article at the publisher’s web-site: http://dx.doi.org/10.1111/bph.12817 Figure S1 Perfusion index calculated as the number of pixels stained +ve for FITC-lectin a sa%o ft h e number of pixels stained +ve for CD31 at 6 and 24 h after CA4P for CA4P alone group and for Y27632 administered 3 h after CA4P ( n>8 for all groups).,Non-OADS,/arxiv_data1/oa_pdf/e4/03/bph0171-4902.PMC4294113.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/00/9a/jmdh-8-001.PMC4294123.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 1–9Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  1Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S7523 9a comparison of effectiveness of hepatitis B  screening and linkage to care among foreign-born  populations in clinical and nonclinical settings edwin chandrasekar1 ravneet Kaur1 sharon song1 Karen e Kim2 1asian Health coalition, chicago,   il, Usa; 2Division of the Biological  sciences and Office of community  engagement and cancer Disparities,   University of chicago, chicago,    il, Usa correspondence: edwin chandrasekar   asian Health coalition, 180 West  Washington Street, Office 1000,   chicago, il 60602, Usa   Tel +1 312 731 8634   email edwin@asianhealth.or gAbstract:  Hepatitis B (HBV) is an urgent, unmet public health issue that affects Asian  Americans  disproportionately.",Non-OADS,/arxiv_data1/oa_pdf/00/9a/jmdh-8-001.PMC4294123.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/00/9a/jmdh-8-001.PMC4294123.pdf
"Available from: http://www.cdc.gov/hepatitis/populations/api.ht m.  Accessed September 22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/00/9a/jmdh-8-001.PMC4294123.pdf
"Available from: http://www.asian- nation.org/14-statistics.shtm l. Accessed September 22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/00/9a/jmdh-8-001.PMC4294123.pdf
Available  from: http://minorityhealth.hhs.gov/omh/browse.aspx?lvl=3&lvlid=63.,Non-OADS,/arxiv_data1/oa_pdf/00/9a/jmdh-8-001.PMC4294123.pdf
Available from: http://www.commonwealthfund.org/~/media/files/ publications/fund-report/2002/mar/diverse-communities--common- concerns--assessing-health-care-quality-for-minority-americans/ collins_diversecommun_523-pdf.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/9a/jmdh-8-001.PMC4294123.pdf
"Available from: http://www.nwrpca.net/health-center- news/253-community-health-workers-as-patient-navigators.htm l.  Accessed September 22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/00/9a/jmdh-8-001.PMC4294123.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/00/9a/jmdh-8-001.PMC4294123.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/9a/jmdh-8-001.PMC4294123.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/fa/dddt-9-291.PMC4294129.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 291–304Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  291Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7284 4Vipegitide: a folded peptidomimetic partial  antagonist of α2β1 integrin with antiplatelet  aggregation activity Tatjana Momic1 Jehoshua Katzhendler1 ela shai2 efrat noy3 hanoch senderowitz3 Johannes a eble4 cezary Marcinkiewicz5 David Varon2 Philip lazarovici1 1school of Pharmacy institute for  Drug research, Faculty of Medicine,   The hebrew University of Jerusalem,   2Department of hematology,   coagulation Unit, hadassah- hebrew  University Medical center, Jerusalem,   israel; 3Department of chemistry,   Bar-ilan University, ramat-gan, israel;   4institute for Physiological chemistry  and Pathobiochemistry, University  of Münster, Münster, germany;   5Department of Bioengineering,   college of engineering, Temple  University, Philadelphia, P a, UsaAbstract:  Linear peptides containing the sequence WKTSRTSHY were used as lead compounds  to synthesize a novel peptidomimetic antagonist of α2β1 integrin, with platelet aggregation- inhibiting activity, named Vipegitide.",Non-OADS,/arxiv_data1/oa_pdf/83/fa/dddt-9-291.PMC4294129.pdf
"This interaction mediates stable platelet binding via two major collagen  receptors, GPVI and integrin α2β1.1 Recently, strong evidence has been provided  to show that GPVI mainly functions as a signaling molecule to activate platelets by  releasing chemical messengers such as adenosine diphosphate (ADP), thrombin, and  thromboxane A2, whereas α2β1 is more involved in firm adhesion of platelets.2 This  adhesion triggers platelet aggregation via platelet αΙΙbβ3 interactions with fibrino - gen, which is essential in the interactions in central blood vessels under shear stress.3 correspondence: Philip lazarovici school of Pharmacy institute for  Drug research, Faculty of Medicine,  The hebrew University of Jerusalem,  Jerusalem 91120, israel Tel +972 2 675 8729 Fax +972 2 675 7490 email philipl@ekmd.huji.ac.i l Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Momic et al Running head recto: α2β1  folded peptidomimetic antagonist with antiplatelet activity DOI: http://dx.doi.org/10.2147/DDDT.S72844",Non-OADS,/arxiv_data1/oa_pdf/83/fa/dddt-9-291.PMC4294129.pdf
Available from: http://www.wma.net/ en/30publications/10policies/b3/index.html.,Non-OADS,/arxiv_data1/oa_pdf/83/fa/dddt-9-291.PMC4294129.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/83/fa/dddt-9-291.PMC4294129.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/fa/dddt-9-291.PMC4294129.pdf
"Version 5.0; http://www.eu roqol.org/about-eq-5d/publica- tions/user-guide.html (accessed October 18, 2013).",Non-OADS,/arxiv_data1/oa_pdf/9d/b9/jgc-11-04-279.PMC4294143.pdf
http://dx.doi.org/10.1016/j.jare.2013.06.011,OADS,/arxiv_data1/oa_pdf/90/69/main.PMC4294278.pdf
http://dx.doi.org/10.1016/j.jare.2013.06.004,OADS,/arxiv_data1/oa_pdf/d1/bb/main.PMC4294279.pdf
http://dx.doi.org/10.1016/j.jare.2013.06.001,OADS,/arxiv_data1/oa_pdf/99/71/main.PMC4294280.pdf
Reston (VA): American College of Radiology (ACR); 2010. p. 10 [cited 2010 October 1] Availablefrom: < http://www.guidelines.gov/content.aspx?id=32509 >.,Non-OADS,/arxiv_data1/oa_pdf/99/71/main.PMC4294280.pdf
[Epub ahead ofprint] doi: http://dx.doi.org/10.1177/0883073813486296 .,Non-OADS,/arxiv_data1/oa_pdf/99/71/main.PMC4294280.pdf
http://dx.doi.org/10.1016/j.jare.2013.08.005,OADS,/arxiv_data1/oa_pdf/d3/cf/main.PMC4294311.pdf
http://dx.doi.org/10.1016/j.jare.2013.07.009,OADS,/arxiv_data1/oa_pdf/e4/e4/main.PMC4294312.pdf
http://dx.doi.org/10.1016/j.jare.2013.08.003,OADS,/arxiv_data1/oa_pdf/37/00/main.PMC4294313.pdf
http://dx.doi.org/10.1016/j.jare.2013.07.005,OADS,/arxiv_data1/oa_pdf/24/ce/main.PMC4294314.pdf
http://dx.doi.org/10.1016/j.jare.2013.07.008,OADS,/arxiv_data1/oa_pdf/48/a1/main.PMC4294315.pdf
<http://www.dowcorning.com/content/publishedlit/ rubber_tech98.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/48/a1/main.PMC4294315.pdf
http://dx.doi.org/10.1016/j.jare.2013.07.001,OADS,/arxiv_data1/oa_pdf/9f/e5/main.PMC4294316.pdf
http://dx.doi.org/10.1016/j.jare.2013.08.002,OADS,/arxiv_data1/oa_pdf/7a/9e/main.PMC4294317.pdf
http://dx.doi.org/10.1016/j.jare.2013.07.003,OADS,/arxiv_data1/oa_pdf/22/e3/main.PMC4294318.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http://www.nature.",Non-OADS,/arxiv_data1/oa_pdf/34/cc/jcbfm2014169a.PMC4294395.pdf
"For the DEGs, gene IDs were converted to humanENSEMBL gene IDs using g:orth function from G:pro ﬁler (http://biit.cs.ut.ee/ gpro ﬁler), taking advantage of the more complete gene ontology anno- tations of the human genes and improving, in this way, the subsequentanalysis of the functional categories.",OADS,/arxiv_data1/oa_pdf/9a/87/jcbfm2014171a.PMC4294397.pdf
The complete microarray data have been deposited in NCBI ’s Gene Expression Omnibus and are accessible through GEO Series accession number GSE57836 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE57836).,OADS,/arxiv_data1/oa_pdf/9a/87/jcbfm2014171a.PMC4294397.pdf
"Gene ontology enrichment analy-sis was performed using Database for Annotation, Visualization, andIntegrated Discovery (DAVID) software tools (http://david.abcc.ncifcrf.gov),and the resulting categories were considered signi ﬁcant at Po0.05.",OADS,/arxiv_data1/oa_pdf/9a/87/jcbfm2014171a.PMC4294397.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http://www.nature.",Non-OADS,/arxiv_data1/oa_pdf/9a/87/jcbfm2014171a.PMC4294397.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/6e/main.PMC4294421.pdf
Wild-type (WT) as well as mutant proteins have been http://dx.doi.org/10.1016/j.pep.2014.11.006 1046-5928/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/92/6e/main.PMC4294421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/92/6e/main.PMC4294421.pdf
"[37] < http://www.ncbi.nlm.nih.gov/snp/?term=CES1&SITE=NcbiHome&submit=Go > National Center for Biotechnology Information (2011, October 13), retrieved 15.11.2011.U.",OADS,/arxiv_data1/oa_pdf/92/6e/main.PMC4294421.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/28/jer-10-6-343.PMC4294434.pdf
Copyright © 2014 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 343Evolution of exercise rehabilitation Haemi Jee Application of exercise has evolved significantly over recent  years.,Non-OADS,/arxiv_data1/oa_pdf/59/28/jer-10-6-343.PMC4294434.pdf
"Department of Health & Fitness Management,   Namseoul University, 91 Daehak-ro, Seonghwan-eup,   Sebuk-gu, Cheonan 331-707, Korea E-mail: wlgpal9@gmail.comhttp://dx.doi.org/10.12965/jer.140181Editorial Journal of Exercise Rehabilitation 2014;10(6):343-343",Non-OADS,/arxiv_data1/oa_pdf/59/28/jer-10-6-343.PMC4294434.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/9f/jer-10-6-344.PMC4294435.pdf
"Copyright © 2014 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 344*Corresponding author:  Seung Jun Choi Division of Sports and Health Science, Kyungsung University, 309 Suyoung-ro,  Nam-gu, Busan 608-736, Korea  Tel: +85-51-663-4955, Fax: +82-51-663-4956, Email: choisj@ks.ac.kr Received:  November 12, 2014 / Accepted:  November 17, 2014Differential susceptibility on myosin heavy chain isoform  following eccentric-induced muscle damage Seung Jun Choi* Division of Sports and Health Science, Kyungsung University, Busan, Korea Based on myosin heavy chain (MHC) isoform, human skeletal muscle fi - bers can be categorized into three fiber types, type I, IIa, IIx fibers, and  each fiber type has different characteristics.",Non-OADS,/arxiv_data1/oa_pdf/fd/9f/jer-10-6-344.PMC4294435.pdf
http://dx.doi.org/10.12965/jer.140171Review Article Journal of Exercise Rehabilitation 2014;10(6):344-348,Non-OADS,/arxiv_data1/oa_pdf/fd/9f/jer-10-6-344.PMC4294435.pdf
"http://www.e-jer.org     345 http://dx.doi.org/10.12965/jer.140171Choi SJ  •  Fiber type difference on eccentric-induced muscle damage PREVIOUS STUDIES IN DISTINCT  SUSCEPTIBILITY ON MHC ISOFORM Studies on humans have reported a greater susceptibility of fast- twitch fibers to damage (Asp et al., 1998; Friden et al., 1983;  Jones et al., 1986).",Non-OADS,/arxiv_data1/oa_pdf/fd/9f/jer-10-6-344.PMC4294435.pdf
"http://dx.doi.org/10.12965/jer.140171Choi SJ  •  Fiber type difference on eccentric-induced muscle damage 346    http://www.e-jer.orgtachments for thick and thin filaments (Yamaguchi et al., 1985).",OADS,/arxiv_data1/oa_pdf/fd/9f/jer-10-6-344.PMC4294435.pdf
http://www.e-jer.org     347 http://dx.doi.org/10.12965/jer.140171Choi SJ  •  Fiber type difference on eccentric-induced muscle damage hybrid fibers (IIa/IIx) are further sensitive to a standardized in vitro   eccentric contraction.,Non-OADS,/arxiv_data1/oa_pdf/fd/9f/jer-10-6-344.PMC4294435.pdf
http://dx.doi.org/10.12965/jer.140171Choi SJ  •  Fiber type difference on eccentric-induced muscle damage 348    http://www.e-jer.orgAppl Physiol 2004;97:1803-1813.,Non-OADS,/arxiv_data1/oa_pdf/fd/9f/jer-10-6-344.PMC4294435.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
"Copyright © 2014 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 349*Corresponding author:  Joohyung Lee  College of Physical Education, Kookmin University, 77 Jeongneung-ro,   Seongbuk-gu, Seoul 136-702, Korea Tel: +82-2-910-4782, Fax: +82-2-910-4789, E-mail: jolee@kookmin.ac.kr Received:  December 8, 2014 / Accepted:  December 17, 2014A review of nutritional intervention on delayed onset  muscle soreness.",Non-OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
Previous literatures have speculated that the cause of DOMS is http://dx.doi.org/10.12965/jer.140179Review Article Journal of Exercise Rehabilitation 2014;10(6):349-356,Non-OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
"http://dx.doi.org/10.12965/jer.140179Kim J, et al.",OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
"•  DOMS and nutritional intervention  350    http://www.e-jer.orgdue to structural muscle damages and perturbation of calcium ho - meostasis or acute inflammatory responses to exercise (Armstrong  et al., 1984; Smith et al., 1991).",Non-OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
"http://www.e-jer.org     351 http://dx.doi.org/10.12965/jer.140179Kim J, et al.",OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
"http://dx.doi.org/10.12965/jer.140179Kim J, et al.",OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
"•  DOMS and nutritional intervention  352    http://www.e-jer.orgpotential mechanism for reducing DOMS by ingestion with poly - phenol is its action on membrane stability and reduced lipid per - oxidation by inhibiting peroxyl radical activation (Jówko et al.,  2011).",Non-OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
"http://www.e-jer.org     353 http://dx.doi.org/10.12965/jer.140179Kim J, et al.",OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
"http://dx.doi.org/10.12965/jer.140179Kim J, et al.",OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
"•  DOMS and nutritional intervention  354    http://www.e-jer.orgis lyprionol, extracted from New Zealand green-lipped mussel  (Sinclair et al., 2000).",Non-OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
"http://www.e-jer.org     355 http://dx.doi.org/10.12965/jer.140179Kim J, et al.",OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
"http://dx.doi.org/10.12965/jer.140179Kim J, et al.",OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
•  DOMS and nutritional intervention  356    http://www.e-jer.orgSports Exerc 2010;42:493-498.,Non-OADS,/arxiv_data1/oa_pdf/89/f3/jer-10-6-349.PMC4294436.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/7d/jer-10-6-357.PMC4294437.pdf
"Copyright © 2014 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 357*Corresponding author:  Soon Gi Baek  Department of Leisure Sports, College of Health Science, Jungwon University,   85 Munmu-ro, Goesan-gun, Chungcheongbuk-do 367-700, Korea  Tel: +82-43-830-8840, Fax: +82-43-830-8679, E-mail: bsg@jwu.ac.kr Received:  November 30, 2014 / Accepted:  December 17, 2014The effect of Alexander technique training program:   A qualitative study of ordinary behavior application  Soo-Yeon Kim1, Soon Gi Baek2,* 1Kohwang Medical Research Institute, College of Medicine, Kyung Hee University, Seoul, Korea 2Department of Sports Health Medicine, College of Health Science, Jungwon University, Goesan-gun, Chungcheongbuk-do, Korea The purpose of this study was to configure and apply the Alexander  technique training program and assess the effect of program through physical, emotional and behavioral aspects.",Non-OADS,/arxiv_data1/oa_pdf/3a/7d/jer-10-6-357.PMC4294437.pdf
"Furthermore, Alexander technique education has been  applied in the fields of performing arts such as theatre, dance and http://dx.doi.org/10.12965/jer.140177Original Article Journal of Exercise Rehabilitation 2014;10(6):357-361",Non-OADS,/arxiv_data1/oa_pdf/3a/7d/jer-10-6-357.PMC4294437.pdf
"http://dx.doi.org/10.12965/jer.140177Kim S-Y, et al.",OADS,/arxiv_data1/oa_pdf/3a/7d/jer-10-6-357.PMC4294437.pdf
"•  The effect of Alexander technique training program 358    http://www.e-jer.orgmusic, with assessed improvements in performance (Fortin and  Girard, 2005).",Non-OADS,/arxiv_data1/oa_pdf/3a/7d/jer-10-6-357.PMC4294437.pdf
"http://www.e-jer.org     359 http://dx.doi.org/10.12965/jer.140177Kim S-Y, et al.",OADS,/arxiv_data1/oa_pdf/3a/7d/jer-10-6-357.PMC4294437.pdf
"http://dx.doi.org/10.12965/jer.140177Kim S-Y, et al.",OADS,/arxiv_data1/oa_pdf/3a/7d/jer-10-6-357.PMC4294437.pdf
•  The effect of Alexander technique training program 360    http://www.e-jer.orgchange.,Non-OADS,/arxiv_data1/oa_pdf/3a/7d/jer-10-6-357.PMC4294437.pdf
"http://www.e-jer.org     361 http://dx.doi.org/10.12965/jer.140177Kim S-Y, et al.",OADS,/arxiv_data1/oa_pdf/3a/7d/jer-10-6-357.PMC4294437.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/ca/jer-10-6-362.PMC4294438.pdf
"Copyright © 2014 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 362*Corresponding author:  Hee-Tae Roh Department of Physical Education, Y onsei University, 50 Y onsei-ro,   Seodaemun-gu, Seoul 120-749, Korea  Tel: +82-2-2123-3199, Fax: +82-2-2123-3199, E-mail: htroh@yonsei.ac.kr Received:  December 2, 2014 / Accepted:  December 17, 2014The effects of ketogenic diet on oxidative stress and  antioxidative capacity markers of Taekwondo athletes Hyun-seung Rhyu1, Su-Youn Cho2, Hee-Tae Roh3,* 1Department of Sports Health Medicine, College of Health Science, Jungwon University, Goesan-gun, Chungcheongbuk-do, Korea 2Department of Human Movement Science, Seoul Women’s University, Seoul, Korea 3Department of Physical Education, Yonsei University, Seoul, Korea The purpose of this study was to investigate the effects of the ketogenic  diet through 3 weeks on oxidative stress and antioxidative capacity markers in Taekwondo athletes.",Non-OADS,/arxiv_data1/oa_pdf/18/ca/jer-10-6-362.PMC4294438.pdf
"When such a physiological state, called ketosis, http://dx.doi.org/10.12965/jer.140178Original Article Journal of Exercise Rehabilitation 2014;10(6):362-366",Non-OADS,/arxiv_data1/oa_pdf/18/ca/jer-10-6-362.PMC4294438.pdf
"http://www.e-jer.org     363 http://dx.doi.org/10.12965/jer.140178Rhyu H, et al.",OADS,/arxiv_data1/oa_pdf/18/ca/jer-10-6-362.PMC4294438.pdf
"http://dx.doi.org/10.12965/jer.140178Rhyu H, et al.",OADS,/arxiv_data1/oa_pdf/18/ca/jer-10-6-362.PMC4294438.pdf
"•  Effect of ketogenic diet on oxidative stress 364    http://www.e-jer.orgdiet, as well as between KD and NKD groups, were determined by  two-way analysis of variance (ANOVA) using SPSS 18.0 for Win - dows.",OADS,/arxiv_data1/oa_pdf/18/ca/jer-10-6-362.PMC4294438.pdf
"http://www.e-jer.org     365 http://dx.doi.org/10.12965/jer.140178Rhyu H, et al.",OADS,/arxiv_data1/oa_pdf/18/ca/jer-10-6-362.PMC4294438.pdf
"http://dx.doi.org/10.12965/jer.140178Rhyu H, et al.",OADS,/arxiv_data1/oa_pdf/18/ca/jer-10-6-362.PMC4294438.pdf
•  Effect of ketogenic diet on oxidative stress 366    http://www.e-jer.orgdeath?,Non-OADS,/arxiv_data1/oa_pdf/18/ca/jer-10-6-362.PMC4294438.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/b0/jer-10-6-367.PMC4294439.pdf
"Copyright © 2014 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 367*Corresponding author:  Bog Ja Jeoung Department of Exercise Rehabilitation & Welfare, College of Health Science,   191 Hambakmoeiro, Y eonsu-gu, Incheon 461-701, Korea Tel: +82-32-820-4766, Fax: +82-32-820-4049, E-mail: bogja05@gachon.ac.kr Received:  November 30, 2014 / Accepted:  December 17, 2014The relationship between attention deficit hyperactivity  disorder and health-related physical fitness in university  students Bog Ja Jeoung* Department of Exercise Rehabilitation & Welfare, College of Health Science, Gachon University, Incheon, Korea College students with a tendency toward attention deficit/hyperactivity  disorder (ADHD) tend to act impulsively because they cannot control their behavior.",Non-OADS,/arxiv_data1/oa_pdf/88/b0/jer-10-6-367.PMC4294439.pdf
"Moreover, because the inci -http://dx.doi.org/10.12965/jer.140175Original Article Journal of Exercise Rehabilitation 2014;10(6):367-371",Non-OADS,/arxiv_data1/oa_pdf/88/b0/jer-10-6-367.PMC4294439.pdf
"http://dx.doi.org/10.12965/jer.140175Jeoung BJ  •  ADHD and physical fitness 368    http://www.e-jer.orgdence rate of psychopathology (e.g., antisocial behavior and mood  disorders) is high in individuals with ADHD, a therapeutic ap - proach is needed to address emotional problems.",Non-OADS,/arxiv_data1/oa_pdf/88/b0/jer-10-6-367.PMC4294439.pdf
http://www.e-jer.org     369 http://dx.doi.org/10.12965/jer.140175Jeoung BJ  •  ADHD and physical fitness was recorded.,OADS,/arxiv_data1/oa_pdf/88/b0/jer-10-6-367.PMC4294439.pdf
"http://dx.doi.org/10.12965/jer.140175Jeoung BJ  •  ADHD and physical fitness 370    http://www.e-jer.orgDISCUSSION This study confirmed a close relationship between participants’  muscular strength and endurance, abdominal obesity, and flexibil - ity and their risk factors for ADHD.",Non-OADS,/arxiv_data1/oa_pdf/88/b0/jer-10-6-367.PMC4294439.pdf
http://www.e-jer.org     371 http://dx.doi.org/10.12965/jer.140175Jeoung BJ  •  ADHD and physical fitness body as a whole.,Non-OADS,/arxiv_data1/oa_pdf/88/b0/jer-10-6-367.PMC4294439.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/55/jer-10-6-372.PMC4294440.pdf
"Copyright © 2014 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 372*Corresponding author:  Y oung Ock Kim  Department of Medicinal Crop Research Institute, National Institute of  Horticultural & Herbal Science, Rural Development Administration,   76-3 Bisanri, Soymyen, Eumseong-gun, Chungcheongbuk-do 369-873, Korea  Tel: +82-43-871-5585, Fax: +82-43-871-5589, E-mail: kyo9128@korea.kr Received:  November 10, 2014 / Accepted:  December 17, 2014Osteoprotective effect of extract from Achyranthes  japonica  in ovariectomized rats Jin-sung Kim1, Sang-Won Lee1, Su-Kang Kim2, Sae-Won Na3, Young-Ock Kim1,* 1Department of Medicinal Crop Research Institute, National Institute of Horticultural & Herbal Science, Rural Development Administration, Eumseong-gun,   Chungcheongbuk-do, Korea  2Kohwang Medical Research Institute, School of Medicine, Kyung Hee University, Seoul, Korea  3College of Veterinary Medicine, Chonbuk National University, Jeonju, Korea This study was carried out to investigate the effects of the Achyrantes  japonica ( A. japonica) extract on serum level of hormones from osteo - porosis induced ovariectomized rats.",Non-OADS,/arxiv_data1/oa_pdf/9a/55/jer-10-6-372.PMC4294440.pdf
"Hence,  sex steroid-related changes in GH and IGF-1 secretion may impact http://dx.doi.org/10.12965/jer.140169Original Article Journal of Exercise Rehabilitation 2014;10(6):372-377",Non-OADS,/arxiv_data1/oa_pdf/9a/55/jer-10-6-372.PMC4294440.pdf
"http://www.e-jer.org     373 http://dx.doi.org/10.12965/jer.140169Kim J-S, et al.",OADS,/arxiv_data1/oa_pdf/9a/55/jer-10-6-372.PMC4294440.pdf
"http://dx.doi.org/10.12965/jer.140169Kim J-S, et al.",OADS,/arxiv_data1/oa_pdf/9a/55/jer-10-6-372.PMC4294440.pdf
•  Osteoprotective effect of Achyranthes japonica 374    http://www.e-jer.orgsidered significant for values of P<0.05.,Non-OADS,/arxiv_data1/oa_pdf/9a/55/jer-10-6-372.PMC4294440.pdf
"http://www.e-jer.org     375 http://dx.doi.org/10.12965/jer.140169Kim J-S, et al.",OADS,/arxiv_data1/oa_pdf/9a/55/jer-10-6-372.PMC4294440.pdf
"http://dx.doi.org/10.12965/jer.140169Kim J-S, et al.",OADS,/arxiv_data1/oa_pdf/9a/55/jer-10-6-372.PMC4294440.pdf
•  Osteoprotective effect of Achyranthes japonica 376    http://www.e-jer.orgDISCUSSION This study showed that the A. japonica  enlargements IGF/IG - FBP on osteoporosis induced-ovariectomy rats.,Non-OADS,/arxiv_data1/oa_pdf/9a/55/jer-10-6-372.PMC4294440.pdf
"http://www.e-jer.org     377 http://dx.doi.org/10.12965/jer.140169Kim J-S, et al.",OADS,/arxiv_data1/oa_pdf/9a/55/jer-10-6-372.PMC4294440.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/71/jer-10-6-378.PMC4294441.pdf
"Copyright © 2014 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 378*Corresponding author:  Han Jung Department of Urology, Gachon University Gil Medical Center, Gachon University  of Medicine and Science, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon  405-760, Korea Tel: +82-32-460-3334, Fax: +82-32-460-8340, Email: urohana@gilhospital.com Received:  November 13, 2014 / Accepted:  December 17, 2014Modified laparoscopic intravesical nonrefluxing ureteral  reimplantation with psoas hitch using a submucosal  tunneling Chang-Hee Kim, Joo Hwan Ro, Han Jung* Department of Urology, Gachon University Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea We aimed to study the safety and efficacy of the cystoscopy-assisted  nonrefluxing ureteral reimplantation technique using submucosal tun - neling during laparoscopic ureteroneocystostomy (UNC) with a psoas hitch in patients with distal ureter stricture after gynecologic surgery.",Non-OADS,/arxiv_data1/oa_pdf/68/71/jer-10-6-378.PMC4294441.pdf
MATERIALS AND METHODS We reviewed the medical records of six female patients who un - derwent surgical repair in patients with distal ureter stricture after http://dx.doi.org/10.12965/jer.140174Original Article Journal of Exercise Rehabilitation 2014;10(6):378-382,Non-OADS,/arxiv_data1/oa_pdf/68/71/jer-10-6-378.PMC4294441.pdf
"http://www.e-jer.org     379 http://dx.doi.org/10.12965/jer.140174Kim C-H, et al.",OADS,/arxiv_data1/oa_pdf/68/71/jer-10-6-378.PMC4294441.pdf
"http://dx.doi.org/10.12965/jer.140174Kim C-H, et al.",OADS,/arxiv_data1/oa_pdf/68/71/jer-10-6-378.PMC4294441.pdf
•  A novel approach of nonrefluxing ureteral reimplantation 380    http://www.e-jer.orgorifice (Fig.,Non-OADS,/arxiv_data1/oa_pdf/68/71/jer-10-6-378.PMC4294441.pdf
"http://www.e-jer.org     381 http://dx.doi.org/10.12965/jer.140174Kim C-H, et al.",OADS,/arxiv_data1/oa_pdf/68/71/jer-10-6-378.PMC4294441.pdf
"http://dx.doi.org/10.12965/jer.140174Kim C-H, et al.",OADS,/arxiv_data1/oa_pdf/68/71/jer-10-6-378.PMC4294441.pdf
•  A novel approach of nonrefluxing ureteral reimplantation 382    http://www.e-jer.orgCONFLICT OF INTEREST No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/68/71/jer-10-6-378.PMC4294441.pdf
"This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
"Copyright © 2014 Korean Society of Exercise Rehabilitation http://www.e-jer.orgpISSN 2288-176X eISSN 2288-1778 383*Corresponding author:  Joo-Ho Chung Kohwang Medical Research Institute, School of Medicine, Kyung Hee University,   26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Korea Tel: +82-2-961-0281, Fax: +82-2-968-0560, E-mail: jhchung@khu.ac.kr Received:  November 8, 2014 / Accepted:  November 17, 2014Association of BID SNPs (rs8190315 and rs2072392) and  clinical features of benign prostate hyperplasia in Korean  population Hosik Seok1, Su Kang Kim1, Koo Han Yoo2, Byung-Cheol Lee3, Young Ock Kim4, Joo-Ho Chung1,* 1Department of Pharmacology and Kohwang Medical Research Institute, School of Medicine, Kyung Hee University, Seoul, Korea 2Department of Urology, Collage of Medicine, Kyung Hee University, Seoul, Korea 3Department of Internal Medicine, College of Oriental Medicine, Kyung Hee University, Seoul, Korea 4Herbal Crop Utilization Research Team, Department of Medicinal Crop Research Institute, National Institute of Horticulture & Herbal Science, Rural Administration,   Eumseong, Korea Exercise has beneficial effect on cancer apoptosis and benign prostatic  hyperplasia (BPH).",Non-OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
http://dx.doi.org/10.12965/jer.140168Original Article Journal of Exercise Rehabilitation 2014;10(6):383-388,Non-OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
"http://dx.doi.org/10.12965/jer.140168Seok H, et al.",OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
"•  BID SNPs and BPH 384    http://www.e-jer.orgMoreover, BID expression is related to cellular reaction to choles - terol oxidation (Jung et al., 2014), insulin resistance (Alkhouri et  al., 2010), effect of FTY720 to chronic myelogenous leukemia cells  (Kiyota et al., 2013), and interestingly, polymorphism of BID may  be related to breast cancer (Gaudet et al., 2009).",Non-OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
"They were searched from the SNP data - base in NCBI (http://www.ncbi.nlm.nih.gov/SNP), and reviewed  to select the region in exons and near exons.",OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
"Statistical analysis In the analysis of genotypes and allele frequencies, SNPStats  (http://bioinfo.iconcologia.net/index.php?module =Snpstats) and  SPSS 20.0 (SPSS Inc., Chicago, IL, USA) were used to obtain odds  ratios (ORs), 95% confidence intervals (CIs), and P-values of multi - ple logistic regression models.",OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
"http://www.e-jer.org     385 http://dx.doi.org/10.12965/jer.140168Seok H, et al.",OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
"http://dx.doi.org/10.12965/jer.140168Seok H, et al.",OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
"•  BID SNPs and BPH 386    http://www.e-jer.orgDISCUSSION In our study result, BID SNPs were not associated with develop - ment of BPH, however, prostate volume of BPH patients were as - sociated with BID SNPs.",OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
"http://www.e-jer.org     387 http://dx.doi.org/10.12965/jer.140168Seok H, et al.",OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
"http://dx.doi.org/10.12965/jer.140168Seok H, et al.",OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
"•  BID SNPs and BPH 388    http://www.e-jer.orgLin J, Zhou J, Xu W, Hong Z, Peng J. Qianliening capsule inhibits benign  prostatic hyperplasia angiogenesis via the HIF-1alpha signaling path - way.",Non-OADS,/arxiv_data1/oa_pdf/a7/2e/jer-10-6-383.PMC4294442.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/a1/rju141.PMC4294453.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/f8/rju148.PMC4294454.pdf
Using postmortem brains from FXS patients and Fmr1 knockout  © 2014 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/fe/nihms-652749.PMC4294557.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and six figures and can be found with this article online at  http://dx.doi.org/10.1016/j.celrep.2014.10.064 .,OADS,/arxiv_data1/oa_pdf/9b/fe/nihms-652749.PMC4294557.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/07/ijwh-7-019.PMC4294621.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 19–29International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  19OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S7190 6adherence with ethinylestradiol 20 µg/ drospirenone 3 mg in a flexible extended regimen  supported by the use of a digital tablet dispenser  with or without acoustic alarm: an open-label,  randomized, multicenter study Inka Wiegratz1,2 Jörg elliesen3 anna Maria Paoletti4 anja Walzer3 Bodo Kirsch3 1Kinderwunschpraxis am Goetheplatz,   Frankfurt, Germany; 2MVZ  Kinderwunschzentrum Wiesbaden  GmbH, Wiesbaden, Germany; 3Bayer  HealthCare Pharmaceuticals, Berlin,   Germany; 4clinica Ostetrica e  Ginecologica, University of Cagliari,   Cagliari, Italy correspondence: Inka Wiegratz  Obstetrics and Gynecology, Gynecological  Endocrinology and Reproductive Medicine,  Kinderwunschpraxis am Goetheplatz,  Kaiserstrasse 3, 60311 Frankfurt, Germany   Tel +49 69 9686 9699   Fax +49 69 9686 9670   email inka.wiegratz@web.d eObjective:  To evaluate the effect of a digital dispenser’ s acoustic alarm function on adher - ence to ethinylestradiol (EE) 20 µg/drospirenone 3  mg in a flexible extended regimen  (EE/drospirenoneFlex) among women in five European countries (France, Germany, Italy, Spain,  UK) seeking oral contraception.",Non-OADS,/arxiv_data1/oa_pdf/41/07/ijwh-7-019.PMC4294621.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/41/07/ijwh-7-019.PMC4294621.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/07/ijwh-7-019.PMC4294621.pdf
Available from: http://www.arhp.,Non-OADS,/arxiv_data1/oa_pdf/41/07/ijwh-7-019.PMC4294621.pdf
Available from: http://www.mydr.com.au/medicines/cmis/yaz- flex-table ts.,Non-OADS,/arxiv_data1/oa_pdf/41/07/ijwh-7-019.PMC4294621.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/7e/ijn-10-371.PMC4294622.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 371–385International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  371OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7301 7cationic additives in nanosystems activate  cytotoxicity and inflammatory response of human  neutrophils: lipid nanoparticles versus polymeric  nanoparticles Tsong-long hwang1,2 Ibrahim A Aljuffali3 Chwan-Fwu Lin4,5 Yuan-Ting Chang6 Jia-Y ou Fang6–8 1Cell Pharmacology Laboratory,   graduate Institute of Natural  Products, 2Chinese Herbal Medicine  Research T eam, Healthy Aging  Research Center, Chang Gung  University, Kweishan, Taoyuan, Taiwan;   3Department of Pharmaceutics,   College of Pharmacy, King Saud  University, Riyadh, Saudi Arabia;   4Department of cosmetic science,   5Chronic Diseases and Health  Promotion Research Center, Chang  gung University of science and  T echnology, Kweishan, Taoyuan, Taiwan;   6Pharmaceutics Laboratory, Graduate  Institute of Natural Products, Chang  Gung University, Kweishan, Taoyuan,   Taiwan; 7Research Center for Industry  of Human Ecology, Chang Gung  University of Science and T echnology,   Kweishan, Taoyuan, Taiwan; 8Chang  Gung Memorial Hospital, Kweishan,   Taoyuan, TaiwanAbstract:  This report compares the effect of lipid and polymeric nanoparticles upon human  neutrophils in the presence of cationic surfactants.",Non-OADS,/arxiv_data1/oa_pdf/96/7e/ijn-10-371.PMC4294622.pdf
"PLGA is approved by the  US Food and Drug Administration (FDA) for use in parenteral injections, implants, correspondence: Jia-You Fang Pharmaceutics Laboratory, Graduate  Institute of Natural Products, Chang  gung University, 259 Wen- hwa 1st road,  Kweishan, Taoyuan 333, Taiwan Tel +886 3 211 8800 ext 5521 Fax +886 3 211 8236 email fajy@mail.cgu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Hwang et al Running head recto: Effects of lipid versus polymeric nanoparticles on human neutrophils DOI: http://dx.doi.org/10.2147/IJN.S73017",Non-OADS,/arxiv_data1/oa_pdf/96/7e/ijn-10-371.PMC4294622.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/96/7e/ijn-10-371.PMC4294622.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/7e/ijn-10-371.PMC4294622.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/52/rju149.PMC4294632.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/49/ijwh-7-075.PMC4294645.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 75–83International Journal of Women’s Health Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/82/49/ijwh-7-075.PMC4294645.pdf
"Or use: http://dvpr.es/11zjpN 2Dove press submit your manuscript | www.dovepress.co m Dove press  75OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S6866 7Seroprevalence of rubella-specific IgM and IgG  antibodies among pregnant women seen in a  tertiary hospital in Nigeria Okikiola M Olajide1 Maryam Aminu1 abdullahi J randawa2 Daniel S Adejo2 1Department of Microbiology, Faculty  of Science, Ahmadu Bello University,   2Department of Obstetrics and  Gynaecology, Ahmadu Bello University  T eaching Hospital, Zaria, Nigeria Correspondence: Maryam Aminu   Department of Microbiology,   Faculty of Science, Ahmadu Bello   University, Zaria, Kaduna, Nigeria   Tel +234 803 328 7031   email maryamaminu@yahoo.co mBackground:  Rubella is a contagious viral infection that in pregnant women leads to the infec - tion of a developing fetus, causing fetal death or congenital rubella syndrome.",Non-OADS,/arxiv_data1/oa_pdf/82/49/ijwh-7-075.PMC4294645.pdf
"Available from: http://www.mayoclinic.com/health/rubella/DS00332/ DSECTION=preventio n. Accessed March 30, 2012.",Non-OADS,/arxiv_data1/oa_pdf/82/49/ijwh-7-075.PMC4294645.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/82/49/ijwh-7-075.PMC4294645.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/49/ijwh-7-075.PMC4294645.pdf
"Available  from: http://www.who.int/mediacentre/factsheets/fs367/e n. Accessed  June 26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/82/49/ijwh-7-075.PMC4294645.pdf
Available  from: http://emedicine.medscape.com/article/1133108-overview.,Non-OADS,/arxiv_data1/oa_pdf/82/49/ijwh-7-075.PMC4294645.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/6d/dddt-9-321.PMC4294646.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 321–331Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  321Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7216 5Screening strategies to identify HSP70 modulators  to treat Alzheimer’s disease Jayanthi Repalli Daniel Meruelo Department of Pathology, New Y ork  University, Langone Medical Center,   New Y ork, NY, USAAbstract:  Alzheimer’s disease, the most common type of dementia, is a progressive brain disease  that destroys cognitive function and eventually leads to death.",Non-OADS,/arxiv_data1/oa_pdf/d5/6d/dddt-9-321.PMC4294646.pdf
"This article discusses the importance of eliminating beta amyloid  and tau, and reviews state of the art screening methodologies that are suited to this  task, discussing their advantages and limitations.Correspondence: Daniel Meruelo Gene Therapy Center, 180 varick Street,  Room 802, New York, NY 10014, USA Tel +1 212 263 5599 Fax +1 212 263 8211 email dm01@mac.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Repalli and Meruelo Running head recto: Identifying HSP70 modulators for Alzheimer’s disease DOI: http://dx.doi.org/10.2147/DDDT.S72165",Non-OADS,/arxiv_data1/oa_pdf/d5/6d/dddt-9-321.PMC4294646.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d5/6d/dddt-9-321.PMC4294646.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/6d/dddt-9-321.PMC4294646.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/c2/ijn-10-399.PMC4294647.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 399–408International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  399OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7015 3Detection of a fluorescent-labeled avidin-nucleic acid  nanoassembly by confocal laser endomicroscopy  in the microvasculature of chronically inflamed  intestinal mucosa andrea Buda1,* sonia Facchin1,* elisa Dassie2 Elisabetta Casarin3  Mark a Jepson4 helmut Neumann5 giorgia hatem1 stefano realdon6 renata D’Incà1 giacomo carlo sturniolo1 Margherita Morpurgo3 1Department of surgical, Oncological,   and gastroenterological sciences,   University of Padova, 2Department  of Molecular Medicine, University of  Padova, Padova, Italy; 3Department of  Pharmaceutical and Pharmacological  Sciences, University of Padova, Padova,   Italy; 4School of Biochemistry and  Wolfson Bioimaging Facility, University  of Bristol, Bristol, UK; 5ludwig Demlig  endoscopic center of excellence,   ESGE Endoscopy Training Center,   University of Erlangen-Nuremberg,   Erlangen, Germany; 6Veneto Institute  of Oncology IOV-IRCCS, Padova, Italy *These authors contributed equally to  this work Abstract:  Inflammatory bowel diseases are chronic gastrointestinal pathologies causing great  discomfort in both children and adults.",Non-OADS,/arxiv_data1/oa_pdf/c6/c2/ijn-10-399.PMC4294647.pdf
"Standard treatments to induce disease remission include amin - osalicylates, corticosteroids, and immunosuppressive agents such as thiopurines and  anti-tumor necrosis factor- α. Immunomodulator and combination therapies constitute  a significant advance in the management of IBD.4–7 However, the onset of action is  delayed with some of these drugs, and/or important adverse systemic effects often correspondence: Margherita Morpurgo Pharmaceutical and Pharmacological  Sciences Department, University  of Padova, via Marzolo 5, 35131  Padova, Italy Tel +39 04 9827 5330 Fax +39 04 9827 5366 email margherita.morpurgo@unipd.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Buda et al Running head recto: IBD-related detection of ANANAS-nanoparticles by CLE DOI: http://dx.doi.org/10.2147/IJN.S70153",Non-OADS,/arxiv_data1/oa_pdf/c6/c2/ijn-10-399.PMC4294647.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c6/c2/ijn-10-399.PMC4294647.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/c2/ijn-10-399.PMC4294647.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/73/40/ijn-10-433.PMC4294648.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 433–445International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  433OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7632 9Barium titanate nanoparticles and hypergravity  stimulation improve differentiation of  mesenchymal stem cells into osteoblasts antonella rocca1,2 attilio Marino1,2 Veronica rocca3 stefania Moscato4 giuseppe de Vito5,6 Vincenzo Piazza5 Barbara Mazzolai1 Virgilio Mattoli1 Thu Jennifer Ngo-anh7 gianni ciofani1 1Istituto Italiano di T ecnologia,   center for Micro-Bio robotics @ sssa, Pontedera, Italy, 2scuola  superiore sant’anna, The Bio robotics  Institute, Pontedera, Italy, 3Università  di Pisa, Dipartimento di Ingegneria  dell’Informazione, Pisa, Italy,   4Università di Pisa, Dipartimento di  Medicina clinica e sperimentale, Pisa,   Italy, 5Istituto Italiano di T ecnologia,   center for Nanotechnology  Innovation @N esT, Pisa, Italy, 6scuola  Normale superiore, N esT, Pisa, Italy,   7Directorate of human spaceflight  and Operations, european space  agency, Noordwijk, the NetherlandsBackground:  Enhancement of the osteogenic potential of mesenchymal stem cells (MSCs)  is highly desirable in the field of bone regeneration.",Non-OADS,/arxiv_data1/oa_pdf/73/40/ijn-10-433.PMC4294648.pdf
"Keywords:  mesenchymal stem cells, hypergravity, barium titanate nanoparticles, osteogenesis Introduction Physical stimuli can significantly alter cellular behavior, giving rise to biochemical  signals involved in molecular response.1 This process is called mechanotransduc - tion, and the responsible structures sensitive to mechanical forces are most probably  cytoskeleton elements.2 A number of studies have demonstrated that cells are sensitive to several kinds  of physical cues (shear stress, topography, mechanical deformation, etc), influencing  cell migration,3 differentiation,4 and proliferation.5 Among these stimuli, gravity is  required for the correct development of land-based organisms, and in particular for  the skeleton and for the muscle and nervous systems.6 An increasing amount of research is focused on the effects of gravity alterations  on the physiological processes, but also on the possibility to exploit this stimulus as  a potential therapeutic cue.7–9 As an example, improved regeneration of infarcted  myocardium has been achieved after injection of stem cells differentiated following correspondence: antonella rocca/   gianni ciofani center for Micro-Biorobotics, Istituto  Italiano di Tecnologia (IIT@sssa),  34 Viale rinaldo Piaggio, Pontedera,  Pisa 56025, Italy Tel +39 050 883 089 Fax +39 050 883 497 email antonella.rocca@iit.i t/ gianni.ciofani@iit.i tJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Rocca et al Running head recto: BTNPs and hypergravity for MSC osteo-differentiation DOI: http://dx.doi.org/10.2147/IJN.S76329",Non-OADS,/arxiv_data1/oa_pdf/73/40/ijn-10-433.PMC4294648.pdf
"Cell area  and different shape descriptors were calculated with ImageJ  software ( http://rsb.info.nih.gov/i j) analyzing at least 50 well- distinct cells, acquired with an inverted optical microscope  (Nikon Eclipse Ti).",OADS,/arxiv_data1/oa_pdf/73/40/ijn-10-433.PMC4294648.pdf
"With regard  to image analysis, data were tested with the nonparametric  Kruskal–Wallis analysis followed by the Nemenyi–Damico– Wolfe–Dunn post hoc test to assess significance using R soft - ware ( http://www.r-project.or g).",Non-OADS,/arxiv_data1/oa_pdf/73/40/ijn-10-433.PMC4294648.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/73/40/ijn-10-433.PMC4294648.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/40/ijn-10-433.PMC4294648.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 47–58International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  47RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S7446 2eribulin for the treatment of metastatic breast  cancer: an update on its safety and efficacy Mark K Doherty Patrick G Morris Department of Medical Oncology,   Beaumont Hospital, Dublin, IrelandAbstract:  Breast cancer remains a leading cause of cancer-related death internationally.",Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
"Finally, for patients with tumors that lack expression of the estrogen receptor, HER2, Correspondence: Patrick G Morris Department of Medical Oncology,  Beaumont Hospital, Dublin 9, Ireland Tel +353 1 809 3000 email patrickmorris@beaumont.i e Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Doherty and Morris Running head recto: Eribulin in metastatic breast cancer DOI: http://dx.doi.org/10.2147/IJWH.S74462",Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://globocan.iarc.fr .,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
"Available from: http://www.accessdata.fda.gov/ drugsatfda_docs /label/2010/201532lbl.pd f. Accessed July 10 , 2014.",Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Public_assessment_report/human/002084/ WC500105115.pd f. Accessed July 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
"Available from:  http://www.ncpe.ie/wp-content/uploads/2011/03/Eribulin-Halaven- Summary1.pd f. Accessed July 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
"Available from:  http://www.pcodr.ca/idc/groups/pcodr/documents/pcodrdocument/ pcodr-halaven-in-egr.pd f. Accessed July 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://clinicaltrials.gov/show/ NCT0159675 1.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://clinicaltrials.gov/show/NCT0179558 6.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Avail - able from: http://clinicaltrials.gov/show/NCT0212046 9.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://clinicaltrials.gov/show/NCT0191296 3.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://clinicaltrials.gov/show/ NCT0194140 7.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://clinicaltrials.gov/show/NCT0206108 5.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://clinicaltrials.gov/show/NCT0182778 7.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://clinicaltrials.gov/show/ NCT0217544 6.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://clinicaltrials.gov/show/NCT0200059 6.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://clinicaltrials.gov/ show/NCT0203752 9.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://clinicaltrials.gov/show/ NCT0166925 2.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://clinicaltrials.gov/show/NCT0143928 2.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available from: http://clinicaltrials.gov/show/ NCT0149858 8.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
Available  from: http://www.clinicaltrials.gov/show/NCT015930 2.,Non-OADS,/arxiv_data1/oa_pdf/76/1a/ijwh-7-047.PMC4294649.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/d7/dddt-9-333.PMC4294650.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 333–347Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  333Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6726 4Current and emerging treatment options  for ANCA-associated vasculitis: potential role  of belimumab and other BAFF/APRiL targeting  agents Aleksander Lenert1 Petar Lenert2 1Division of Rheumatology, University  of Kentucky, Kentucky Clinic,   Lexington, KY, USA; 2Division of  immunology, Department of internal  Medicine, The University of iowa,   iowa City, iA, USAAbstract:  Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)  comprises several clinical entities with diverse clinical presentations, outcomes, and nonunifying  pathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/b8/d7/dddt-9-333.PMC4294650.pdf
"The connecting pathologic feature of this group  of diseases is a necrotizing small-vessel vasculitis commonly affecting multiple organs,  including lungs and kidneys (pulmonary–renal syndromes).1 Despite grouping them  together under the umbrella of AAV, there are significant clinical and pathophysiologic Correspondence: Petar Lenert Division of immunology, Department  of internal Medicine, The University  of iowa, C428-2GH, 200 Hawkins Drive,  iowa City, iA 52242, USA email petar-lenert@uiowa.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Lenert and Lenert Running head recto: Targeting BAFF for the treatment of AAV DOI: http://dx.doi.org/10.2147/DDDT.S67264 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/b8/d7/dddt-9-333.PMC4294650.pdf
Or use: http://dvpr.es/1ByluV Wvideo abstract,Non-OADS,/arxiv_data1/oa_pdf/b8/d7/dddt-9-333.PMC4294650.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b8/d7/dddt-9-333.PMC4294650.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/d7/dddt-9-333.PMC4294650.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/81/dddt-9-305.PMC4294651.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 305–312Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  305Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7613 5Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Huang et al Running head recto: Sample sizes in phase II clinical trials DOI: http://dx.doi.org/10.2147/DDDT.S76135 Sample sizes in dosage investigational clinical  trials:  a systematic evaluation Abstract:  The main purpose of investigational phase II clinical trials is to explore indications and  effective doses.",Non-OADS,/arxiv_data1/oa_pdf/d0/81/dddt-9-305.PMC4294651.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d0/81/dddt-9-305.PMC4294651.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/81/dddt-9-305.PMC4294651.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/63/ijn-10-419.PMC4294652.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 419–432International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  419OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7489 1effective near-infrared photodynamic therapy  assisted by upconversion nanoparticles conjugated  with photosensitizers Qing Qing Dou1 choon Peng T eng1 enyi Ye1 Xian Jun loh1–3 1Institute of Materials research and  engineering, a*sT ar, singapore;   2Department of Materials science  and engineering, National University  of singapore, singapore; 3singapore  eye research Institute, singaporeAbstract:  A drug model photosensitizer–conjugated upconversion nanoparticles nanocomplex  was explored for application in near-infrared photodynamic therapy.",Non-OADS,/arxiv_data1/oa_pdf/8a/63/ijn-10-419.PMC4294652.pdf
"UCNs are inorganic luminescent materials made from lanthanide elements.21,22  UCNs absorb NIR light but emit UV -visible light, which can be used as a transducer  to perform NIR PDT with a wide range of clinically approved photosensitizers for correspondence: Xian Jun loh Institute of Materials research and  engineering, a*sTar, 3 research link,  singapore 117602, singapore   Tel +65 6874 1088   email lohxj@imre.a-star.edu.s g;  xianjun_l oh@scholars.a-star.edu.s g Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Dou et al Running head recto: An NIR photodynamic therapy agent with UCNs as transducers DOI: http://dx.doi.org/10.2147/IJN.S74891",Non-OADS,/arxiv_data1/oa_pdf/8a/63/ijn-10-419.PMC4294652.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8a/63/ijn-10-419.PMC4294652.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/63/ijn-10-419.PMC4294652.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/33/f0/dddt-9-349.PMC4294653.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 349–417Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  349Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7167 7Plumbagin elicits differential proteomic responses  mainly involving cell cycle, apoptosis, autophagy,  and epithelial-to-mesenchymal transition pathways  in human prostate cancer Pc-3 and DU145 cells Jia-Xuan Qiu1,2 Zhi-Wei Zhou3,4 Zhi-Xu he4 ruan Jin Zhao5 Xueji Zhang6 lun Yang7 shu-Feng Zhou3,4 Zong-Fu Mao1 1school of Public health, Wuhan University,   Wuhan, hubei, People’s republic of china;   2Department of Oral and Maxillofacial  surgery, The First affiliated hospital  of nanchang University, nanchang, Jiangxi,   People’s republic of china; 3Department  of Pharmaceutical sciences, college  of Pharmacy, University of south Florida,   Tampa, Fl, Usa; 4guizhou Provincial Key  laboratory for regenerative Medicine,   stem cell and Tissue engineering research  center and sino-U s Joint laboratory  for Medical sciences, guiyang Medical  University, guiyang, guizhou, People’s  republic of china; 5center for Traditional  chinese Medicine, sarasota, Fl, Usa;   6research center for Bioengineering and  sensing Technology, University of science  and Technology Beijing, Beijing, People’s  republic of china; 7Bio-X institutes,   Key laboratory for the genetics  of Development and neuropsychiatric  Disorders (Ministry of education), shanghai  Jiao Tong University, shanghai, People’s  republic of chinaAbstract:  Plumbagin (PLB) has exhibited a potent anticancer effect in preclinical studies,  but the molecular interactome remains elusive.",Non-OADS,/arxiv_data1/oa_pdf/33/f0/dddt-9-349.PMC4294653.pdf
"Keywords:  EMT, proteomics, SILAC  Introduction Prostate cancer is the second most common cancer in men worldwide, after lung  cancer.1 There were over 903,500 new prostate cancer cases reported worldwide and correspondence: Zong-Fu Mao  school of Public health, Wuhan University,  185 Donghu road, Wuchang District, Wuhan  430071, hubei, People’s republic of china Tel +86 27 6875 9609 email zfmao@126.co m  shu-Feng Zhou Department of Pharmaceutical sciences,  college of Pharmacy, University of south  Florida, 12901 Bruce B Downs Blvd., MDc 30,  Tampa, Fl 33612, Usa Tel +1 813 974 6276 Fax +1 813 905 9885 email szhou@health.usf.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Qiu et al Running head recto: Plumbagin elicits a proteomic response in prostate cancer cells DOI: http://dx.doi.org/10.2147/DDDT.S71677",Non-OADS,/arxiv_data1/oa_pdf/33/f0/dddt-9-349.PMC4294653.pdf
"Available from: http://globocan.iarc.fr,  accessed on November 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/33/f0/dddt-9-349.PMC4294653.pdf
Atlanta: 2011Available from: http://www.can - cer.org/research/cancerfactsfigures/globalcancerfactsfigures/.,Non-OADS,/arxiv_data1/oa_pdf/33/f0/dddt-9-349.PMC4294653.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/33/f0/dddt-9-349.PMC4294653.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/f0/dddt-9-349.PMC4294653.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f4/6c/ijwh-7-059.PMC4294654.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 59–73International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  59OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S75030cost effectiveness of endometrial ablation   with the novasure® system versus other   global ablation modalities and hysterectomy   for treatment of abnormal uterine bleeding:   Us commercial and Medicaid payer perspectives Jeffrey D Miller1 gregory M lenhart1 Machaon M Bonafede1 cindy M Basinski2 andrea s lukes3 Kathleen a Troeger4 1Truven Health analytics, cambridge,   Ma, 2Basinski, llc, newburgh, In ,  3carolina Women’s research and  Wellness center, Durham, nc,  4Hologic, Inc, Marlborough, M a, Usa correspondence: Jeffrey D Miller   Truven Health analytics,   150 cambridge Park Drive,  2nd Floor,  cambridge, Ma  02140, Usa   email jeffrey.d.miller@truvenhealth.co mObjectives:  Abnormal uterine bleeding (AUB) interferes with physical, emotional, and  social well-being, impacting the quality of life of more than  10 million women in the USA.",Non-OADS,/arxiv_data1/oa_pdf/f4/6c/ijwh-7-059.PMC4294654.pdf
"available from: http://www.ispor.org/research_pdfs/43/pdffiles/PIH17.pd f and http://www.ispor.org/ research_pdfs/43/pdffiles/PIH22.pd f. Data also adapted from Bonafede MM, Miller JD, laughlin-Tommaso sK, lukes as, Meyer nM, lenhart gM.",OADS,/arxiv_data1/oa_pdf/f4/6c/ijwh-7-059.PMC4294654.pdf
"available from: http://www.ispor.org/research_pdfs/43/pdffiles/PIH17.pd f and http://www.ispor.org/ research_pdfs/43/pdffiles/PIH22.pd f. Data also adapted from Bonafede MM, Miller JD, laughlin-Tommaso sK, lukes as, Meyer nM, lenhart gM.",OADS,/arxiv_data1/oa_pdf/f4/6c/ijwh-7-059.PMC4294654.pdf
"available from:  http://www.ispor.org/research_pdfs/43/pdffiles/PIH17.pd f and http://www.ispor.org/ research_pdfs/43/pdffiles/PIH22.pd f. Data also adapted from Bonafede MM, Miller JD,  laughlin-Tommaso sK, lukes as, Meyer nM, lenhart gM.",OADS,/arxiv_data1/oa_pdf/f4/6c/ijwh-7-059.PMC4294654.pdf
available  from: http://www.ispor.org/research_pdfs/43/pdffiles/PIH17.pd f and http://www.,Non-OADS,/arxiv_data1/oa_pdf/f4/6c/ijwh-7-059.PMC4294654.pdf
"available online at http://www.ssa.gOv/oact/sTaTs/ table4c6.html#s s (accessed  June 19, 2 014).",OADS,/arxiv_data1/oa_pdf/f4/6c/ijwh-7-059.PMC4294654.pdf
"Available  from: http://www.accessdata.fda.gov/cdrh_docs/pdf/P010013a.pd f.  Accessed October  18, 2014.",OADS,/arxiv_data1/oa_pdf/f4/6c/ijwh-7-059.PMC4294654.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/f4/6c/ijwh-7-059.PMC4294654.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/6c/ijwh-7-059.PMC4294654.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/13/ijwh-7-041.PMC4294656.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 41–46International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  41ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S7044 2Is routine antenatal venereal disease research  laboratory test still justified?,Non-OADS,/arxiv_data1/oa_pdf/a1/13/ijwh-7-041.PMC4294656.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a1/13/ijwh-7-041.PMC4294656.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/13/ijwh-7-041.PMC4294656.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/23/1c/ijn-10-387.PMC4294657.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 387–397International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  387OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7355 8Molecular photoacoustic imaging of breast cancer  using an actively targeted conjugated polymer ghayathri Balasundaram1,* chris Jun hui ho1,* Kai li2 Wouter Driessen3 Us Dinish1 chi lok Wong1 Vasilis Ntziachristos3 Bin liu2 Malini Olivo1,4 1Bio-Optical Imaging group,   singapore Bioimaging consortium  (sBIc), 2Institute of Materials  research and engineering (IM re),   agency for science, Technology  and research (a*sT ar), singapore;   3Institute of Biological and Medical  Imaging, helmholtz center Munich,   Neuherberg, germany; 4school  of Physics, National University  of Ireland, galway, Ireland *These authors contributed equally  to this workAbstract:  Conjugated polymers (CPs) are upcoming optical contrast agents in view of their  unique optical properties and versatile synthetic chemistry.",Non-OADS,/arxiv_data1/oa_pdf/23/1c/ijn-10-387.PMC4294657.pdf
"Currently, various exogenous contrast agents have been explored for PA imaging, in correspondence: Malini Olivo Bio-Optical Imaging group, singapore  Bioimaging consortium (sBIc), agency  for science, Technology and research  (a*sTar), 11 Biopolis Way, # 01-02,  helios, singapore 138667 Tel +65 6478 8745 Fax +65 6478 9957 email malini_olivo@sbic.a-star.edu.s g  Bin liu Institute of Materials research and  engineering (IMre), agency for science,  Technology and research (a*sTar),  3 research link, singapore 117602 Tel +65 6513 1273 email cheliub@nus.edu.s g Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Balasundaram et al Running head recto: In vivo targeted photoacoustic imaging of breast cancer DOI: http://dx.doi.org/10.2147/IJN.S73558",Non-OADS,/arxiv_data1/oa_pdf/23/1c/ijn-10-387.PMC4294657.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/23/1c/ijn-10-387.PMC4294657.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/23/1c/ijn-10-387.PMC4294657.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/79/db/161.PMC4294665.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6c/6e/172.PMC4294666.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/70/a5/185.PMC4294667.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d0/42/195.PMC4294668.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9c/ee/205.PMC4294669.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5d/3a/218.PMC4294670.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0b/ce/229.PMC4294671.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/25/46/238.PMC4294672.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f9/15/256.PMC4294673.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/82/d3/270.PMC4294674.pdf
Two months after publication  it is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/24/36/283.PMC4294675.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4a/0e/294.PMC4294676.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/76/26/305.PMC4294677.pdf
T wo months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/08/67/316.PMC4294678.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc- sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0e/ce/327.PMC4294679.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a0/c8/339.PMC4294680.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/20/fe/350.PMC4294681.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/ licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c1/a2/359.PMC4294682.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b6/d5/373.PMC4294683.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/0d/ndt-11-067.PMC4294689.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 67–73Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  67OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7430 3Factors associated with the risk of relapse  in schizophrenic patients after a response to  electroconvulsive therapy: a retrospective study chiyo shibasaki1 Minoru Takebayashi1,2 Yasutaka Fujita1 shigeto Yamawaki3 1Division of Psychiatry and  Neuroscience, institute for clinical  research, National hospital  Organization (N hO) Kure Medical  center and chugoku cancer center,   Kure, hiroshima, Japan; 2Department  of Psychiatry, N hO Kure Medical  center and chugoku cancer center,   Kure, hiroshima, Japan; 3Department  of Psychiatry and Neurosciences,   Division of Frontier Medical science,   Programs for Biomedical research,   graduate school of Biomedical  sciences, hiroshima University,   Minami-ku, hiroshima, JapanPurpose:  Electroconvulsive therapy (ECT) is an effective treatment for depression and  schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/86/0d/ndt-11-067.PMC4294689.pdf
"When antipsychotic medication  was introduced in the 1950s, the use of ECT for schizophrenia declined.1 However,  due to resistance and intolerance to pharmacotherapy in some patients, ECT can be  beneficial2 and therefore ECT for schizophrenia is still being performed worldwide.3,4  Several national guidelines suggest the use of ECT for schizophrenia in particular  circumstances.5 The American Psychiatric Association (APA)6 suggests that “ECT  is effective for psychotic exacerbations in schizophrenic patients, when illness is of  the catatonic type, when the psychotic symptoms are abrupt or recent in onset, or  when there is a past history of favorable response to ECT” and “ECT is effective for  psychotic disorders related to schizophrenia, that is, schizophreniform disorders and  schizoaffective disorders”.correspondence: Minoru Takebayashi Department of Psychiatry, National  hospital Organization Kure Medical  center and chugoku cancer center,   3-1 aoyama, Kure, hiroshima   737-0023, Japan Tel +81 82 322 3111 Fax +81 82 321 0478 email mtakebayashi@kure-nh.go.j p shigeto Yamawaki Department of Psychiatry and  Neurosciences, Division of Frontier  Medical science, Programs for Biomedical  research, graduate school of Biomedical  sciences, hiroshima University,   1-2-3 Kasumi, Minami-ku,   hiroshima 734-8553, Japan Tel +81 82 257 5555 Fax +81 82 257 5209 email yamawaki@hiroshima-u.ac.j pJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Shibasaki et al Running head recto: Relapse after ECT in schizophrenic patients DOI: http://dx.doi.org/10.2147/NDT.S74303",Non-OADS,/arxiv_data1/oa_pdf/86/0d/ndt-11-067.PMC4294689.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/86/0d/ndt-11-067.PMC4294689.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/0d/ndt-11-067.PMC4294689.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/4f/jpr-8-021.PMC4294690.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 21–32Journal of Pain Research Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/05/4f/jpr-8-021.PMC4294690.pdf
"Or use: http://dvpr.es/1tVLK6 WDove press submit your manuscript | www.dovepress.co m Dove press  21Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/JPR.S6473 0Pain catastrophizing as a risk factor for chronic pain  after total knee arthroplasty: a systematic review Lindsay C Burns1–3  Sarah e Ritvo1  Meaghan K Ferguson1  Hance Clarke3–5  Ze’ev Seltzer3,5  Joel Katz1,3–5 1Department of Psychology, York  University, T oronto, ON, Canada;   2Arthritis Research Centre of Canada,   vancouver, BC, Canada; 3Department  of Anesthesia and Pain Management,   T oronto General Hospital, T oronto,   ON, Canada; 4Department of  Anesthesia, University of T oronto,   T oronto, ON, Canada; 5Centre for the  Study of Pain, Faculties of Dentistry  and Medicine, University of T oronto,   T oronto, ON, Canada Correspondence: Lindsay C Burns;   Joel Katz   Department of Psychology, Behavioral   Science Building, York University,   4700 Keele Street, Toronto,   ON M3J 1P3, Canada   email lcburns@yorku.c a; jkatz@yorku.c aBackground:  Total knee arthroplasty (TKA) is a common and costly surgical procedure.",Non-OADS,/arxiv_data1/oa_pdf/05/4f/jpr-8-021.PMC4294690.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/05/4f/jpr-8-021.PMC4294690.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/4f/jpr-8-021.PMC4294690.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/7d/ndt-11-075.PMC4294691.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 75–85Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  75OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7323 5The impact of internalizing symptoms on autistic  traits in adolescents with restrictive anorexia  nervosa sara calderoni1,* Pamela Fantozzi1,* giulia Balboni2 Veronica Pagni1 emilio Franzoni3 Fabio apicella1 antonio Narzisi1 sandra Maestro1 Filippo Muratori1,4 1irccs stella Maris Foundation,   2Department of surgery, Medical,   Molecular and critical area  Pathology, University of Pisa, Pisa,   italy; 3child Neuropsychiatric Unit,   Women, children and adolescents  health Department, University  hospital s Orsola-Malpighi, Bologna,   italy; 4Department of clinical and  experimental Medicine, University  of Pisa, Pisa, italy *These authors contributed equally  to this workBackground:  Although previous studies indicated a positive association between restrictive  anorexia-nervosa (AN-R) and autistic traits, the potential interference of psychiatric internal - izing comorbidity on this association is not yet fully investigated.",Non-OADS,/arxiv_data1/oa_pdf/f5/7d/ndt-11-075.PMC4294691.pdf
"The clinical presentation involves impairment in the socio-communicative  abilities, as well as the presence of restrictive and repetitive patterns of behavior, correspondence: sara calderoni IRCCS Stella Maris Scientific Foundation,  Via dei giacinti, 2, i-56018 calambrone,  Pisa, italy Tel +39 050 88 6292 Fax +39 050 88 6247 email sara.calderoni@fsm.unipi.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Calderoni et al Running head recto: Autistic traits and internalizing psychopathology in anorexia DOI: http://dx.doi.org/10.2147/NDT.S73235",Non-OADS,/arxiv_data1/oa_pdf/f5/7d/ndt-11-075.PMC4294691.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f5/7d/ndt-11-075.PMC4294691.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/7d/ndt-11-075.PMC4294691.pdf
http://dx.doi.org/10.1016/j.jare.2013.03.008,OADS,/arxiv_data1/oa_pdf/e3/9d/main.PMC4294710.pdf
http://dx.doi.org/10.1016/j.jare.2012.11.004,OADS,/arxiv_data1/oa_pdf/5d/35/main.PMC4294711.pdf
"Fresh veg- etable and fruit exports are having a signiﬁcant market share.And to cope with EU regulations and standards ( http:// www.globalgap.org ;http://ec.europa.eu/agriculture/organic/ eu-policy/legislation_en ), producing countries, including Egypt, are exploring every means to adopt environment- friendly approaches.",Non-OADS,/arxiv_data1/oa_pdf/5d/35/main.PMC4294711.pdf
"Rhizospheric microorganism (RMO) in the plant–soil sys- tem are principal players in environmentally friendly agricul- tural practices, referred to as organic farming (bio-farming, bio-dynamic) as well as good agricultural practices (GAPs).Such practices are carefully regulated and certiﬁed on govern-mental (EC 834 &889 regulations, http://ec.europa.eu/agricul- ture/organic/eu-policy/legislation_en ).)",Non-OADS,/arxiv_data1/oa_pdf/5d/35/main.PMC4294711.pdf
"or private (EurepGAP, now GLOBALG.A.P, http://www.globalgap.org ) levels.",Non-OADS,/arxiv_data1/oa_pdf/5d/35/main.PMC4294711.pdf
http://dx.doi.org/10.1016/j.jare.2013.02.004,OADS,/arxiv_data1/oa_pdf/4d/c9/main.PMC4294712.pdf
http://dx.doi.org/10.1016/j.jare.2013.04.004,OADS,/arxiv_data1/oa_pdf/e2/4e/main.PMC4294713.pdf
http://dx.doi.org/10.1016/j.jare.2013.05.002,OADS,/arxiv_data1/oa_pdf/2a/b5/main.PMC4294714.pdf
"ART fact sheet, < http://www.eshre.eu/Guidelines- and-Legal/ART-fact-sheet.aspx >; 2013.",Non-OADS,/arxiv_data1/oa_pdf/2a/b5/main.PMC4294714.pdf
"Assisted reproductive technology in Australia and New Zealand, <http://www.aihw.",Non-OADS,/arxiv_data1/oa_pdf/2a/b5/main.PMC4294714.pdf
< http://www.cdc.gov/art/ ART2006/PDF/2006ART.pdf >; 2006.,Non-OADS,/arxiv_data1/oa_pdf/2a/b5/main.PMC4294714.pdf
"Fertility guideline: fertility guideline: assessment and treatment forpeople with fertility problems, < http://www.nice.org.uk/ nicemedia/pdf/CG011niceguideline.pdf >; 2004.",Non-OADS,/arxiv_data1/oa_pdf/2a/b5/main.PMC4294714.pdf
"Good clinical treatment in assisted reproduction – an ESHRE position paper, < http://www.eshre.eu/binarydata.aspx?",Non-OADS,/arxiv_data1/oa_pdf/2a/b5/main.PMC4294714.pdf
http://dx.doi.org/10.1016/j.jare.2013.03.004,OADS,/arxiv_data1/oa_pdf/4f/55/main.PMC4294715.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/ j.jare.2013.03.004 .",OADS,/arxiv_data1/oa_pdf/4f/55/main.PMC4294715.pdf
http://dx.doi.org/10.1016/j.jare.2012.12.002,OADS,/arxiv_data1/oa_pdf/5d/2a/main.PMC4294716.pdf
http://dx.doi.org/10.1016/j.jare.2013.03.005,OADS,/arxiv_data1/oa_pdf/56/cf/main.PMC4294717.pdf
http://dx.doi.org/10.1016/j.jare.2013.01.002,OADS,/arxiv_data1/oa_pdf/10/ca/main.PMC4294718.pdf
http://dx.doi.org/10.1016/j.jare.2013.03.001,OADS,/arxiv_data1/oa_pdf/a5/ea/main.PMC4294719.pdf
http://dx.doi.org/10.1016/j.jare.2013.05.005,OADS,/arxiv_data1/oa_pdf/55/38/main.PMC4294720.pdf
http://dx.doi.org/10.1016/j.jare.2012.11.007,OADS,/arxiv_data1/oa_pdf/89/27/main.PMC4294721.pdf
http://dx.doi.org/10.1016/j.jare.2012.11.002,OADS,/arxiv_data1/oa_pdf/a1/72/main.PMC4294722.pdf
http://dx.doi.org/10.1016/j.jare.2013.01.007,OADS,/arxiv_data1/oa_pdf/ba/70/main.PMC4294723.pdf
http://dx.doi.org/10.1016/j.jare.2013.01.004,OADS,/arxiv_data1/oa_pdf/ee/11/main.PMC4294724.pdf
http://dx.doi.org/10.1016/j.jare.2013.03.006,OADS,/arxiv_data1/oa_pdf/d6/34/main.PMC4294725.pdf
http://dx.doi.org/10.1016/j.jare.2013.01.008,OADS,/arxiv_data1/oa_pdf/5e/00/main.PMC4294726.pdf
http://dx.doi.org/10.1016/j.jare.2013.03.009,OADS,/arxiv_data1/oa_pdf/8c/ff/main.PMC4294727.pdf
http://dx.doi.org/10.1016/j.jare.2013.05.004,OADS,/arxiv_data1/oa_pdf/71/3b/main.PMC4294728.pdf
http://dx.doi.org/10.1016/j.jare.2013.01.006,OADS,/arxiv_data1/oa_pdf/69/47/main.PMC4294729.pdf
"[12] Lam W, Hamill G, Robinson D, Raghunathan R, Kee C. Submerged propeller jet; 2005. http://www.wseas.us/e- library/conferences/ 2005udine/papers/491-218.doc [cited November 2012].",Non-OADS,/arxiv_data1/oa_pdf/69/47/main.PMC4294729.pdf
http://dx.doi.org/10.1016/j.jare.2013.04.002,OADS,/arxiv_data1/oa_pdf/ef/da/main.PMC4294730.pdf
http://dx.doi.org/10.1016/j.jare.2012.11.005,OADS,/arxiv_data1/oa_pdf/5a/32/main.PMC4294731.pdf
"The construction of Aswan High Dam secured Egypt with an annual supply of 55.5 ·109m3of water, controlled the maximum ﬂow to 2900 m3/s compared to 8100 m3/s, and re- duced the suspended sediment from 129 million tonnes/year to less than 2.27 million tonnes/year; both measured at GaafraStation 34 km downstream Aswan ( http://en.wikipedia.org/ wiki/Nile ).",Non-OADS,/arxiv_data1/oa_pdf/86/4e/main.PMC4294732.pdf
http://dx.doi.org/10.1016/j.jare.2012.12.004,OADS,/arxiv_data1/oa_pdf/86/4e/main.PMC4294732.pdf
http://dx.doi.org/10.1016/j.jare.2013.02.002,OADS,/arxiv_data1/oa_pdf/cd/fc/main.PMC4294733.pdf
http://dx.doi.org/10.1016/j.jare.2013.05.001,OADS,/arxiv_data1/oa_pdf/2a/b5/main.PMC4294734.pdf
"The open reading frame (ORF), translation of nucleotide sequences to amino acid sequences and functional motifs suchas asn-glycosylation and myristylation of the gene productswere predicted by using the computer software Generunner version 3.05 (hastings Software Inc. Hastings, NY, USA; http://www.generunner.net ).",OADS,/arxiv_data1/oa_pdf/2a/b5/main.PMC4294734.pdf
http://dx.doi.org/10.1016/j.jare.2013.05.003,OADS,/arxiv_data1/oa_pdf/b9/05/main.PMC4294735.pdf
< http://www.epa.gov/opp00001/methods/ rammethods/1998_072M.pdf >.,OADS,/arxiv_data1/oa_pdf/b9/05/main.PMC4294735.pdf
< http://www.ec.europa.eu/ food/plant/protection/resources/qualcontrol_en.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/b9/05/main.PMC4294735.pdf
http://dx.doi.org/10.1016/j.jare.2013.02.003,OADS,/arxiv_data1/oa_pdf/24/00/main.PMC4294736.pdf
< http://www.cdc.gov/arthriti s/basics/osteoarthritis.,Non-OADS,/arxiv_data1/oa_pdf/24/00/main.PMC4294736.pdf
<http://www.Who.ORG >.,Non-OADS,/arxiv_data1/oa_pdf/24/00/main.PMC4294736.pdf
"Evidence-Based Complement Altern Med 2012;2012:570431, http://dx.doi.org/ 10.1155/2012/570431 .",OADS,/arxiv_data1/oa_pdf/24/00/main.PMC4294736.pdf
< http://www.soundtells.com/ AcupressureOnline/index.htm >.,Non-OADS,/arxiv_data1/oa_pdf/24/00/main.PMC4294736.pdf
"Cochrane Database Syst Rev 2011;19(1):CD007854, < http://www.ncbi.nlm.nih.gov/pubmed/ 21249697 >.",OADS,/arxiv_data1/oa_pdf/24/00/main.PMC4294736.pdf
http://dx.doi.org/10.1016/j.jare.2013.03.007,OADS,/arxiv_data1/oa_pdf/f4/38/main.PMC4294737.pdf
http://dx.doi.org/10.1016/j.jare.2013.04.005,OADS,/arxiv_data1/oa_pdf/7a/12/main.PMC4294738.pdf
http://dx.doi.org/10.1016/j.jare.2012.10.001,OADS,/arxiv_data1/oa_pdf/e2/fc/main.PMC4294739.pdf
http://dx.doi.org/10.1016/j.jare.2013.01.001,OADS,/arxiv_data1/oa_pdf/fa/0a/main.PMC4294740.pdf
http://dx.doi.org/10.1016/j.jare.2013.03.003,OADS,/arxiv_data1/oa_pdf/8e/74/main.PMC4294741.pdf
"Arab J Chem 2012, http://dx.doi.org/10.1016/ j.arabjc.2012.10.017.",OADS,/arxiv_data1/oa_pdf/8e/74/main.PMC4294741.pdf
http://dx.doi.org/10.1016/j.jare.2012.11.006,OADS,/arxiv_data1/oa_pdf/62/ab/main.PMC4294742.pdf
http://dx.doi.org/10.1016/j.jare.2012.11.008,OADS,/arxiv_data1/oa_pdf/ff/68/main.PMC4294743.pdf
http://dx.doi.org/10.1016/j.jare.2013.04.003,OADS,/arxiv_data1/oa_pdf/28/d2/main.PMC4294744.pdf
http://dx.doi.org/10.1016/j.jare.2013.01.003,OADS,/arxiv_data1/oa_pdf/d5/63/main.PMC4294745.pdf
< http://www.matjazperc.com/ejp/time.html > [Retrieved 07.08.10].,Non-OADS,/arxiv_data1/oa_pdf/d5/63/main.PMC4294745.pdf
http://dx.doi.org/10.1016/j.jare.2013.12.005,OADS,/arxiv_data1/oa_pdf/9e/5c/main.PMC4294746.pdf
Available from: <https://www.naspi.org/File.aspx?ﬁleID=537 >.,OADS,/arxiv_data1/oa_pdf/9e/5c/main.PMC4294746.pdf
Available from: <http://www.wecc.biz/committees/StandingCommittees/OC/ TOS/RWG/Lists/Calendar/Attachments/13/06a-RAS_Guide_5.02.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/9e/5c/main.PMC4294746.pdf
Available from: < http://www.wecc.biz/committees/Standing Committees/OC/TOS/RWG/Lists/Calendar/Attachments/4/ WECC-RAS-CATALOG%2010-22-2008%20Master.pdf >.Cyber-physical security of WAMPAC in smart gridty of Wide-Area Monitoring 489,Non-OADS,/arxiv_data1/oa_pdf/9e/5c/main.PMC4294746.pdf
http://dx.doi.org/10.1016/j.jare.2013.08.001,OADS,/arxiv_data1/oa_pdf/27/3a/main.PMC4294747.pdf
http://dx.doi.org/10.1016/j.jare.2014.03.001,OADS,/arxiv_data1/oa_pdf/99/a6/main.PMC4294748.pdf
< https://isc.sans.edu/ submissions.html >.,Non-OADS,/arxiv_data1/oa_pdf/99/a6/main.PMC4294748.pdf
"CRA; November 2003, < http://www.cra.org/ Activities/grand.challenges/security/home.html >.",Non-OADS,/arxiv_data1/oa_pdf/99/a6/main.PMC4294748.pdf
http://dx.doi.org/10.1016/j.jare.2014.01.002,OADS,/arxiv_data1/oa_pdf/b5/9e/main.PMC4294749.pdf
<http://www.icir.org/enterprise-tracing/download.html >.,Non-OADS,/arxiv_data1/oa_pdf/b5/9e/main.PMC4294749.pdf
http://dx.doi.org/10.1016/j.jare.2014.02.006,OADS,/arxiv_data1/oa_pdf/21/8d/main.PMC4294750.pdf
"[9] Terence Eden, ‘‘Car Hacking – With Bluetooth OBD’’ June 12, 2012, < http://shkspr.mobi/blog/2012/12/car-hacking-with- bluetooth-obd/ > (accessed 24.04.13).",Non-OADS,/arxiv_data1/oa_pdf/21/8d/main.PMC4294750.pdf
[14] < http://www.abiresearch.com/ >.,Non-OADS,/arxiv_data1/oa_pdf/21/8d/main.PMC4294750.pdf
"[15] The Town Talk, Technology: Only you – and your care – know where you’ve been.’’ May 24, 2013, < http://lobby.la.psu.edu/ _107th/093_OBD_Service_Info/Organ izational_Statements/SEMA/ SEMA_OBD_frequent_questions.htm > (accessed 25.04.13).",Non-OADS,/arxiv_data1/oa_pdf/21/8d/main.PMC4294750.pdf
"[16] Brandon John, ‘‘Are drivers ready for Big Brother car insurance plans?’’ April 24, 2012, < http://www.foxnews.com/leisure/2012/ 04/24/are-drivers-ready-for-big-brother-car-insurance-plans/ >.",Non-OADS,/arxiv_data1/oa_pdf/21/8d/main.PMC4294750.pdf
"[22] Voice of America, ‘‘Multi, Social Media Play Huge Role in Solving Boston Bombing, April 26, 2013m < http://www.voanews.",Non-OADS,/arxiv_data1/oa_pdf/21/8d/main.PMC4294750.pdf
"[24] Lance Ulanoff, Mashable Op-ed, ‘‘Boston Bombings: Truth, Justice and the Wild West of Social Media,’’ April 28, 2013.<http://mashable.com/2013/04/18/boston-bombings-wild-west- of-social-media/ >.",Non-OADS,/arxiv_data1/oa_pdf/21/8d/main.PMC4294750.pdf
"[25] Bensinger Ken, Chang Andrea, Los Angeles Times, ‘‘Boston Bombings: Socil media spirals out of control,’’ April 20, 2013<http://articles.latimes.com/2013/apr/20/business/la-ﬁ-boston- bombings-media-20130420 > (accessed 28.04.13).",Non-OADS,/arxiv_data1/oa_pdf/21/8d/main.PMC4294750.pdf
"[26] Jonathan Dyer, BBC Radio, ‘‘Social Media and the Boston Bombings,’’ 27 April 2013, < http://www.bbc.co.uk/programmes/ p017cr7p > (accessed 28.04.13).Security in Smart Cities 497",Non-OADS,/arxiv_data1/oa_pdf/21/8d/main.PMC4294750.pdf
http://dx.doi.org/10.1016/j.jare.2013.06.002,OADS,/arxiv_data1/oa_pdf/60/68/main.PMC4294751.pdf
http://dx.doi.org/10.1016/j.jare.2013.06.003,OADS,/arxiv_data1/oa_pdf/6b/f4/main.PMC4294752.pdf
http://dx.doi.org/10.1016/j.jare.2013.11.008,OADS,/arxiv_data1/oa_pdf/d8/8e/main.PMC4294753.pdf
http://dx.doi.org/10.1016/j.jare.2013.06.010,OADS,/arxiv_data1/oa_pdf/f4/5d/main.PMC4294754.pdf
http://dx.doi.org/10.1016/j.jare.2013.11.006,OADS,/arxiv_data1/oa_pdf/c6/58/main.PMC4294755.pdf
< http://www.oracle.com/ technetwork/java/seccodeguide-139067.html > [retrieved 05.09.12].,OADS,/arxiv_data1/oa_pdf/c6/58/main.PMC4294755.pdf
< https://www.owasp.org/images/0/08/ OWASP_SCP_Quick_Reference_Guide_v2.pdf > [retrieved 15.03.13].,Non-OADS,/arxiv_data1/oa_pdf/c6/58/main.PMC4294755.pdf
< http://www.veracode.com/reports/index.html > [retrieved 20.12.11].,Non-OADS,/arxiv_data1/oa_pdf/c6/58/main.PMC4294755.pdf
< http://www8.hp.com/ us/en/software-solutions/ software.html?compURI=1338812#.UUnHuVthvUY >.Table 4 Summary of user study.,OADS,/arxiv_data1/oa_pdf/c6/58/main.PMC4294755.pdf
< http://www.veracode.com/ products/static >.,Non-OADS,/arxiv_data1/oa_pdf/c6/58/main.PMC4294755.pdf
< http://www.bsimm2.com/resources/ > [retrieved 20.12.11].,Non-OADS,/arxiv_data1/oa_pdf/c6/58/main.PMC4294755.pdf
< http://roller.apache.org >.,Non-OADS,/arxiv_data1/oa_pdf/c6/58/main.PMC4294755.pdf
< http://web.nvd.nist.gov/view/vuln/ detail?vulnId=CVE-2012-2380 >.,OADS,/arxiv_data1/oa_pdf/c6/58/main.PMC4294755.pdf
< http://rollerweblogger.org/project/entry/ roller_501_security_ﬁx >.,Non-OADS,/arxiv_data1/oa_pdf/c6/58/main.PMC4294755.pdf
< http://rollerweblogger.org/project/ >.,Non-OADS,/arxiv_data1/oa_pdf/c6/58/main.PMC4294755.pdf
< https://issues.apache.org/jira/browse/ ROL-1701 >.,Non-OADS,/arxiv_data1/oa_pdf/c6/58/main.PMC4294755.pdf
http://dx.doi.org/10.1016/j.jare.2013.11.005,OADS,/arxiv_data1/oa_pdf/f3/6a/main.PMC4294756.pdf
< http://www.icir.org/ enterprise-tracing/ > [accessed January 2013].,OADS,/arxiv_data1/oa_pdf/f3/6a/main.PMC4294756.pdf
http://dx.doi.org/10.1016/j.jare.2013.11.001,OADS,/arxiv_data1/oa_pdf/8f/e5/main.PMC4294757.pdf
http://dx.doi.org/10.1016/j.jare.2013.06.006,OADS,/arxiv_data1/oa_pdf/70/b9/main.PMC4294758.pdf
http://dx.doi.org/10.5037/ jomr.2010.1201 .,Non-OADS,/arxiv_data1/oa_pdf/70/b9/main.PMC4294758.pdf
http://dx.doi.org/10.1016/j.jare.2014.01.007,OADS,/arxiv_data1/oa_pdf/61/a7/main.PMC4294759.pdf
http://dx.doi.org/10.1016/j.jare.2014.01.001,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4294760.pdf
Results and discussion We obtained a data set of valid (benign) domain names and a data set of attack domain names associated with fast ﬂux activ-ity from http://pcsei.twbbs.org/datasets/-1-fast-ﬂux-attaack- datasets .,OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4294760.pdf
"They collected a list of benign domain names from sources such as well-known top websites listed by Alexa(http://www.alexa.com/topsites ), and lists of popular blogs.",OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4294760.pdf
"They collected the fast ﬂux data sets from sources such as AT- LAS ( http://atlas.arbor.net/summary/fastﬂux ), domain name system blacklists ( http://www.dnsbl.info/ ), and FluXOR [2].",OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4294760.pdf
"We collected a large list of words from internet sources such as the Wiktionary frequency lists ( http://en.wik- tionary.org/wiki/Wiktionary:Frequency_lists ), a text corpus from project Gutenberg ( http://norvig.com/big.txt ), a list of common male and female ﬁrst and last names ( http://www.",Non-OADS,/arxiv_data1/oa_pdf/4c/6a/main.PMC4294760.pdf
http://dx.doi.org/10.1016/j.jare.2013.06.005,OADS,/arxiv_data1/oa_pdf/72/55/main.PMC4294761.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/77/mder-8-057.PMC4294762.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 57–64Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  57REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S7085 6Brain delivery of small interfering ribonucleic   acid and drugs through intranasal administration  with nano-sized polymer micelles Takanori Kanazawa School of Pharmacy, Tokyo University  of Pharmacy and Life Sciences,    T okyo, Japan Correspondence: Takanori Kanazawa   School of Pharmacy, Tokyo University   of Pharmacy and Life Sciences,   1432-1 Horinouchi, Hachioji,   Tokyo 192-0392, Japan   Tel/Fax +81 42 676 4493   Email kanazawa@toyaku.ac.j pAbstract:  Recently, the development of effective strategies for enhancing drug delivery to  the brain has been a topic of great interest in both clinical and pharmaceutical fields.",Non-OADS,/arxiv_data1/oa_pdf/56/77/mder-8-057.PMC4294762.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/56/77/mder-8-057.PMC4294762.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fd/c5/mder-8-047.PMC4294763.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 47–56Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  47ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S75852Device-length changes and implant function  following surgical implantation of the Kinespring  in cadaver knees Michael J Mcn icholas1 stefan M gabriel2 anton g clifford2 Evelyne M hasler2 1aintree University hospital, Teaching  hospital, Major Trauma centre, nhs  Foundation Trust, liverpool, UK;   2Moximed, hayward, ca, Usa correspondence: stefan M gabriel   Moximed, 26460 corporate   Boulevard – suite 100, hayward,   ca 94545, Usa   Tel +1 650 336 3252   Email sgabriel@moximed.co mIntroduction:  The KineSpring implant system has been shown to provide load reductions at  the medial compartment of the knee, and has demonstrated clinical success in reducing pain  and increasing function in patients with medial knee osteoarthritis.",Non-OADS,/arxiv_data1/oa_pdf/fd/c5/mder-8-047.PMC4294763.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/fd/c5/mder-8-047.PMC4294763.pdf
http://dx.doi.org/10.1016/j.jare.2012.09.008,OADS,/arxiv_data1/oa_pdf/fc/96/main.PMC4294781.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.012,OADS,/arxiv_data1/oa_pdf/2e/28/main.PMC4294782.pdf
http://dx.doi.org/10.1016/j.jare.2012.09.003,OADS,/arxiv_data1/oa_pdf/40/cb/main.PMC4294783.pdf
http://dx.doi.org/10.1016/j.jare.2012.09.001,OADS,/arxiv_data1/oa_pdf/10/56/main.PMC4294784.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.014,OADS,/arxiv_data1/oa_pdf/72/6b/main.PMC4294785.pdf
http://dx.doi.org/10.1016/j.jare.2012.10.004,OADS,/arxiv_data1/oa_pdf/ed/60/main.PMC4294786.pdf
http://dx.doi.org/10.1016/j.jare.2012.11.003,OADS,/arxiv_data1/oa_pdf/e2/6a/main.PMC4294787.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.006,OADS,/arxiv_data1/oa_pdf/91/0a/main.PMC4294788.pdf
"Outreach Magazine of the United Brachial Plexus Network, inc., 2005, issue 17:8-10.<http://www.ubpn.org/Docs/Outreach/SP2005.pdf >.",Non-OADS,/arxiv_data1/oa_pdf/91/0a/main.PMC4294788.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.005,OADS,/arxiv_data1/oa_pdf/1b/ec/main.PMC4294789.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.009,OADS,/arxiv_data1/oa_pdf/24/4e/main.PMC4294790.pdf
http://dx.doi.org/10.1016/j.jare.2013.06.008,OADS,/arxiv_data1/oa_pdf/e0/1f/main.PMC4294791.pdf
http://dx.doi.org/10.1016/j.jare.2012.09.007,OADS,/arxiv_data1/oa_pdf/42/88/main.PMC4294792.pdf
"Structural, optical and electrical characterization of PVA/CuI polymer composites, Optik- International Journal for Light and Electron Optics: http://dx.doi.org/10.1016/j.ijleo.2012.05.009 .",OADS,/arxiv_data1/oa_pdf/42/88/main.PMC4294792.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.013,OADS,/arxiv_data1/oa_pdf/bb/d3/main.PMC4294793.pdf
"Also, there was a minor change  in the field name from “voiding dysfunction” to “lower A commitment to excellence Kwangsung Park , MD, PhD Editor-in-Chief Department of Urology, Chonnam National University Medical School, 160 Baekseo-ro, Dong-gu, Gwangju 501-746, Korea  E-mail: uropark@gmail.comKorean J Urol 2015;56:1-2. http://dx.doi.org/10.4111/kju.2015.56.1.1 pISSN 2005-6737  •  eISSN 2005-6745Editorial ⓒ The Korean Urological Association, 2015 urinary tract dysfunction.”   Beginning in January 2015, many new changes are  expected in the KJU.",Non-OADS,/arxiv_data1/oa_pdf/40/bb/kju-56-1.PMC4294849.pdf
orgPark http://dx.doi.org/10.4111/kju.2015.56.1.1 USA) and also checks whether the submission meets the  criteria of publication ethics.,Non-OADS,/arxiv_data1/oa_pdf/40/bb/kju-56-1.PMC4294849.pdf
"Keywords:  Androgens; Diabetes mellitus; Metabolic syndrome X; Prostatic neoplasmsKorean J Urol 2015;56:12-18. http://dx.doi.org/10.4111/kju.2015.56.1.12 pISSN 2005-6737  •  eISSN 2005-6745Review Article Received:  28 August, 2014   •  Accepted:  24 October, 2014 Corresponding Author:  Sung Chul Kam Department of Urology, Gyeongsang National University Hospital, 79 Gangnam-ro, Jinju 660-702, Korea TEL: +82-55-750-8849, FAX: +82-55-757-4503, E-mail: kamsungchul@hanmail.net ⓒ The Korean Urological Association, 2015 to changes in body habitus and lipid profiles and an  increased risk for insulin resistance, diabetes, and  metabolic syndrome [8-10].",Non-OADS,/arxiv_data1/oa_pdf/da/75/kju-56-12.PMC4294850.pdf
"A prospective study was conducted  on changes in body composition caused by 1 year of GnRH This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/75/kju-56-12.PMC4294850.pdf
"orgChoi and Kam http://dx.doi.org/10.4111/kju.2015.56.1.12 is an independent risk factor for cardiovascular disease  [26,27].",OADS,/arxiv_data1/oa_pdf/da/75/kju-56-12.PMC4294850.pdf
"orgChoi and Kam http://dx.doi.org/10.4111/kju.2015.56.1.12 assessment should be repeated at 6 and 12 months, with  subsequent testing.",Non-OADS,/arxiv_data1/oa_pdf/da/75/kju-56-12.PMC4294850.pdf
orgChoi and Kam http://dx.doi.org/10.4111/kju.2015.56.1.12 45.,OADS,/arxiv_data1/oa_pdf/da/75/kju-56-12.PMC4294850.pdf
"Keywords:  Genetic polymorphism; Human SRD5A2 protein; Prostatic neoplasmsKorean J Urol 2015;56:19-30. http://dx.doi.org/10.4111/kju.2015.56.1.19 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Genomics/Stem Cells in Urology Received:  14 August, 2014   •  Accepted:  27 November, 2014                   See Editorial on page 30.",Non-OADS,/arxiv_data1/oa_pdf/b0/21/kju-56-19.PMC4294851.pdf
"The androgen biosynthesis pathway might be This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/21/kju-56-19.PMC4294851.pdf
"orgChoi et al http://dx.doi.org/10.4111/kju.2015.56.1.19 asso  ciated with prostate carcinogenesis, and single- nucleotide polymorphisms (SNPs) related to this pathway  might describe race disparities in prostate cancer [3].",OADS,/arxiv_data1/oa_pdf/b0/21/kju-56-19.PMC4294851.pdf
"SNP selection  from the International HapMap database (Han Chinese  [CHB], Japanese [JPN]) proceeded as follows: (1) extraction  of  all genotypes from CHB and JPN populations in  the SRD5A2  gene region by using HapMart of the  International HapMap database (version: release #27;  http://www.hapmap.org), (2) calculation of minor allele  frequency (MAF) and linkage disequilibrium (LD) by  use of  Haploview software (Cambridge, MA, USA; http:// www.broad.mit.edu/mpg/haploview), and (3) selection of  SNPs with MAF>0.05 and tagging SNPs if  several SNPs  showed high LD (>0.98).",Non-OADS,/arxiv_data1/oa_pdf/b0/21/kju-56-19.PMC4294851.pdf
"To achieve optimal correction  for multiple testing of markers, representing SNPs in LD  with each other, the effective number of independent  marker loci was calculated by using SNPSpD software  (http://genepi.qimr.edu.au/general/daleN/SNPSpD/), a  program that is based on the spectral decomposition of  matrices of pair-wise LD among markers [16] .",OADS,/arxiv_data1/oa_pdf/b0/21/kju-56-19.PMC4294851.pdf
orgChoi et al http://dx.doi.org/10.4111/kju.2015.56.1.19 discovered.,OADS,/arxiv_data1/oa_pdf/b0/21/kju-56-19.PMC4294851.pdf
orgChoi et al http://dx.doi.org/10.4111/kju.2015.56.1.19 Table 3.,OADS,/arxiv_data1/oa_pdf/b0/21/kju-56-19.PMC4294851.pdf
orgChoi et al http://dx.doi.org/10.4111/kju.2015.56.1.19 Table 5.,OADS,/arxiv_data1/oa_pdf/b0/21/kju-56-19.PMC4294851.pdf
orgChoi et al http://dx.doi.org/10.4111/kju.2015.56.1.19 studies.,OADS,/arxiv_data1/oa_pdf/b0/21/kju-56-19.PMC4294851.pdf
"SUPPLEMENTARY MATERIALS Scan this QR code to see the supplementary materials,  or visit http://kjurology.org/src/sm/kju-56-19-s001.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b0/21/kju-56-19.PMC4294851.pdf
orgChoi et al http://dx.doi.org/10.4111/kju.2015.56.1.19 races.,OADS,/arxiv_data1/oa_pdf/b0/21/kju-56-19.PMC4294851.pdf
January 2015. http://dx.doi.org/10.4111/kju.2015.56.1.19,OADS,/arxiv_data1/oa_pdf/b0/21/kju-56-19.PMC4294851.pdf
"Keywords:  Pain; Pain management; Physical examination, Scrotum Korean J Urol 2015;56:3-11. http://dx.doi.org/10.4111/kju.2015.56.1.3 pISSN 2005-6737  •  eISSN 2005-6745Review Article Received:  28 October, 2014   •  Accepted:  4 December, 2014 Corresponding Author:  Hossein Sadeghi-Nejad Center for Male Reproductive Medicine & Microsurgery, Hackensack University Medical Center, 20 Prospect Ave., Suite 711, Hackensack, NJ 07601, USA TEL: +1-201-342-7977, FAX: +1-201-342-0623, E-mail: hossein@ix.netcom.com ⓒ The Korean Urological Association, 2015 Sensory fibers from both the upper ureter and the  testis travel through spinal cord segments T11 and T12.",Non-OADS,/arxiv_data1/oa_pdf/31/bc/kju-56-3.PMC4294852.pdf
"Testicular  tumors most of ten present as a painless scrotal mass, a  finding that must be assumed to be testicular cancer until This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/bc/kju-56-3.PMC4294852.pdf
orgGordhan and Sadeghi-Nejad http://dx.doi.org/10.4111/kju.2015.56.1.3 proven otherwise.,Non-OADS,/arxiv_data1/oa_pdf/31/bc/kju-56-3.PMC4294852.pdf
orgGordhan and Sadeghi-Nejad http://dx.doi.org/10.4111/kju.2015.56.1.3 49 boys for acute epididymis and found only 1 to have a  relevant structural urinary tract malformation [23] .,Non-OADS,/arxiv_data1/oa_pdf/31/bc/kju-56-3.PMC4294852.pdf
orgGordhan and Sadeghi-Nejad http://dx.doi.org/10.4111/kju.2015.56.1.3 internal spermatic vein.,Non-OADS,/arxiv_data1/oa_pdf/31/bc/kju-56-3.PMC4294852.pdf
orgGordhan and Sadeghi-Nejad http://dx.doi.org/10.4111/kju.2015.56.1.3 M. Acute scrotal pain in children: results of 543 surgical explo - rations.,Non-OADS,/arxiv_data1/oa_pdf/31/bc/kju-56-3.PMC4294852.pdf
"Keywords:  Squamous cell carcinoma; Transitional cell carcinoma; Urinary bladder; VaccinesKorean J Urol 2015;56:31-40. http://dx.doi.org/10.4111/kju.2015.56.1.31 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Urological Oncology Received:  4 September, 2014   •  Accepted:  12 October, 2014 Corresponding Author:  Rania Makboul Department of Pathology, Faculty of Medicine, Assiut University, 7111, Assiut, Egypt TEL: +20882411939, FAX: +20882332278, E-mail: rania_makboul@yahoo.com ⓒ The Korean Urological Association, 2015 wide with around 330,000 cases diagnosed every year.",Non-OADS,/arxiv_data1/oa_pdf/b8/1f/kju-56-31.PMC4294853.pdf
"TCC is the most This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/1f/kju-56-31.PMC4294853.pdf
"orgMakboul et al http://dx.doi.org/10.4111/kju.2015.56.1.31 common type in Western countries [1], whereas SCC  predominates in some countries in Asia and Africa owing  to endemic schistosomiasis [2] .",Non-OADS,/arxiv_data1/oa_pdf/b8/1f/kju-56-31.PMC4294853.pdf
"orgMakboul et al http://dx.doi.org/10.4111/kju.2015.56.1.31 Percentage of positive Ki67 staining in tumor cells  ranged from 10% to 100% with a mean of 47% (standard  error, ±2.6) and a median of 45% (standard deviation, ±2.5).",OADS,/arxiv_data1/oa_pdf/b8/1f/kju-56-31.PMC4294853.pdf
"orgMakboul et al http://dx.doi.org/10.4111/kju.2015.56.1.31 group 1, in which only 7 of 50 developed recurrence.",OADS,/arxiv_data1/oa_pdf/b8/1f/kju-56-31.PMC4294853.pdf
"orgMakboul et al http://dx.doi.org/10.4111/kju.2015.56.1.31 In the TCC specimens studied here, high significant  associations were found between altered survivin  expression with high grade and stage of tumors and Ki67 ­ LI.",OADS,/arxiv_data1/oa_pdf/b8/1f/kju-56-31.PMC4294853.pdf
"orgMakboul et al http://dx.doi.org/10.4111/kju.2015.56.1.31 A, Kawami S, et al.",OADS,/arxiv_data1/oa_pdf/b8/1f/kju-56-31.PMC4294853.pdf
"Keywords:  Adjuvant chemotherapy, Kidney pelvis, Transitional cell carcinoma, Ureter, Urinary tractKorean J Urol 2015;56:41-47. http://dx.doi.org/10.4111/kju.2015.56.1.41 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Urological Oncology Received:  5 August, 2014   •  Accepted:  30 October, 2014 Corresponding Author:  Woong Kyu Han Department of Urology, Urological Science Institute, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea TEL: +82-2-2228-2310, FAX: +82-2-312-2538, E-mail: hanwk@yuhs.ac ⓒ The Korean Urological Association, 2015 advances in endoscopic and minimally invasive treatments  during the past two decades, UTUC continues to portend  a poor prognosis, with approximately 28% of patients  experiencing a recurrence of disease outside the bladder  and 23% of  patients dying of  the disease within 5 years [2].This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/f5/kju-56-41.PMC4294854.pdf
"orgLee et al http://dx.doi.org/10.4111/kju.2015.56.1.41 Although advanced UTUC is associated with poor  oncologic outcomes, there is no standardized therapy  conferring a survival benefit after radical nephro­ ureterectomy (RNU).",Non-OADS,/arxiv_data1/oa_pdf/90/f5/kju-56-41.PMC4294854.pdf
orgLee et al http://dx.doi.org/10.4111/kju.2015.56.1.41 other variables (Table 3).,OADS,/arxiv_data1/oa_pdf/90/f5/kju-56-41.PMC4294854.pdf
orgLee et al http://dx.doi.org/10.4111/kju.2015.56.1.41 dissection.,OADS,/arxiv_data1/oa_pdf/90/f5/kju-56-41.PMC4294854.pdf
http://dx.doi.org/10.1111/bju.12801.,Non-OADS,/arxiv_data1/oa_pdf/90/f5/kju-56-41.PMC4294854.pdf
"Keywords:  Cystectomy; Postoperative complication; Robotics; Urinary diversionKorean J Urol 2015;56:48-55. http://dx.doi.org/10.4111/kju.2015.56.1.48 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Laparoscopy/Robotics Received:  26 August, 2014   •  Accepted:  21 October, 2014 Corresponding Author:  Seok Ho Kang Department of Urology, Korea University Anam Hospital, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Korea TEL: +82-2-920-5367, FAX: +82-2-928-7864, E-mail: mdksh@korea.ac.kr ⓒ The Korean Urological Association, 2015with invasive bladder cancer [1].",Non-OADS,/arxiv_data1/oa_pdf/f6/1d/kju-56-48.PMC4294855.pdf
"Despite improvements  in surgical technique, technology, and perioperative  care, cystectomy with urinary diversion remains a  morbid operation with a substantial complication rate This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/1d/kju-56-48.PMC4294855.pdf
orgPyun et al http://dx.doi.org/10.4111/kju.2015.56.1.48 used to predict the risk factors of complications.,OADS,/arxiv_data1/oa_pdf/f6/1d/kju-56-48.PMC4294855.pdf
"orgPyun et al http://dx.doi.org/10.4111/kju.2015.56.1.48 urinary tract obstruction, mechanical obstruction, and  thromboembolism occurred as major complications in 11  patients.",Non-OADS,/arxiv_data1/oa_pdf/f6/1d/kju-56-48.PMC4294855.pdf
orgPyun et al http://dx.doi.org/10.4111/kju.2015.56.1.48 related to it are scarce.,OADS,/arxiv_data1/oa_pdf/f6/1d/kju-56-48.PMC4294855.pdf
"Keywords:  Bone density; Lithotripsy; Ureteral calculiKorean J Urol 2015;56:56-62. http://dx.doi.org/10.4111/kju.2015.56.1.56 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Endourology/Urolithiasis Received:  5 September, 2014   •  Accepted:  27 October, 2014 Corresponding Author:  Hae Won Lee Department of Urology, Dongguk University Ilsan Hospital, 27 Dongguk-ro, Ilsandong-gu, Goyang 410-773, Korea TEL: +82-31-961-7453, FAX: +82-31-961-7457, E-mail: urmarine@dumc.or.kr ⓒ The Korean Urological Association, 2015stone within 5 years [1] .",Non-OADS,/arxiv_data1/oa_pdf/a0/01/kju-56-56.PMC4294856.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/01/kju-56-56.PMC4294856.pdf
orgLim et al http://dx.doi.org/10.4111/kju.2015.56.1.56 interpretations evaluated all KUB results.,OADS,/arxiv_data1/oa_pdf/a0/01/kju-56-56.PMC4294856.pdf
orgLim et al http://dx.doi.org/10.4111/kju.2015.56.1.56 respectively).,OADS,/arxiv_data1/oa_pdf/a0/01/kju-56-56.PMC4294856.pdf
orgLim et al http://dx.doi.org/10.4111/kju.2015.56.1.56 larger cohorts are needed to validate these findings.,OADS,/arxiv_data1/oa_pdf/a0/01/kju-56-56.PMC4294856.pdf
"Keywords:  Ureter; Ureterolithiasis; UreteroscopyKorean J Urol 2015;56:63-67. http://dx.doi.org/10.4111/kju.2015.56.1.63 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Endourology/Urolithiasis Received:  5 August, 2014   •  Accepted:  15 October, 2014 Corresponding Author:  Xeng Inn Fam Department of Surgery, Universiti Kebangsaan Malaysia Medical Center, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia TEL: +60391456202, FAX: +60391456684, E-mail: xenginn@gmail.com ⓒ The Korean Urological Association, 2015 with a large burden of calculi that are impacted into the  ureteral mucosa.",Non-OADS,/arxiv_data1/oa_pdf/ae/d7/kju-56-63.PMC4294857.pdf
"orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/d7/kju-56-63.PMC4294857.pdf
"orgXeng Inn Fam et al http://dx.doi.org/10.4111/kju.2015.56.1.63 This happens even with recent innovations, such as the  latest ureteroscopes, which come with smaller diameters,  and the latest techniques for shattering stones by use of a  Holmium laser [4,5] .",Non-OADS,/arxiv_data1/oa_pdf/ae/d7/kju-56-63.PMC4294857.pdf
"orgXeng Inn Fam et al http://dx.doi.org/10.4111/kju.2015.56.1.63 study had a diameter of 3 cm, and the longest period of  impaction was 12 months.",OADS,/arxiv_data1/oa_pdf/ae/d7/kju-56-63.PMC4294857.pdf
"Keywords:  Prevalence; Prostatic hyperplasiaKorean J Urol 2015;56:68-75. http://dx.doi.org/10.4111/kju.2015.56.1.68 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Lower Urinary Tract Dysfunction Received:  4 August, 2014   •  Accepted:  21 October, 2014 Corresponding Author:  Hong Sang Moon Department of Urology, Hanyang University Guri Hospital, 153 Gyeongchun-ro, Guri 471-701, Korea TEL: +82-31-560-2374, Fax: +82-31-560-2372, E-mail: moonuro@hanyang.ac.kr ⓒ The Korean Urological Association, 2015symptoms including nocturia, incomplete voiding, urgency,  and hesitancy and comes to the fore as a significant  health problem interrupting the quality of life of men  over middle age.",Non-OADS,/arxiv_data1/oa_pdf/61/3f/kju-56-68.PMC4294858.pdf
"The current Korean population is aging very This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/3f/kju-56-68.PMC4294858.pdf
orgGoh et al http://dx.doi.org/10.4111/kju.2015.56.1.68 2.,OADS,/arxiv_data1/oa_pdf/61/3f/kju-56-68.PMC4294858.pdf
orgGoh et al http://dx.doi.org/10.4111/kju.2015.56.1.68 criteria have not been established.,OADS,/arxiv_data1/oa_pdf/61/3f/kju-56-68.PMC4294858.pdf
"orgGoh et al http://dx.doi.org/10.4111/kju.2015.56.1.68 First, the subjects were not a random sample of the  population because we recruited subjects through a  prostate health screening campaign.",Non-OADS,/arxiv_data1/oa_pdf/61/3f/kju-56-68.PMC4294858.pdf
"ED and cardiovascular diseases Korean J Urol 2015;56:76-81. http://dx.doi.org/10.4111/kju.2015.56.1.76 pISSN 2005-6737  •  eISSN 2005-6745Original Article - Sexual Dysfunction/Infertility ⓒ The Korean Urological Association, 2015share common risk factors such as cigarette smoking,  obesity, metabolic syndrome, and a sedentary way of  life.",Non-OADS,/arxiv_data1/oa_pdf/81/ad/kju-56-76.PMC4294859.pdf
"Epidemiological surveys This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/ad/kju-56-76.PMC4294859.pdf
"orgCanat et al http://dx.doi.org/10.4111/kju.2015.56.1.76 RESUL TS The 183 patients who underwent coronary angiography  were categorized in three groups: single-vessel occlusion  (group 1), two-vessel occlusion (group 2), and three-vessel  occlusion (group 3).",OADS,/arxiv_data1/oa_pdf/81/ad/kju-56-76.PMC4294859.pdf
orgCanat et al http://dx.doi.org/10.4111/kju.2015.56.1.76 limitation of  our study.,Non-OADS,/arxiv_data1/oa_pdf/81/ad/kju-56-76.PMC4294859.pdf
"Keywords:  Cardiomyopathies; Heart failure; Paraneoplastic syndromes; Renal cell carcinomaKorean J Urol 2015;56:82-85. http://dx.doi.org/10.4111/kju.2015.56.1.82 pISSN 2005-6737  •  eISSN 2005-6745Case Report Received:  23 June, 2014   •  Accepted:  1 August, 2014 Corresponding Author:   Allen Sim  Department of Urology, Singapore General Hospital, Blk 4, Level 1, Urology Centre, Outram Road, Singapore 169608 TEL: +65 6326 6808, FAX: +65 6326 6804, E-mail: allen.sim.s.p@sgh.com.sg ⓒ The Korean Urological Association, 2015neuromyopathy, vasculopathy, and glomerulopathy.",Non-OADS,/arxiv_data1/oa_pdf/7f/27/kju-56-82.PMC4294860.pdf
"Chest This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/27/kju-56-82.PMC4294860.pdf
orgLee et al http://dx.doi.org/10.4111/kju.2015.56.1.82 descending colon.,OADS,/arxiv_data1/oa_pdf/7f/27/kju-56-82.PMC4294860.pdf
"Publisher  byElsevier  B.V.   http://dx.doi.org/10.1016/j.coviro.2013.05.005 Introduction Respiratory  syncytial  virus  (RSV)  is  a  leading  cause  of morbidity  in  infants,  and  is  increasingly  appreciated  as  a major  cause  of  illness  and  death  in  susceptible  adults.",Non-OADS,/arxiv_data1/oa_pdf/f0/c9/main.PMC4295022.pdf
J  Infect  Dis  2013  http://dx.doi.org/ 10.1093/infdis/jit038 .,OADS,/arxiv_data1/oa_pdf/f0/c9/main.PMC4295022.pdf
http://dx.doi.org/10.1016/j.jare.2013.04.001,OADS,/arxiv_data1/oa_pdf/89/f1/main.PMC4295035.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.007,OADS,/arxiv_data1/oa_pdf/31/eb/main.PMC4295036.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.008,OADS,/arxiv_data1/oa_pdf/2c/07/main.PMC4295037.pdf
Source : http://gong.nso.edu/data/magmap/Fig.,OADS,/arxiv_data1/oa_pdf/2c/07/main.PMC4295037.pdf
In particular the results for conditions since late 2006 can be accessed at the GONG observatory pages at http://gong.nso.e- du/data/magmap .,OADS,/arxiv_data1/oa_pdf/2c/07/main.PMC4295037.pdf
http://www.predsci.com/stereo/ .,Non-OADS,/arxiv_data1/oa_pdf/2c/07/main.PMC4295037.pdf
In the SOHO LASCO C2 images ( http://sohowww.nascom.nasa.gov ) they appear as extra coronal rays.,OADS,/arxiv_data1/oa_pdf/2c/07/main.PMC4295037.pdf
"Astrophys J 2011;734, doi: http://dx.doi.org/10.1088/ 0004-637X/734/1/7 .228 J.G.",OADS,/arxiv_data1/oa_pdf/2c/07/main.PMC4295037.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.002,OADS,/arxiv_data1/oa_pdf/78/9a/main.PMC4295038.pdf
Event description and data coverage A candidate CME/shock event observed on 2003 November 1st included in the online CDAW LASCO CME catalog (http://cdaw.gsfc.nasa.gov/CME_list/index.html )[9]was se- lected by using a UVCS catalog of CMEs [10]composed by over 1000 events crossing the UVCS slit during the CME detection.,OADS,/arxiv_data1/oa_pdf/78/9a/main.PMC4295038.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.010,OADS,/arxiv_data1/oa_pdf/68/d0/main.PMC4295039.pdf
Data sets and data processing The geomagnetic index data aa used in this paper is taken from a homogeneous series established by Mayaud [2]and available per day on http://isgi.latmos.ipsl.fr/ since 1868.,OADS,/arxiv_data1/oa_pdf/68/d0/main.PMC4295039.pdf
"IAGA special Sopron book series 5,Springer; 2011. doi: http://dx.doi.org/10.1007/978-90-481-9858- 08.",Non-OADS,/arxiv_data1/oa_pdf/68/d0/main.PMC4295039.pdf
http://dx.doi.org/10.1029/2006JA012130 .,Non-OADS,/arxiv_data1/oa_pdf/68/d0/main.PMC4295039.pdf
http://dx.doi.org/10.1029/ 2007GL031123 .Geomagnetism during solar cycle 23: Characteristics 273,Non-OADS,/arxiv_data1/oa_pdf/68/d0/main.PMC4295039.pdf
http://dx.doi.org/10.1029/2007JA012437 .,Non-OADS,/arxiv_data1/oa_pdf/68/d0/main.PMC4295039.pdf
http://dx.doi.org/10.1029/2011JA017422 .,Non-OADS,/arxiv_data1/oa_pdf/68/d0/main.PMC4295039.pdf
http://dx.doi.org/10.5194/angeo-29-1365 .,Non-OADS,/arxiv_data1/oa_pdf/68/d0/main.PMC4295039.pdf
J Geophys Res 2002;107:118. http://dx.doi.org/10.1029/2001JA000504 .,OADS,/arxiv_data1/oa_pdf/68/d0/main.PMC4295039.pdf
"J Geophys Lett 2008;35:L18103, doi: http://dx.doi.org/10.1029/2008GL034896 .",Non-OADS,/arxiv_data1/oa_pdf/68/d0/main.PMC4295039.pdf
http://dx.doi.org/10.1016/j.jare.2012.11.001,OADS,/arxiv_data1/oa_pdf/fa/7f/main.PMC4295040.pdf
"The data used to prepare Tables 1, 2 and 3 have been obtained from Kandilli Observatory, Bogazici University, Tur-key and from URL: http://sidc.oma.be ,http:// www.spaceweather.com .",OADS,/arxiv_data1/oa_pdf/fa/7f/main.PMC4295040.pdf
"1 The monthly means (blue) and monthly smoothed (red) sunspot numbers for the latest three cycles and ascending phase,the data given from, http://sidc.oma.be/sunspot-data .",OADS,/arxiv_data1/oa_pdf/fa/7f/main.PMC4295040.pdf
http://dx.doi.org/10.1016/j.jare.2012.09.002,OADS,/arxiv_data1/oa_pdf/d5/17/main.PMC4295041.pdf
http://dx.doi.org/10.1016/j.jare.2013.02.001,OADS,/arxiv_data1/oa_pdf/b2/01/main.PMC4295042.pdf
This prediction seems to be in verygood agreement with the real progress of solar cycle 24 (see http://www.swpc.noaa.gov/SolarCycle/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/01/main.PMC4295042.pdf
Adv Astron 2012;2012:7. http://dx.doi.org/10.1155/ 2012/85486 .,OADS,/arxiv_data1/oa_pdf/b2/01/main.PMC4295042.pdf
<http://www.hindawi.com/ journals/aa/2012/854867/ >.,Non-OADS,/arxiv_data1/oa_pdf/b2/01/main.PMC4295042.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.011,OADS,/arxiv_data1/oa_pdf/17/0b/main.PMC4295043.pdf
http://dx.doi.org/ 10.1029/2009RG00031 .,Non-OADS,/arxiv_data1/oa_pdf/17/0b/main.PMC4295043.pdf
http://dx.doi.org/ 10.1007/BF00145940 .,Non-OADS,/arxiv_data1/oa_pdf/17/0b/main.PMC4295043.pdf
http://dx.doi.org/10.1029/ 1999JA00026 .,Non-OADS,/arxiv_data1/oa_pdf/17/0b/main.PMC4295043.pdf
J Geophys Res 2002:107. http://dx.doi.org/10.1029/2001JA00755 .,OADS,/arxiv_data1/oa_pdf/17/0b/main.PMC4295043.pdf
Space Sci Rev 2011:158. http://dx.doi.org/10.1007/s11214-011-9780- .,Non-OADS,/arxiv_data1/oa_pdf/17/0b/main.PMC4295043.pdf
Using dynamo theory to predict the sunspot number in solar cycle 21.Geophys Res Lett 1978;5:411. http://dx.doi.org/10.1029/ GL005i005p00411 .,Non-OADS,/arxiv_data1/oa_pdf/17/0b/main.PMC4295043.pdf
http://dx.doi.org/10.1029/ 2010GL044143 .,Non-OADS,/arxiv_data1/oa_pdf/17/0b/main.PMC4295043.pdf
http://dx.doi.org/10.1016/j.jare.2012.10.003,OADS,/arxiv_data1/oa_pdf/f0/4c/main.PMC4295044.pdf
"Inhttp://www.astro.uson.mx/ we present daily images of the Sun, usually the full disk in H a.",Non-OADS,/arxiv_data1/oa_pdf/f0/4c/main.PMC4295044.pdf
http://dx.doi.org/10.1016/j.jare.2012.09.006,OADS,/arxiv_data1/oa_pdf/2b/63/main.PMC4295045.pdf
http://dx.doi.org/10.1016/j.jare.2012.10.002,OADS,/arxiv_data1/oa_pdf/e0/af/main.PMC4295046.pdf
"The used data are taken from the site of National GeophysicalData Center, USA (ftp://ftp.ngdc.noaa.gov/STP/SOLAR_- DATA/SUNSPOT_NUMBER/maxmin.new).",OADS,/arxiv_data1/oa_pdf/e0/af/main.PMC4295046.pdf
http://dx.doi.org/10.1029/2006 GL 027053 .,Non-OADS,/arxiv_data1/oa_pdf/e0/af/main.PMC4295046.pdf
http://dx.doi.org/ 10.1007/s10509-007-9729-9 .,Non-OADS,/arxiv_data1/oa_pdf/e0/af/main.PMC4295046.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.003,OADS,/arxiv_data1/oa_pdf/e2/e2/main.PMC4295047.pdf
http://dx.doi.org/10.1016/j.jare.2012.09.004,OADS,/arxiv_data1/oa_pdf/a3/47/main.PMC4295048.pdf
http://dx.doi.org/10.1016/j.jare.2012.12.003,OADS,/arxiv_data1/oa_pdf/28/10/main.PMC4295049.pdf
http://dx.doi.org/10.1016/j.jare.2012.08.001,OADS,/arxiv_data1/oa_pdf/00/2f/main.PMC4295050.pdf
"The top panel shows northern and southern HMFmagnitude and polarity; the middle panel the HMF magnitude and the HCS tilt angle at Earth (courtesy of the WSO, http:// www.wso.stanford.edu ;http://www.cohoweb.gsfc.nasa.gov ).",Non-OADS,/arxiv_data1/oa_pdf/00/2f/main.PMC4295050.pdf
http://dx.doi.org/10.1016/j.jare.2013.03.002,OADS,/arxiv_data1/oa_pdf/9d/8a/main.PMC4295051.pdf
http://unfccc.int/kyoto_protocol/items/2830.php (2013).,Non-OADS,/arxiv_data1/oa_pdf/45/4e/srep07811.PMC4295086.pdf
http://www.oie.int/ (2013).,Non-OADS,/arxiv_data1/oa_pdf/45/4e/srep07811.PMC4295086.pdf
http://www.magrama.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/srep07811.PMC4295086.pdf
Government of Castilla y Leo ´n.Decree 17/2013 of the Region of Castilla y Leo ´n http://www.jcyl.es/ (2013).,Non-OADS,/arxiv_data1/oa_pdf/45/4e/srep07811.PMC4295086.pdf
http://www.idee.es (2014).,Non-OADS,/arxiv_data1/oa_pdf/45/4e/srep07811.PMC4295086.pdf
http://www.anfac.com/ (2011).,Non-OADS,/arxiv_data1/oa_pdf/45/4e/srep07811.PMC4295086.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f0/34/srep07818.PMC4295088.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7812 | DOI: 10.1038/srep07812 8",Non-OADS,/arxiv_data1/oa_pdf/c1/11/srep07812.PMC4295089.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a7/a5/srep07807.PMC4295091.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7807 | DOI: 10.1038/srep07807 9",Non-OADS,/arxiv_data1/oa_pdf/a7/a5/srep07807.PMC4295091.pdf
co-wrote the paper.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c3/63/srep07810.PMC4295092.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2a/c7/srep07808.PMC4295093.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ea/f3/srep07803.PMC4295095.pdf
URL http://dx.doi.org/10.1002/andp.201200226.,OADS,/arxiv_data1/oa_pdf/e7/b6/srep07809.PMC4295096.pdf
URL http://dx.doi.org/10.1038/nature10461.,OADS,/arxiv_data1/oa_pdf/e7/b6/srep07809.PMC4295096.pdf
URL http://www.mdpi.com/1099-4300/15/6/2100.,Non-OADS,/arxiv_data1/oa_pdf/e7/b6/srep07809.PMC4295096.pdf
URL http://dx.doi.org/10.1007/ BF01011769.,Non-OADS,/arxiv_data1/oa_pdf/e7/b6/srep07809.PMC4295096.pdf
Author contributions D.G.-K. develop the idea and did the calculations under the guidance of G.K. Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e7/b6/srep07809.PMC4295096.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7809 | DOI: 10.1038/srep07809 6",Non-OADS,/arxiv_data1/oa_pdf/e7/b6/srep07809.PMC4295096.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Dr. Williams is member of the scientific advisory board of Meditope Biosciences, Inc. and owns stock in the company.",Non-OADS,/arxiv_data1/oa_pdf/a5/fe/srep07817.PMC4295097.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/30/af/srep07768.PMC4295099.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7768 | DOI: 10.1038/srep07768 8",Non-OADS,/arxiv_data1/oa_pdf/30/af/srep07768.PMC4295099.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/26/fa/srep07798.PMC4295100.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6f/e0/srep07792.PMC4295103.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7792 | DOI: 10.1038/srep07792 4",Non-OADS,/arxiv_data1/oa_pdf/6f/e0/srep07792.PMC4295103.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f5/a3/srep07795.PMC4295104.pdf
supervised the project.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e7/04/srep07805.PMC4295106.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7805 | DOI: 10.1038/srep07805 9",Non-OADS,/arxiv_data1/oa_pdf/e7/04/srep07805.PMC4295106.pdf
"Then, the images were normalized to an average intensity of 0 with a standard derivation of 1 using KBI plugins (http://hasezawa.ib.k.u-tokyo.ac.jp/ zp/Kbi/ImageJKbiPlugins) as previously described22.",OADS,/arxiv_data1/oa_pdf/c1/26/srep07794.PMC4295107.pdf
"For image analysis procedures in our proposed method (Figure 1), we used the CARTA ImageJ plugin in KBI version 1192 (freely available at http://hasezawa.ib.k.u-tokyo.ac.jp/zp/Kbi/RegionSearch)with KBI Features version 2, which contains 296 features (http://hasezawa.ib.k.u- tokyo.ac.jp/zp/Kbi/KbiFeatures02) 4.",OADS,/arxiv_data1/oa_pdf/c1/26/srep07794.PMC4295107.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c1/26/srep07794.PMC4295107.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7814 | DOI: 10.1038/srep07814 4",Non-OADS,/arxiv_data1/oa_pdf/68/4b/srep07814.PMC4295108.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7816 | DOI: 10.1038/srep07816 8",Non-OADS,/arxiv_data1/oa_pdf/99/e3/srep07816.PMC4295109.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/75/f2/srep07730.PMC4295110.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7730 | DOI: 10.1038/srep07730 7",Non-OADS,/arxiv_data1/oa_pdf/75/f2/srep07730.PMC4295110.pdf
String analysis .Protein-protein interactions were predicted using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database v9.0 (http://www.string-db.org/).,OADS,/arxiv_data1/oa_pdf/ff/b7/srep07819.PMC4295111.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7819 | DOI: 10.1038/srep07819 8",Non-OADS,/arxiv_data1/oa_pdf/ff/b7/srep07819.PMC4295111.pdf
supervised the project.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/68/6c/srep07802.PMC4295112.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/srep07791.PMC4295113.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e0/16/ijhrba-03-03-22688.PMC4295122.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/22/b0/aapm-04-04-18514.PMC4295123.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/fb/50/ijhrba-03-03-18669.PMC4295124.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/82/83/ijhrba-03-03-19223.PMC4295125.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in  noncommercial usages, provided the original work is properly cited..1.",Non-OADS,/arxiv_data1/oa_pdf/cc/7f/ijhrba-03-03-18053.PMC4295126.pdf
"This is an open-access article distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/34/51/ijhrba-03-03-18857.PMC4295127.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a8/9d/jjm-07-12143.PMC4295314.pdf
Available from: http://www.HyFlex®  cm.com/DevDownloads/30464A_HYFLEX® -CM_bro.,Non-OADS,/arxiv_data1/oa_pdf/65/9b/JIOH-6-1.PMC4295443.pdf
http://www.tribal.,Non-OADS,/arxiv_data1/oa_pdf/d7/6c/JIOH-6-26.PMC4295450.pdf
Available from: http://www.indexmundi.com/india/ demographics_profile.html.,Non-OADS,/arxiv_data1/oa_pdf/66/d3/JIOH-6-56.PMC4295457.pdf
Available from: http://www.update ox.com/ India/district-wise population-India –as-of 2011-census.,OADS,/arxiv_data1/oa_pdf/66/d3/JIOH-6-56.PMC4295457.pdf
Available from: http://www.dentalhealthweek.,Non-OADS,/arxiv_data1/oa_pdf/2b/30/JIOH-6-i.PMC4295469.pdf
(http://www.who.int/influenza/human_animal_interface/influenza_ h7n9/riskassessment_h7n9_27june14.pdf)(Accessed 27 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/54/41/srep07630.PMC4295517.pdf
(http://wwwnc.cdc.gov/eid/article/20/11/14- 0608_article)(Accessed 17 July 2014).,OADS,/arxiv_data1/oa_pdf/54/41/srep07630.PMC4295517.pdf
(http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId 520836)(Accessed 26 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/54/41/srep07630.PMC4295517.pdf
(http://crofsblogs.typepad.com/h5n1/2014/03/china-guangdong-farm-culls- chickens-after-h7n9-found-in-macau.html) (Accessed 17 March 2014).,Non-OADS,/arxiv_data1/oa_pdf/54/41/srep07630.PMC4295517.pdf
(http://www.who.int/influenza/gisrs_laboratory/cnic_serological_diagnosis_hai_a_h7n9_20131220.pdf) (Accessed20 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/54/41/srep07630.PMC4295517.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/54/41/srep07630.PMC4295517.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 7630 | DOI: 10.1038/srep07630 8",Non-OADS,/arxiv_data1/oa_pdf/54/41/srep07630.PMC4295517.pdf
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jcte.2014.08.001Journal of Clinical & Translational Endocrinology 1 (2014) 151 e160 Open access under CC BY-NC-ND license.Open access under CC BY-NC-ND license.,OADS,/arxiv_data1/oa_pdf/2c/39/main.PMC4295520.pdf
http://dx.doi.org/10.1016/S1473-3099(12)70275-X .,OADS,/arxiv_data1/oa_pdf/2c/39/main.PMC4295520.pdf
Clin Nutr 2013 Nov 26. pii: S0261-5614(13)00320-8. http://dx.doi.org/10.1016/j.clnu.,OADS,/arxiv_data1/oa_pdf/2c/39/main.PMC4295520.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/6b/imcrj-8-023.PMC4295524.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 23–27International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  23Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S7425 0aCtH gel in the treatment of multiple sclerosis  exacerbation: a case study salvatore Napoli Neuro Institute of New england,   Foxborough, M a, Usa Correspondence: salvatore Napoli   Neuro Institute of New england,   15 payson Road, Foxborough,  Massachusetts 02035, Usa   tel +1 781 551 5812   Fax +1 508 698 8671   email sqnapoli@gmail.co mAbstract:  Patients may refuse, be unable to use, or show nonresponse to conventional steroid  treatment of multiple sclerosis (MS) exacerbation.",Non-OADS,/arxiv_data1/oa_pdf/03/6b/imcrj-8-023.PMC4295524.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/03/6b/imcrj-8-023.PMC4295524.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/6b/imcrj-8-023.PMC4295524.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/8d/mder-8-065.PMC4295528.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 65–70Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  65ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S7640 9characterizing the continuously acquired  cardiovascular time series during hemodialysis,  using median hybrid filter preprocessing   noise reduction scott Wilson1,2 andrea Bowyer3 stephen B harrap4 1Department of Renal Medicine,   The alfred hospital, 2Baker iDi,   Melbourne, 3Department of  anaesthesia, Royal Melbourne  hospital, 4University of Melbourne,   Parkville, Vic , australia correspondence: scott Wilson   alfred health, l4 Main Block alfred  hospital, 55 commercial Road,  Melbourne, Vic 3004, australia   Tel +61 3 9076 2580   Fax +61 3 9076 3494   Email s.wilson@alfred.org.a uAbstract:  The clinical characterization of cardiovascular dynamics during hemodialysis (HD) has  important pathophysiological implications in terms of diagnostic, cardiovascular risk assessment,  and treatment efficacy perspectives.",Non-OADS,/arxiv_data1/oa_pdf/9e/8d/mder-8-065.PMC4295528.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/9e/8d/mder-8-065.PMC4295528.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ab/9c/jbm-6-025.PMC4295530.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Blood Medicine 2015:6 25–29Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  25Short reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/JBM.S6406 7post hoc analysis of the relationship between  baseline white blood cell count and survival  outcome in a randomized phase III trial of  decitabine in older patients with newly diagnosed  acute myeloid leukemia Christopher Arthur1 Jaroslav Cermak2 Jacques Delaunay3 Jiří Mayer4 Grzegorz Mazur5 Xavier thomas6 Agnieszka Wierzbowska7 Mark M Jones8 erhan Berrak8 hagop Kantarjian9 1Department of haematology, royal  North Shore hospital, Sydney, NSW,  Australia; 2Institute of hematology  and Blood transfusion, prague, Czech  republic; 3Department of Clinical  hematology, University of Nantes, Nantes,  France; 4Department of Internal Medicine,  Masaryk University hospital Brno,  Central european Institute of technology,  Brno, Czech republic; 5Department of  Hematology, Wrocław Medical University,  Wrocław, Poland; 6Department of  hematology, edouard herriot hospital,  Lyon, France; 7Copernicus Memorial  hospital, Lodz, poland; 8oncology product  Creation Unit, eisai Inc.,  Woodcliff Lake,  NJ, USA; 9Department of Leukemia,  University of texas MD Anderson Cancer  Center, houston, tX, USA Correspondence: Christopher Arthur   Department of haematology,   royal North Shore hospital,   Pacific Highway, St Leonards,   Sydney, NSW 2065, Australia   tel +61 2 9926 7601   Fax +61 2 9906 1635   email carthur@nsccahs.health.nsw.gov.a uBackground:  In a Phase III trial, 485 patients ( $65 years) with newly diagnosed acute myeloid  leukemia received decitabine 20 mg/m2 intravenously for 5 days every 4 weeks or a treatment  choice (supportive care or cytarabine 20 mg/m2 subcutaneously for 10 days every 4 weeks).",Non-OADS,/arxiv_data1/oa_pdf/ab/9c/jbm-6-025.PMC4295530.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/ab/9c/jbm-6-025.PMC4295530.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/9c/jbm-6-025.PMC4295530.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/a2/jmdh-8-011.PMC4295531.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 11–20Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  11Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S7171 8an intervention designed to improve sensory  impairments in the elderly and indoor lighting  in their homes: an exploratory randomized  controlled trial gro gade Haanes1 Marit Kirkevold2 Dag Hofoss2 gunnar Horgen1 grethe eilertsen1 1Department of Health sciences,   Buskerud and Vestfold University  college, Drammen, norway; 2institute  of Health and society, University of  Oslo, Oslo, norway correspondence: gro gade Haanes   Department of Health sciences,   Buskerud and Vestfold University   college, PO Box 7053, n-3007   Drammen, norway   Tel +47 93 437 662   Fax +47 3 2206 410   email gro.gade.haanes@hbv.n oBackground:  Vision and hearing impairments in the elderly (aged over 80 years) and poor  indoor lighting conditions in a home-care setting are risk factors for functional decline, reduced  social participation, withdrawal, and accidents.",Non-OADS,/arxiv_data1/oa_pdf/de/a2/jmdh-8-011.PMC4295531.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/de/a2/jmdh-8-011.PMC4295531.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/a2/jmdh-8-011.PMC4295531.pdf
Available from:  http://www.wh o.int/pbd/deafness/hearing_impairment_grades/en /.,Non-OADS,/arxiv_data1/oa_pdf/de/a2/jmdh-8-011.PMC4295531.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/38/ndt-11-097.PMC4295534.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 97–106Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  97Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6581 5Neuroinflammatory responses to traumatic  brain injury: etiology, clinical consequences,  and therapeutic opportunities Diego Lozano* Gabriel S Gonzales- Portillo* Sandra Acosta ike de la Pena Naoki Tajiri Yuji Kaneko Cesar v Borlongan Department of Neurosurgery  and Brain Repair, University of South  Florida Morsani College of Medicine,   Tampa, FL, USA *These authors contributed equally  to this workAbstract:  Traumatic brain injury (TBI) is a serious public health problem accounting for  1.4 million emergency room visits by US citizens each year.",Non-OADS,/arxiv_data1/oa_pdf/e4/38/ndt-11-097.PMC4295534.pdf
"To this end, the clinical test used most is the Glasgow coma scale, which Correspondence: Cesar v Borlongan Center of excellence for Aging and Brain  Repair, Department of Neurosurgery  and Brain Repair, University of South  Florida Morsani College of Medicine,  12901 Bruce B Downs Blvd,   Tampa, FL, USA Tel +1 813 974 3154 Fax +1 813 974 3078 email cborlong@health.usf.ed u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Lozano et al Running head recto: Research advances in TBI DOI: http://dx.doi.org/10.2147/NDT.S65815",Non-OADS,/arxiv_data1/oa_pdf/e4/38/ndt-11-097.PMC4295534.pdf
London: InTech; 2011. http://dx.doi.org/10.5772/2854 8  27.,Non-OADS,/arxiv_data1/oa_pdf/e4/38/ndt-11-097.PMC4295534.pdf
2014. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/38/ndt-11-097.PMC4295534.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e4/38/ndt-11-097.PMC4295534.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/38/ndt-11-097.PMC4295534.pdf
2014. http://dx.doi.org/10.1007/s11011-014-9623- 3  95.,Non-OADS,/arxiv_data1/oa_pdf/e4/38/ndt-11-097.PMC4295534.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/04/ndt-11-087.PMC4295537.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 87–95Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  87OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7069 4An open-label, flexible-dose study of paliperidone  extended-release in chinese patients with  first-onset psychosis TianMei si1 Qing rong Tan2 Kerang Zhang3 Yang Wang4 Qing rui4 1Peking University Institute of Mental  health, Key Laboratory of Mental  Health, Ministry of Health (Peking  University), Beijing, 2Fourth Military  Medical University, First hospital,   Xi’an, 3shanxi Medical University,   First hospital, shanxi, 4Janssen  research and Development, Beijing,   People’s Republic of ChinaBackground:  Antipsychotic medications facilitate the improvement of psychotic symptoms in  patients with first-episode psychosis.",Non-OADS,/arxiv_data1/oa_pdf/1f/04/ndt-11-087.PMC4295537.pdf
"Further, relapse in young patients affects their long-term psychosocial correspondence: TianMei si Peking University Institute of Mental  health, huayuanbeilu 51#, haidian  District, Beijing 100191, People’s  Republic of China Tel +86 10 8280 1948 email si.tian-mei@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Si et al Running head recto: Paliperidone extended-release in first-onset psychosis patients DOI: http://dx.doi.org/10.2147/NDT.S70694",Non-OADS,/arxiv_data1/oa_pdf/1f/04/ndt-11-087.PMC4295537.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1f/04/ndt-11-087.PMC4295537.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/04/ndt-11-087.PMC4295537.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Taken together, previous research data suggests that HFG triggers aberrant activation of the NLRP3-ASC-Caspase 1 immune system in metabolic disorders, and the mitochondrion appears to be the common pathway for these events.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.04.001 2213-2317/ &2014 The Authors.",OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: HFD, high-fat diet; BMM, bone marrow-derived macrophage; MCP-1, monocyte chemotactic protein-1; PA, palmitic acid; T2D, type 2 diabetes;ROS, reactive oxygen species; Lamp, lysosome-associated membrane protein; LC3I/II, light chain 3I/II; DLP1, dynamin-like protein; NLR, NOD-like receptors; CHX, cycloheximide; LPS, lipopolysaccharide; rheb, Ras homolog enriched in brain; KIF5B, kinesin family member 5B ∗Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Dixit, The NLRP3 in ﬂammasome instigates obesity-induced in ﬂammation and insulin resistance, Nature Medicine 17 (2011) 179 –188, http://dx.doi.org/10.1038/nm.2279 21217695 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Jo, Upregulated NLRP3 inﬂammasome activation in patients with type 2 diabetes, Diabetes 62 (2013) 194 –204, http://dx.doi.org/10.2337/db12-0420 23086037 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Brickey, J.P. Ting, Fatty acid-induced NLRP3-ASC in ﬂammasome activation interferes with insulin signaling, Nature Immunology 12 (2011) 408 –415, http://dx.doi.org/10.1038/ ni.2022 21478880 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Donath, Free fatty acids induce a proin ﬂammatory response in islets via the abundantly expressed interleukin-1 receptor I, Endocrinology 150 (2009) 5218 –5229, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Czech, G. Kunos, Activation of the Nlrp3 in ﬂammasome in in ﬁltrating macrophages by endo- cannabinoids mediates beta cell loss in type 2 diabetes, Nature Medicine 19 (2013) 1132 –1140, http://dx.doi.org/10.1038/nm.3265 23955712 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Kahn, E. C. Lavelle, L.A. O ’Neill, Activation of the NLRP3 in ﬂammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes,Nature Immunology 11 (2010) 897 –904, http://dx.doi.org/10.1038/ni.1935 20835230 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"[10] R. Zhou, A.S. Yazdi, P. Menu, J. Tschopp, A role for mitochondria in NLRP3 inﬂammasome activation, Nature 469 (2011) 221 –225, http://dx.doi.org/ 10.1038/nature09663 21124315 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"East, M. Campanella, Ca2þin quality control: an unresolved riddle critical to autophagy and mitophagy, Autophagy 9 (2013) 1710 –1719, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"[13] V. Deretic, S. Jiang, N. Dupont, Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and in ﬂamma- tion, Trends in Cell Biology 22 (2012) 397 –406, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Green, Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis, Nature 450 (2007) 1253 –1257, http://dx.doi.org/10.1038/nature06421 18097414 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Rezvani, R. Rossignol, G. Benard, Rheb regulates mitophagy induced by mitochondrial energetic status, Cell Metabolism 17 (2013) 719 –730, http://dx.doi.org/10.1016/j.cmet.2013.03.014 23602449 .",OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Kittler, Miro1 is a calcium sensor forglutamate receptor-dependent localization of mitochondria at synapses, Neuron 61 (2009) 541 –555, http://dx.doi.org/10.1016/j.neuron.2009.01.030 19249275 .",OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Wieckowski, P. Pinton, Mitochondrial calcium homeostasis as potential target for mito- chondrial medicine, Mitochondrion 12 (2012) 77 –85, http://dx.doi.org/ 10.1016/j.mito.2011.07.004 21798374 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"[19] M. Cagalinec, D. Sa ﬁulina, M. Liiv, J. Liiv, V. Choubey, P. Wareski, V. Veksler, A. Kaasik, Principles of the mitochondrial fusion and ﬁssion cycle in neurons, Journal of Cell Science 126 (2013) 2187 –2197, http://dx.doi.org/10.1242/ jcs.118844 23525002 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Virgin, Autophagy in immunity and in ﬂamma- tion, Nature 469 (2011) 323 –335, http://dx.doi.org/10.1038/nature09782 21248839 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Germain, The adaptor MAVS promotes NLRP3 mitochondrial localization and in ﬂammasome activation, Cell 153 (2013) 348 –361, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"[23] Y. Yan, W. Jiang, T. Spinetti, A. Tardivel, R. Castillo, C. Bourquin, G. Guarda, Z. Tian, J. Tschopp, R. Zhou, Omega-3 fatty acids prevent in ﬂammation and metabolic disorder through inhibition of NLRP3 in ﬂammasome activation, Immunity 38 (2013) 1154 –1163, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"[24] J.C. Kagan, T. Horng, NLRP3 in ﬂammasome activation: CD36 serves double duty, Nature Immunology 14 (2013) 772 –774, http://dx.doi.org/10.1038/ ni.2668 23867926 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Moore, CD36 coordinates NLRP3 in ﬂammasome activation by facilitating intracellular nucleation of soluble ligands into particulateligands in sterile in ﬂammation, Nature Immunology 14 (2013) 812 –820, http://dx.doi.org/10.1038/ni.2639 23812099 .S.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Stuart, Activation of caspase-1 by the NLRP3 in ﬂammasome regulates the NADPH oxidase NOX2 to control phagosome function, Nature Immunology 14 (2013) 543 –553, http://dx.doi.org/10.1038/ni.2595 23644505 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"GaleJr., IL-1beta production through theNLRP3 in ﬂammasome by hepatic macrophages links hepatitis C virus infection with liver in ﬂammation and disease, PLoS Pathogens (2013) , http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Green, L. Galluzzi, G. Kroemer, Mitochondria and the autophagy- inﬂammation-cell death axis in organismal aging, Science (New York, N.Y.) 333 (2011) 1109 –1112, http://dx.doi.org/10.1126/science.1201940 21868666 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Kanneganti, Receptor interacting protein kinase 2-mediated mitophagy regulates in ﬂammasome activation during virus infection, Nature Immunology 14 (2013) 480 –488, http://dx.doi.org/10.1038/ni.2563 23525089 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"[36] J. Zhang, Autophagy and mitophagy in cellular damage control, Redox Biology 1 (2013) 19 –23,http://dx.doi.org/10.1016/j.redox.2012.11.008 23946931 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"[37] I. Bhatia-Kissova, N. Camougrand, Mitophagy:a process that adapts to the cell physiology, International Journal of Biochemistry & Cell Biology 45 (2013) 30–33,http://dx.doi.org/10.1016/j.biocel.2012.07.006 22801005 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Long, S. Ortiz-Vega, K. Yonezawa, Insulin and amino-acid regulation of mTOR signaling and kinase activity through the rheb GTPase, Oncogene 25 (2006) 6361 –6372, http://dx.doi.org/10.1038/sj.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"[39] S. Hamada, K. Hara, T. Hamada, H. Yasuda, H. Moriyama, R. Nakayama, M. Nagata, K. Yokono, Upregulation of the mammalian target of rapamycincomplex 1 pathway by Ras homolog enriched in brain in pancreatic beta-cells leads to increased beta-cell mass and prevention of hyperglycemia, Diabetes 58 (2009) 1321 –1332, http://dx.doi.org/10.2337/db08-0519 19258434 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"[40] K. Dezaki, H. Hosoda, M. Kakei, S. Hashiguchi, M. Watanabe, K. Kangawa, T. Yada, Endogenous ghrelin in pancreatic islets restricts insulin release byattenuating Ca 2þsignaling in beta-cells: implication in the glycemic control in rodents, Diabetes 53 (2004) 3142 –3151, http://dx.doi.org/10.2337/dia- betes.53.12.3142 15561944 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"[43] J. Doczi, L. Turiak, S. Vajda, M. Mandi, B. Torocsik, A.A. Gerencser, G. Kiss, C. Konrad, V. Adam-Vizi, C. Chinopoulos, Complex contribution of cyclophilin Dt oC a2þ-induced permeability transition in brain mitochondria, with relation to the bioenergetic state, Journal of Biological Chemistry 286 (2011)6345 –6353, http://dx.doi.org/10.1074/jbc.M110.196600 21173147 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Huang, Targeted inactivation of kinesin-1 inpancreatic beta-cells in vivo leads to insulin secretory de ﬁciency, Diabetes 60 (2011) 320 –330, http://dx.doi.org/10.2337/db09-1078 20870970 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Hoogenraad, TRAK/Milton motor-adaptorproteins steer mitochondrial traf ﬁcking to axons and dendrites, Neuron 77 (2013) 485 –502, http://dx.doi.org/10.1016/j.neuron.2012.11.027 23395375 .",OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Kastner, J.J. Chae, The calcium-sensing receptorregulates the NLRP3 in ﬂammasome through Ca 2þand cAMP, Nature 492 (2012) 123 –127, http://dx.doi.org/10.1038/nature11588 23143333 .",OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Wollheim, P. Maechler, Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells, Endocrinology 145 (2004)667 –678, http://dx.doi.org/10.1210/en.2003-1099 14592952 .",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
"Peyot, M. Prentki, J. Leahy, Islet betacell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fattyrat: severe dysfunction with altered glycerolipid metabolism without steatosisor a falling beta cell mass, Diabetologia 52 (2009) 1122 –1132, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ba/24/main.PMC4295565.pdf
http://dx.doi.org/10.1093/rheumatology/ket191 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1136/ annrheumdis-2012-202750 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1177/1534735411423920 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1002/ibd.21360 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1016/j.jadohealth.2012.01.003 .,OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1016/j.pmrj.,OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1002/art.11377 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.7326/0003-4819-143-9-200511010-00005 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1038/nrneph.2012.16 .,OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/ 10.1136/ard.2008.088302 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1038/nrneph.2012.107 .,OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1007/s11926-012-0291-1 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/ 10.1016/j.pec.2012.02.014 .,OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.3899/jrheum.,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.7326/0003-4819-131-6-199909210-00003 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1016/j.explore.,OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1007/s00296-009-0871-1 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1371/journal.pone.0062817 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/ 10.1002/art.24235 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1002/art.23800 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
http://dx.doi.org/10.1007/s10943-009-9293-3 .,Non-OADS,/arxiv_data1/oa_pdf/90/b9/nihms648011.PMC4295716.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/main.PMC4295719.pdf
http://dx.doi.org/10.1016/j.pmedr.2014.12.003 2211-3355/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/main.PMC4295719.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/main.PMC4295719.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/main.PMC4295719.pdf
"First, in November 2013, three national databases –(1) the American Community Garden Association database ( http://acga.localharvest.org/ ), (2) the Public Gardens Locator provided by the National Gardening Association and the American Public Gardens Association ( http:// www.garden.org/public_gardens/index.php ), and (3) the Therapeutic Landscapes Network ( http://www.healinglandscapes.org/gardens/ map.html )–were searched using the terms “hospital, ”“medical center, ”“academic health center, ”“medicine, ”and “healthcare.",OADS,/arxiv_data1/oa_pdf/f2/d8/main.PMC4295719.pdf
"To examine obesity rates of communities served by gardens, we used health indicator data from the Robert Wood Johnson County Health Rankings & Roadmaps data- base ( http://www.countyhealthrankings.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/main.PMC4295719.pdf
"Socio-demographic characteristics Region USA P⁎ Northeast n = 24 Midwest n = 39 South n = 25 West n = 22 Garden total n = 110 Adult obesity (%) 24.2 28.9 29.4 24 27 34.9 b.001 High school or higher (%) 86.9 89.2 83.7 84.9 86.6 85.7 .11Bachelor degree or higher (%) 36.6 27.1 27.6 29.3 29.7 28.5 .21Hispanic/Latino (%) 15.9 7.4 14.2 27.5 14.8 16.9 .15White (non-Hispanic) (%) 64 78.8 53.8 55.2 65.2 63 .3165 years or older (%) 14 14.8 12.9 13.9 14 13.7 .27 Median household income ($) 61,628 50,553 47,426 57,509 53,650 53,046 .62 ⁎P-value compares socio-demographic characteristics of the 110 communities served by healthcare-based gardens to average US socio-demographic characteristics based on census data ( http://quickfacts.census.gov/qfd/index.html ) and county health-rankings data ( http://www.countyhealthrankings.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/main.PMC4295719.pdf
"American Community Garden Association, Columbus (OH) ( http://www.communitygarden.org/learn .A c c e s s e dN o v e m b e r1 ,2 0 1 0 ) The Patient Protection and Affordable Care Act (PPACA), 42 USC §9007.",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/main.PMC4295719.pdf
( http://www.gpo.,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/main.PMC4295719.pdf
(http://www.nytimes.com/2010/08/13/business/13veggies.html?_r=1&scp= 1&sq=massachusetts+farmers+market+prescriptions&st=cse .,Non-OADS,/arxiv_data1/oa_pdf/f2/d8/main.PMC4295719.pdf
"Prev Chronic Dis 10, E27(http://www.cdc.gov/pcd/issues/2013/13_0105.htm .",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/main.PMC4295719.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/a3/ijwh-7-085.PMC4295895.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 85–93International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  85orIg Inal researcHopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S7483 2Intention toward the continuation of female  genital mutilation in Bale Zone, ethiopia Daniel Bogale1 Desalegn Markos2 Muhammedawel Kaso1 1Department of Public Health,   2Department of nursing, college  of Medicine and Health sciences,   Madawalabu University, Bale goba,   ethiopiaBackground:  Female genital mutilation (FGM) is a harmful traditional practice that is deeply  rooted in Africa.",Non-OADS,/arxiv_data1/oa_pdf/a4/a3/ijwh-7-085.PMC4295895.pdf
"It is a form of sex inequality  that remains deeply entrenched in the social and economic structures of the countries correspondence: Daniel Bogale Department of Public Health, college  of Medicine and Health sciences,  Madawalabu University, Po Box 302,   Bale goba, ethiopia   Tel +2519 1281 8117 email bogaleodo@gmail.co m Journal name: International Journal of Women’s Health Article Designation: original research Y ear: 2015 Volume: 7 Running head verso: Bogale et al Running head recto: Continuation of FGM in Ethiopia DOI: http://dx.doi.org/10.2147/IJWH.S74832",Non-OADS,/arxiv_data1/oa_pdf/a4/a3/ijwh-7-085.PMC4295895.pdf
Available from: http://dhsprogram.com/pubs/pdf/FR179/ FR179[23June2011].pdf.,Non-OADS,/arxiv_data1/oa_pdf/a4/a3/ijwh-7-085.PMC4295895.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a4/a3/ijwh-7-085.PMC4295895.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/a3/ijwh-7-085.PMC4295895.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/a4/dmso-8-029.PMC4295896.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 29–43Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  29REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S4435 2Psychosocial interventions for the diabetic patient John N Harvey Diabetes Research Group, Wrexham  Academic Unit, Bangor University,   Wrexham, UK Correspondence: John N Harvey   Gladstone Centre, Maelor Hospital,  Wrexham LL13 7TD, UK   Email john.harvey@wales.nhs.u kAbstract:  Diabetes usually requires substantial life-long self-management by the patient.",Non-OADS,/arxiv_data1/oa_pdf/e7/a4/dmso-8-029.PMC4295896.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/e7/a4/dmso-8-029.PMC4295896.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/a4/dmso-8-029.PMC4295896.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCore Evidence 2015:10 11–21Core Evidence Dove press submit your manuscript | www.dovepress.co m Dove press  11REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S5594 4Dulaglutide: an evidence-based review of its  potential in the treatment of type 2 diabetes Krystal L Edwards1 Molly G Minze2 1Ambulatory Care Division,   Department of Pharmacy Practice,   School of Pharmacy, Texas Tech  University Health Sciences Center,   Dallas, TX, USA; 2Ambulatory Care  Division, Department of Pharmacy  Practice, School of Pharmacy, Texas  Tech University Health Sciences  Center, Abilene, TX, USA Correspondence: Krystal L Edwards   Texas Tech University Health Sciences  Center, School of Pharmacy,   4500 S Lancaster Rd, Bldg 7,   Rt #119A, Dallas, TX 75216, USA   Tel +1 214 358 9051   Fax +1 214 372 5020   Email krystal.edwards@ttuhsc.ed uIntroduction:  As the prevalence of type 2 diabetes mellitus (T2DM) is anticipated to  continue to rise worldwide, so too are the treatment options also continuing to expand.",Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
"Available from: http://www.redbook.com/ redbook /.40 Abbreviations:  AwP, average wholesale price; GLP-1 RAs, glucagon-like peptide-1  receptor agonist.",Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
Available from: http://www.idf.,Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
Available from:   https://www.nice.org.uk/guidance/cg8 7.,Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
"Available  from: https://www.iqwig.de/download/A05-23_Executive_Summary_  Evaluation_of_the_therapeutic_benefits_and_harms_of_exenatide.pd f.  Accessed November 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
"Core Evidence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/core-evidence-journa lCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of  drugs throughout their development lifecycle from preclinical to post - launch.",Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
Available from: http://clinicaltrials.gov/show/NCT0176937 8.,Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
Available from: http://clinicaltrials.gov/show/ NCT0164450 0.,Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
Avail - able from: http://clinicaltrials.gov/show/NCT0164858 2.,Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
Available from: http://diatribe.org/issues/59/new-now-next/ 5.,Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
"Available from: http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm071627.pd f.  Accessed June 12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
Available  from: http://clinicaltrials.gov/show/NCT0139495 2.,Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
Available from: http://www.redbook.,Non-OADS,/arxiv_data1/oa_pdf/a3/53/ce-10-011.PMC4295897.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/35/clep-7-065.PMC4295898.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2015:7 65–76Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  65REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S4096 6The clinical epidemiology of male osteoporosis:   a review of the recent literature Tina willson1,2 Scott D Nelson1,2 Jonathan Newbold1 Richard E Nelson2,3 Joanne LaFleur1,2 1University of Utah College of  Pharmacy,  2veterans Affairs Salt Lake  City Health Care System,  3University  of Utah School of Medicine, Salt Lake  City, UT, USA Correspondence: Tina willson   Pharmacotherapy Outcomes Research  Center, University of Utah,  30 South   2000 East, Salt Lake City, UT, USA   Email tina.willson@utah.ed uAbstract:  Osteoporosis, a musculoskeletal disease characterized by decreased bone mineral  density (BMD) and an increased risk of fragility fractures, is now recognized as an important  public health problem in men.",Non-OADS,/arxiv_data1/oa_pdf/b7/35/clep-7-065.PMC4295898.pdf
"Available from: http://nof.org/hcp/clinicians-guid e. Accessed April 11, 2014.39 Copyright © 2010.",Non-OADS,/arxiv_data1/oa_pdf/b7/35/clep-7-065.PMC4295898.pdf
The WHO FRAX ( http://www.shef.ac.uk/FRAX/ index.asp x) has been incorporated into many national and  international screening and treatment guidelines worldwide.,Non-OADS,/arxiv_data1/oa_pdf/b7/35/clep-7-065.PMC4295898.pdf
Available at: http://nof.org/articles/23 6.,Non-OADS,/arxiv_data1/oa_pdf/b7/35/clep-7-065.PMC4295898.pdf
"Available from: http://nof.org/hcp/clinicians-guid e.  Accessed April  11, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b7/35/clep-7-065.PMC4295898.pdf
"Available at: http://www.imf.org/external/data.ht m. Accessed  March  24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b7/35/clep-7-065.PMC4295898.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/b7/35/clep-7-065.PMC4295898.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/8e/vhrm-11-049.PMC4295899.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 49–53Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  49ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S7243 8Validation of two automatic devices for the self- measurement of blood pressure according   to the ansi/aaMi/isO81060-2:2009 guidelines:  the Omron BP765 (HeM-7311-Zsa) and the  Omron BP760n (HeM-7320-Z) Hakuo Takahashi Masamichi Y oshika T oyohiko Y okoi Department of clinical sciences and  laboratory Medicine, Kansai Medical  University, Hirakata Osaka, Japan correspondence: Hakuo Takahashi   Department of clinical sciences and  laboratory Medicine, Kansai Medical  University, shin-machi 2-5-1, Hirakata   Osaka 573-1010, Japan   Tel +81 72 804 2773   Fax +81 72 804 2773   email takahash@hirakata.kmu.ac.j pBackground:  Allowing patients to measure their blood pressure (BP) at home will be the  standard for evaluating the disease state as the process of clinical diagnosis, and it is recognized  as having great clinical utility.",Non-OADS,/arxiv_data1/oa_pdf/56/8e/vhrm-11-049.PMC4295899.pdf
They were trained  by the British Hypertension Society’s online program (http://www.bhsoc.,Non-OADS,/arxiv_data1/oa_pdf/56/8e/vhrm-11-049.PMC4295899.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/56/8e/vhrm-11-049.PMC4295899.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/8e/vhrm-11-049.PMC4295899.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/ed/prbm-8-017.PMC4295900.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 17–25Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  17Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S4473 2The true cost of the economic crisis   on psychological well-being: a review Guido van Hal Medical Sociology and Health   Policy, University of Antwerp,   Antwerp, Belgium Correspondence: Guido van Hal   University of Antwerp, Universiteitsplein  1,  2610 Antwerp, Belgium   Tel +32 3 265 25 20  Fax +32 3 265 28 75  email guido.vanhal@uantwerp.b eAbstract:  The recent economic crisis has led to many negative consequences, not the least  having to do with the mental health and well-being of the populations involved.",Non-OADS,/arxiv_data1/oa_pdf/cb/ed/prbm-8-017.PMC4295900.pdf
Or use: http://dvpr.es/1ICWTU R,Non-OADS,/arxiv_data1/oa_pdf/cb/ed/prbm-8-017.PMC4295900.pdf
"Available from: http://health.thewest.com.au/news/1499/ health-cuts-have-consequences-exper t. Accessed July  22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/cb/ed/prbm-8-017.PMC4295900.pdf
"Available  from: http://www.euro.who.int/en/media-centre/events/events/2013/04/ oslo-conference-on-health-systems-and-the-economic-crisi s. Accessed  July 23, 2014.",Non-OADS,/arxiv_data1/oa_pdf/cb/ed/prbm-8-017.PMC4295900.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/cb/ed/prbm-8-017.PMC4295900.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/cb/ed/prbm-8-017.PMC4295900.pdf
Available from: http://articles.latimes.,Non-OADS,/arxiv_data1/oa_pdf/cb/ed/prbm-8-017.PMC4295900.pdf
Available from:  http://www.euro.who.int/__data/assets/pdf_file/0008/134999/e94837.,OADS,/arxiv_data1/oa_pdf/cb/ed/prbm-8-017.PMC4295900.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/3e/ndt-11-125.PMC4295915.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 125–135Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  125Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5471 0Levomilnacipran for the treatment of major  depressive disorder: a review Gregory M Asnis1,2 Margaret A Henderson2 1Department of Psychiatry  and Behavioral Sciences, Albert  einstein College of Medicine,   2Anxiety and Depression Clinic,   Montefiore Medical Center, Bronx,   New Y ork, NY, USAAbstract:  Levomilnacipran (LVM, Fetzima®) was recently approved by the US Food and Drug  Administration for the treatment of major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/b8/3e/ndt-11-125.PMC4295915.pdf
"Keywords:  levomilnacipran, antidepressant, clinical efficacy, functional impairment Introduction Although antidepressants clearly have been significantly effective in the treatment of  major depressive disorder (MDD),1 they have also been disappointing, in that many  patients fail to respond, only have a partial response, cannot continue treatment due to  intolerable side effects, or relapse despite continuing initially successful antidepressant  treatment.2,3 This was highlighted in the STAR*D (Sequenced Treatment Alterna - tives to Relieve Depression) study in which only approximately 30% of patients had  a remission and 50% had a clinical response (improvement of 50% from baseline)  to a 12- to 14-week course of citalopram, a selective serotonin reuptake inhibitor  (SSRI).2,3 In addition, over 40% of patients had significant side effects.3 Lastly, even  for patients who initially responded to treatment with citalopram, approximately 40%  relapsed within one year of continued treatment.2–4 Thus, there is need for alternative Correspondence: Gregory M Asnis Anxiety and Depression Clinic,  Montefiore Medical Center, 111 East  210th Street, Bronx, New York, NY  10467, USA Tel +1 917 597 9408 Fax +1 718 882 4735 email asnisarts@aol.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Asnis and Henderson Running head recto: Levomilnacipran for major depressive disorder DOI: http://dx.doi.org/10.2147/NDT.S54710",Non-OADS,/arxiv_data1/oa_pdf/b8/3e/ndt-11-125.PMC4295915.pdf
"Available from: http://www.frx.com/pi/fetzima_pi.pd f. Accessed  November 2, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b8/3e/ndt-11-125.PMC4295915.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b8/3e/ndt-11-125.PMC4295915.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/3e/ndt-11-125.PMC4295915.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/e7/opth-9-109.PMC4295916.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 109–114Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  109Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7448 1effect of hemodialysis on visual acuity, intraocular  pressure, and macular thickness in patients  with chronic kidney disease elias Chelala1,2,* ali Dirani1,2,* ali Fadlallah1,2 elise slim1,2 Y oussef abdelmassih1,2 henry Fakhoury3 Patrick Baz1,2 riad Bejjani1,2 1Faculty of Medicine, saint-Joseph  University, 2hôtel-Dieu de France  hospital, saint-Joseph University,   3eye and ear hospital, Beirut, lebanon *These two authors contributed  equally to this workBackground:  The aim of this study was to evaluate the effects of hemodialysis (HD) on visual  acuity, intraocular pressure (IOP), and central foveal thickness (CFT) in patients with chronic  kidney disease.",Non-OADS,/arxiv_data1/oa_pdf/f7/e7/opth-9-109.PMC4295916.pdf
"This study examined the short-term changes in ophthalmologic findings, including  best-corrected visual acuity (BCVA), IOP, and central foveal thickness (CFT) before Correspondence: riad Bejjani saint-Joseph University, Faculty of  Medicine, Campus of Medical sciences,  rue de Damas, BP 11-5076 riad el solh,  Beirut 1107 2180, lebanon Tel +961 1 421 235 Tel +961 1 421 023 email rabejjani@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chelala et al Running head recto: Hemodialysis and ocular parameters in CKD DOI: http://dx.doi.org/10.2147/OPTH.S74481",Non-OADS,/arxiv_data1/oa_pdf/f7/e7/opth-9-109.PMC4295916.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f7/e7/opth-9-109.PMC4295916.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/e7/opth-9-109.PMC4295916.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/7f/ndt-11-107.PMC4295917.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 107–113Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  107OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7482 9association between subjective actual sleep  duration, subjective sleep need, age, body mass  index, and gender in a large sample of young adults Nadeem Kalak1 serge Brand1,2 Johannes Beck1 edith holsboer-Trachsler1 M axel Wollmer1,3 1Psychiatric clinics of the University  of Basel, 2Department of sport  and health science, Division of  sport science, University of Basel,   Basel, switzerland; 3asklepios clinic  North Ochsenzoll, asklepios campus  hamburg, Medical Faculty, semmelweis  University, hamburg, germanyBackground:  Poor sleep is a major health concern, and there is evidence that young adults  are at increased risk of suffering from poor sleep.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/ndt-11-107.PMC4295917.pdf
"In this regard, for example, Lund et al25 showed  that over 60% of people aged 17–24 years suffer from sleep difficulties, along with a  broad range of both physical and psychologic issues.26,27 Previous research in Western countries has shown that nearly 40% of young  adults (aged 18–25 years) are overweight or obese,28 and that obesity emerging during  childhood persists, such that overweight children are at greater risk for weight gain correspondence: Nadeem Kalak Psychiatric clinics of the University of  Basel, center for affective, stress and  sleep Disorder, Wilhelm Klein-strasse  27, ch-4012 Basel, switzerland Tel +41 61 325 5236 Fax +41 61 325 5513 email nadeem.kalak@upkbs.c h Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Kalak et al Running head recto: Sleep among young adults DOI: http://dx.doi.org/10.2147/NDT.S74829",Non-OADS,/arxiv_data1/oa_pdf/70/7f/ndt-11-107.PMC4295917.pdf
"Previous studies comparing Internet-administered ques - tionnaires with paper-and-pencil questionnaires have found  the electronic version to have no relative disadvantages.52–54  Accordingly, commercially available software (Globalpark,  http://www.globalpark.co m) was used for data collection.",OADS,/arxiv_data1/oa_pdf/70/7f/ndt-11-107.PMC4295917.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/ndt-11-107.PMC4295917.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/7f/ndt-11-107.PMC4295917.pdf
THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE147 SPECIAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.4.147 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(4):147-150 What is the position of Clinical  and Experimental  Reproductive Medicine  in its scholarly journal network  based on journal metrics?,Non-OADS,/arxiv_data1/oa_pdf/5c/74/cerm-41-147.PMC4295940.pdf
"Its scope is infer - tility, reproductive endocrinology, urology, andrology, the develop - mental biology of gametes and early embryos, basic reproductive  science, reproductive physiology, reproductive immunology, genet - ics, and biology of stem cells (http://ecerm.org/).",Non-OADS,/arxiv_data1/oa_pdf/5c/74/cerm-41-147.PMC4295940.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/74/cerm-41-147.PMC4295940.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.4.147 Clin Exp Reprod Med 2014;41(4):147-150 148flect upon the effect of the conversion to English publication; there - fore, CERM’s metrics were analyzed here, and the position of the jour - nal in the scholarly journal network was elucidated.",OADS,/arxiv_data1/oa_pdf/5c/74/cerm-41-147.PMC4295940.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.4.147 Clin Exp Reprod Med 2014;41(4):147-150 150small number of articles and short period of exposure to researchers  internationally.,OADS,/arxiv_data1/oa_pdf/5c/74/cerm-41-147.PMC4295940.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE151 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.4.151 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(4):151-157 Association of the neutrophil-to-lymphocyte ratio  and CA 125 with the endometriosis score Seul Ki Kim1,2, Jung Yeon Park3, Byung Chul Jee1,2, Chang Suk Suh1,2, Seok Hyun Kim2,3 1Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam; 2Department of Obstetrics and Gynecology,  Seoul National University College of Medicine, Seoul; 3Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea Objective:  To evaluate the association between the severity of endometriosis and the preoperative neutrophil-to-lymphocyte ratio (NLR) and  serum level of cancer antigen 125 (CA 125).",Non-OADS,/arxiv_data1/oa_pdf/f0/36/cerm-41-151.PMC4295941.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/36/cerm-41-151.PMC4295941.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.4.151 Clin Exp Reprod Med 2014;41(4):151-157 152factor alpha in patients with endometriosis, healthy women, and  women with ovarian cysts [12-15].",Non-OADS,/arxiv_data1/oa_pdf/f0/36/cerm-41-151.PMC4295941.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.4.151 Clin Exp Reprod Med 2014;41(4):151-157 154-0.13, p= 0.021) (Figure 3A).",OADS,/arxiv_data1/oa_pdf/f0/36/cerm-41-151.PMC4295941.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.4.151 Clin Exp Reprod Med 2014;41(4):151-157 156related to the pathophysiology of endometriosis, such as the nuclear  factor kappa light-chain enhancer of activated B cells [34].",Non-OADS,/arxiv_data1/oa_pdf/f0/36/cerm-41-151.PMC4295941.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE158 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.4.158 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(4):158-164 Early gonadotropin-releasing hormone antagonist  start improves follicular synchronization and  pregnancy outcome as compared to the conventional  antagonist protocol Chan Woo Park, Yu Im Hwang, Hwa Seon Koo, Inn Soo Kang, Kwang Moon Yang, In Ok Song Division of Reproductive Endocrinology and Infertility, Department Obstetrics and Gynecology, Cheil General Hospital and Women’s Healthcare Center,  Catholic Kwandong University College of Medicine, Seoul, Korea Objective:  To assess whether an early GnRH antagonist start leads to better follicular synchronization and an improved clinical pregnancy rate  (CPR).",Non-OADS,/arxiv_data1/oa_pdf/09/ec/cerm-41-158.PMC4295942.pdf
"GnRH antagonist cycles Received: Nov 6, 2014 ∙ Revised: Dec 10, 2014 ∙ Accepted: Dec 23, 2014 Corresponding author:  In Ok Song  Division of Reproductive Endocrinology and Infertility, Department Obstetrics  and Gynecology, Cheil General Hospital and Women’s Healthcare Center,  Catholic Kwandong University College of Medicine, 17 Seoae-ro 1-gil, Jung-gu,  Seoul 100-380, Korea Tel: +82-2-2000-7525  Fax: +82-2-2000-7477  E-mail: inok222@naver.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/ec/cerm-41-158.PMC4295942.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.4.158 Clin Exp Reprod Med 2014;41(4):158-164 160terone (P4, Progesterone in oil, Watson Pharmaceuticals Inc., Parsip - pany, NJ, USA) daily, starting on the day of oocyte retrieval, and LPS  was continued for another 6 to 8 weeks when a pregnancy was  achieved.",Non-OADS,/arxiv_data1/oa_pdf/09/ec/cerm-41-158.PMC4295942.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.4.158 Clin Exp Reprod Med 2014;41(4):158-164 162the interphase increase in endogenous FSH secretion.,OADS,/arxiv_data1/oa_pdf/09/ec/cerm-41-158.PMC4295942.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.4.158 Clin Exp Reprod Med 2014;41(4):158-164 164lating hormone dynamics during the luteal-follicular transition.,Non-OADS,/arxiv_data1/oa_pdf/09/ec/cerm-41-158.PMC4295942.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE165 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.4.165 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(4):165-167 Effects of feminine cleanser Inclear on sperm  motility: A prospective study Dong-Wook Park1, Jin Hee An1, Sang Chul Han1, Jongwon Lee2, Hyo Serk Lee3, Ju Tae Seo3 1Laboratory of Reproductive Medicine, Cheil General Hospital and Women’s Healthcare Center, Catholic Kwandong University College of Medicine,  Seoul; 2WeTTrust Korea Co., Ltd., Seongnam; 3Department of Urology, Cheil General Hospital and Women’s Healthcare Center, Catholic Kwandong  University College of Medicine, Seoul, Korea  Objective:  The objective of this study is to estimate the effects of Inclear, a feminine cleanser, on sperm motility.",Non-OADS,/arxiv_data1/oa_pdf/4e/7a/cerm-41-165.PMC4295943.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/7a/cerm-41-165.PMC4295943.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.4.165 Clin Exp Reprod Med 2014;41(4):165-167 166timed intercourse repeatedly on days around ovulation, the fear of  failing at conception, and fertility medications.",Non-OADS,/arxiv_data1/oa_pdf/4e/7a/cerm-41-165.PMC4295943.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE168 CASE REPORT http://dx.doi.org/10.5653/cerm.2014.41.4.168 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(4):168-173 A healthy delivery of twins by assisted reproduction  followed by preimplantation genetic screening in a  woman with X-linked dominant incontinentia  pigmenti Myung Joo Kim1, Sang Woo Lyu1, Hyun Ha Seok1, Ji Eun Park2, Sung Han Shim2*, Tae Ki Yoon1* 1Department of Obstetrics and Gynecology, 2Genetics Laboratory, Fertility Center of CHA Gangnam Medical Center, CHA University College of  Medicine, Seoul, Korea The purpose of this study is to report a successful twin pregnancy and delivery in a female patient with X-linked dominant incontinentia pig - menti (IP) who underwent assisted reproductive technology followed by preimplantation genetic screening (PGS).",Non-OADS,/arxiv_data1/oa_pdf/66/6f/cerm-41-168.PMC4295944.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/6f/cerm-41-168.PMC4295944.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.4.168 Clin Exp Reprod Med 2014;41(4):168-173 170A total of nine oocytes were retrieved after controlled ovarian hy - perstimulation with gonadotrophin-releasing hormone antagonist  protocol (cetrorelix, Cetrotide, Merck Serono Europe Ltd., London,  UK; 0.25 mg) using recombinant follicle-stimulating hormone (re - combinant follitropin alfa; GONAL-f, Merck Serono S.p.A, Modugno,  Italy, 225 IU daily), of which seven were fertilized using the intracyto - plasmic sperm injection procedure.",Non-OADS,/arxiv_data1/oa_pdf/66/6f/cerm-41-168.PMC4295944.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.4.168 Clin Exp Reprod Med 2014;41(4):168-173 172[9,10].",OADS,/arxiv_data1/oa_pdf/66/6f/cerm-41-168.PMC4295944.pdf
Avail - able from:// http://www.orpha.net/orphacom/cahiers/docs/GB/,Non-OADS,/arxiv_data1/oa_pdf/66/6f/cerm-41-168.PMC4295944.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE174 CASE REPORT http://dx.doi.org/10.5653/cerm.2014.41.4.174 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(4):174-177 Uterine infarction in a patient with uterine  adenomyosis following biochemical pregnancy Jae-Yeon Lee1,2, Kyu-Ri Hwang1,2, Kyu-Hee Won1,2, Da-Yong Lee1,2, Hye-Won Jeon1,2, Min-Hwan Moon3 1Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center, Seoul; 2Department of Obstetrics and Gynecology, Seoul National  University College of Medicine, Seoul; 3Department of Radiology, SMG-SNU Boramae Medical Center, Seoul, Korea Adenomyosis is a common gynecological disorder characterized by the presence of endometrial glands and stroma deep within the myome - trium associated with myometrial hypertrophy and hyperplasia.",Non-OADS,/arxiv_data1/oa_pdf/88/ff/cerm-41-174.PMC4295945.pdf
